10-Q 1 a0930201510q.htm 10-Q
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
_________________________
FORM 10-Q
_________________________

x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly Period Ended September 30, 2015
OR

¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number 1-12658
_________________________
ALBEMARLE CORPORATION
(Exact name of registrant as specified in its charter)
_________________________

VIRGINIA |  | 54-1692118
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
451 FLORIDA STREET BATON ROUGE, LOUISIANA |  | 70801
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code - (225) 388-8011
_________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer |  | x |  | Accelerated filer |  | ¨
Non-accelerated filer |  | ¨ |  | Smaller reporting company |  | ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Number of shares of common stock, $.01 par value, outstanding as of October 30, 2015: 112,203,154

Table of Contents
ALBEMARLE CORPORATION
INDEX – FORM 10-Q

|  | Page Number(s)
PART I. | FINANCIAL INFORMATION |
Item 1. | Financial Statements (Unaudited) |
| Consolidated Statements of Income - Three Months and Nine Months Ended September 30, 2015 and 2014 | 3
| Consolidated Statements of Comprehensive Income (Loss) - Three Months and Nine Months Ended September 30, 2015 and 2014 | 4
| Condensed Consolidated Balance Sheets - September 30, 2015 and December 31, 2014 | 5
| Consolidated Statements of Changes in Equity - Nine Months Ended September 30, 2015 and 2014 | 6
| Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2015 and 2014 | 7
| Notes to the Condensed Consolidated Financial Statements | 8-48
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 49-69
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 69
Item 4. | Controls and Procedures | 69
PART II. | OTHER INFORMATION |
Item 1. | Legal Proceedings | 70
Item 1A. | Risk Factors | 70
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 70
Item 6. | Exhibits | 71
SIGNATURES |  | 72
EXHIBITS |  |

2

Table of Contents
PART I. FINANCIAL INFORMATION

Item 1. | Financial Statements (Unaudited).

ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands, Except Per Share Amounts)
(Unaudited)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
Net sales | $ | 905,093 |  |  | $ | 642,418 |  |  | $ | 2,720,982 |  |  | $ | 1,846,982 |
Cost of goods sold | 592,883 |  |  | 436,972 |  |  | 1,849,740 |  |  | 1,238,574 |
Gross profit | 312,210 |  |  | 205,446 |  |  | 871,242 |  |  | 608,408 |
Selling, general and administrative expenses | 137,615 |  |  | 66,012 |  |  | 421,092 |  |  | 211,127 |
Research and development expenses | 25,295 |  |  | 22,407 |  |  | 77,123 |  |  | 66,916 |
Restructuring and other, net | (6,804 | ) |  | 293 |  |  | (6,804 | ) |  | 20,625 |
Acquisition and integration related costs | 42,798 |  |  | 10,261 |  |  | 126,487 |  |  | 15,104 |
Operating profit | 113,306 |  |  | 106,473 |  |  | 253,344 |  |  | 294,636 |
Interest and financing expenses | (32,058 | ) |  | (8,749 | ) |  | (100,986 | ) |  | (26,255 | )
Other income (expenses), net | 466 |  |  | (6,618 | ) |  | 50,964 |  |  | (6,454 | )
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 81,714 |  |  | 91,106 |  |  | 203,322 |  |  | 261,927 |
Income tax expense | 16,892 |  |  | 11,737 |  |  | 48,171 |  |  | 46,700 |
Income from continuing operations before equity in net income of unconsolidated investments | 64,822 |  |  | 79,369 |  |  | 155,151 |  |  | 215,227 |
Equity in net income of unconsolidated investments (net of tax) | 6,050 |  |  | 8,650 |  |  | 22,236 |  |  | 28,200 |
Net income from continuing operations | 70,872 |  |  | 88,019 |  |  | 177,387 |  |  | 243,427 |
Loss from discontinued operations (net of tax) | — |  |  | (6,679 | ) |  | — |  |  | (68,473 | )
Net income | 70,872 |  |  | 81,340 |  |  | 177,387 |  |  | 174,954 |
Net income attributable to noncontrolling interests | (5,480 | ) |  | (8,546 | ) |  | (16,733 | ) |  | (23,130 | )
Net income attributable to Albemarle Corporation | $ | 65,392 |  |  | $ | 72,794 |  |  | $ | 160,654 |  |  | $ | 151,824 |
Basic earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.58 |  |  | $ | 1.02 |  |  | $ | 1.45 |  |  | $ | 2.79 |
Discontinued operations | — |  |  | (0.09 | ) |  | — |  |  | (0.87 | )
| $ | 0.58 |  |  | $ | 0.93 |  |  | $ | 1.45 |  |  | $ | 1.92 |
Diluted earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.58 |  |  | $ | 1.01 |  |  | $ | 1.44 |  |  | $ | 2.78 |
Discontinued operations | — |  |  | (0.08 | ) |  | — |  |  | (0.87 | )
| $ | 0.58 |  |  | $ | 0.93 |  |  | $ | 1.44 |  |  | $ | 1.91 |
Weighted-average common shares outstanding – basic | 112,202 |  |  | 78,244 |  |  | 110,840 |  |  | 78,880 |
Weighted-average common shares outstanding – diluted | 112,544 |  |  | 78,659 |  |  | 111,205 |  |  | 79,287 |
Cash dividends declared per share of common stock | $ | 0.29 |  |  | $ | 0.275 |  |  | $ | 0.87 |  |  | $ | 0.825 |

See accompanying Notes to the Condensed Consolidated Financial Statements.
3

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In Thousands)
(Unaudited)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
Net income | $ | 70,872 |  |  | $ | 81,340 |  |  | $ | 177,387 |  |  | $ | 174,954 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Foreign currency translation | (67,520 | ) |  | (100,318 | ) |  | (365,867 | ) |  | (106,380 | )
Pension and postretirement benefits | 2 |  |  | (147 | ) |  | 6 |  |  | (615 | )
Net investment hedge | (3,407 | ) |  | — |  |  | 39,709 |  |  | — |
Interest rate swap | 527 |  |  | (988 | ) |  | 1,580 |  |  | (11,409 | )
Other | (6 | ) |  | 33 |  |  | 24 |  |  | 105 |
Total other comprehensive loss, net of tax | (70,404 | ) |  | (101,420 | ) |  | (324,548 | ) |  | (118,299 | )
Comprehensive income (loss) | 468 |  |  | (20,080 | ) |  | (147,161 | ) |  | 56,655 |
Comprehensive income attributable to noncontrolling interests | (5,083 | ) |  | (8,421 | ) |  | (16,185 | ) |  | (22,727 | )
Comprehensive income (loss) attributable to Albemarle Corporation | $ | (4,615 | ) |  | $ | (28,501 | ) |  | $ | (163,346 | ) |  | $ | 33,928 |

See accompanying Notes to the Condensed Consolidated Financial Statements.
4

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands)
(Unaudited)

| September 30, |  | December 31,
| 2015 |  | 2014
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 234,490 |  |  | $ | 2,489,768 |
Trade accounts receivable, less allowance for doubtful accounts (2015 – $2,486; 2014 – $1,563) | 618,301 |  |  | 385,212 |
Other accounts receivable | 76,271 |  |  | 49,423 |
Inventories | 629,393 |  |  | 358,361 |
Other current assets | 162,460 |  |  | 66,086 |
Total current assets | 1,720,915 |  |  | 3,348,850 |
Property, plant and equipment, at cost | 4,096,921 |  |  | 2,620,670 |
Less accumulated depreciation and amortization | 1,496,069 |  |  | 1,388,802 |
Net property, plant and equipment | 2,600,852 |  |  | 1,231,868 |
Investments | 453,869 |  |  | 194,042 |
Other assets | 191,349 |  |  | 160,956 |
Goodwill | 2,811,086 |  |  | 243,262 |
Other intangibles, net of amortization | 1,896,993 |  |  | 44,125 |
Total assets | $ | 9,675,064 |  |  | $ | 5,223,103 |
Liabilities And Equity |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 371,649 |  |  | $ | 231,705 |
Accrued expenses | 566,932 |  |  | 166,174 |
Current portion of long-term debt | 284,368 |  |  | 711,096 |
Dividends payable | 32,295 |  |  | 21,458 |
Income taxes payable | 67,304 |  |  | 9,453 |
Total current liabilities | 1,322,548 |  |  | 1,139,886 |
Long-term debt | 3,558,964 |  |  | 2,223,035 |
Postretirement benefits | 55,401 |  |  | 56,424 |
Pension benefits | 451,056 |  |  | 170,534 |
Other noncurrent liabilities | 250,737 |  |  | 87,705 |
Deferred income taxes | 761,844 |  |  | 56,884 |
Commitments and contingencies (Notes 2, 10) |  |  |
Equity: |  |  |
Albemarle Corporation shareholders’ equity: |  |  |
Common stock, $.01 par value, issued and outstanding – 112,202 in 2015 and 78,031 in 2014 | 1,122 |  |  | 780 |
Additional paid-in capital | 2,056,082 |  |  | 10,447 |
Accumulated other comprehensive loss | (386,413 | ) |  | (62,413 | )
Retained earnings | 1,473,698 |  |  | 1,410,651 |
Total Albemarle Corporation shareholders’ equity | 3,144,489 |  |  | 1,359,465 |
Noncontrolling interests | 130,025 |  |  | 129,170 |
Total equity | 3,274,514 |  |  | 1,488,635 |
Total liabilities and equity | $ | 9,675,064 |  |  | $ | 5,223,103 |

See accompanying Notes to the Condensed Consolidated Financial Statements.
5

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)

(In Thousands, Except Share |  |  |  |  |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive (Loss) Income |  | Retained Earnings |  | Total Albemarle Shareholders’ Equity |  | Noncontrolling Interests |  | Total Equity
Common Stock |
Data) |  | Shares |  | Amounts |  |  |  |  |  |
Balance at January 1, 2015 |  | 78,030,524 |  |  | $ | 780 |  |  | $ | 10,447 |  |  | $ | (62,413 | ) |  | $ | 1,410,651 |  |  | $ | 1,359,465 |  |  | $ | 129,170 |  |  | $ | 1,488,635 |
Net income |  |  |  |  |  |  |  |  |  | 160,654 |  |  | 160,654 |  |  | 16,733 |  |  | 177,387 |
Other comprehensive loss |  |  |  |  |  |  |  | (324,000 | ) |  |  |  | (324,000 | ) |  | (548 | ) |  | (324,548 | )
Cash dividends declared |  |  |  |  |  |  |  |  |  | (97,607 | ) |  | (97,607 | ) |  | (23,195 | ) |  | (120,802 | )
Stock-based compensation and other |  |  |  |  |  | 10,473 |  |  |  |  |  |  | 10,473 |  |  |  |  | 10,473 |
Exercise of stock options |  | 10,500 |  |  | — |  |  | 342 |  |  |  |  |  |  | 342 |  |  |  |  | 342 |
Tax benefit related to stock plans |  |  |  |  |  | (170 | ) |  |  |  |  |  | (170 | ) |  |  |  | (170 | )
Issuance of common stock, net |  | 69,166 |  |  | 1 |  |  | (1 | ) |  |  |  |  |  | — |  |  |  |  | — |
Acquisition of Rockwood |  | 34,113,064 |  |  | 341 |  |  | 2,036,209 |  |  |  |  |  |  | 2,036,550 |  |  | 3,022 |  |  | 2,039,572 |
Noncontrolling interest assumed in acquisition of Shanghai Chemetall |  |  |  |  |  |  |  |  |  |  |  | — |  |  | 4,843 |  |  | 4,843 |
Shares withheld for withholding taxes associated with common stock issuances |  | (21,276 | ) |  | — |  |  | (1,218 | ) |  |  |  |  |  | (1,218 | ) |  |  |  | (1,218 | )
Balance at September 30, 2015 |  | 112,201,978 |  |  | $ | 1,122 |  |  | $ | 2,056,082 |  |  | $ | (386,413 | ) |  | $ | 1,473,698 |  |  | $ | 3,144,489 |  |  | $ | 130,025 |  |  | $ | 3,274,514 |
Balance at January 1, 2014 |  | 80,052,842 |  |  | $ | 801 |  |  | $ | 9,957 |  |  | $ | 116,245 |  |  | $ | 1,500,358 |  |  | $ | 1,627,361 |  |  | $ | 115,415 |  |  | $ | 1,742,776 |
Net income |  |  |  |  |  |  |  |  |  | 151,824 |  |  | 151,824 |  |  | 23,130 |  |  | 174,954 |
Other comprehensive loss |  |  |  |  |  |  |  | (117,896 | ) |  |  |  | (117,896 | ) |  | (403 | ) |  | (118,299 | )
Cash dividends declared |  |  |  |  |  |  |  |  |  | (64,905 | ) |  | (64,905 | ) |  | (7,612 | ) |  | (72,517 | )
Stock-based compensation and other |  |  |  |  |  | 10,016 |  |  |  |  |  |  | 10,016 |  |  |  |  | 10,016 |
Exercise of stock options |  | 77,546 |  |  | 1 |  |  | 2,712 |  |  |  |  |  |  | 2,713 |  |  |  |  | 2,713 |
Shares repurchased |  | (1,967,069 | ) |  | (20 | ) |  | (13,321 | ) |  |  |  | (136,659 | ) |  | (150,000 | ) |  |  |  | (150,000 | )
Tax benefit related to stock plans |  |  |  |  |  | 836 |  |  |  |  |  |  | 836 |  |  |  |  | 836 |
Issuance of common stock, net |  | 135,578 |  |  | 1 |  |  | (1 | ) |  |  |  |  |  | — |  |  |  |  | — |
Shares withheld for withholding taxes associated with common stock issuances |  | (50,144 | ) |  | (1 | ) |  | (3,207 | ) |  |  |  |  |  | (3,208 | ) |  |  |  | (3,208 | )
Balance at September 30, 2014 |  | 78,248,753 |  |  | $ | 782 |  |  | $ | 6,992 |  |  | $ | (1,651 | ) |  | $ | 1,450,618 |  |  | $ | 1,456,741 |  |  | $ | 130,530 |  |  | $ | 1,587,271 |

See accompanying Notes to the Condensed Consolidated Financial Statements.
6

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
(Unaudited)

| Nine Months Ended September 30,
| 2015 |  | 2014
Cash and cash equivalents at beginning of year | $ | 2,489,768 |  |  | $ | 477,239 |
Cash flows from operating activities: |  |  |
Net income | 177,387 |  |  | 174,954 |
Adjustments to reconcile net income to cash flows from operating activities: |  |  |
Depreciation and amortization | 200,372 |  |  | 78,344 |
(Gain) loss associated with restructuring and other | (6,804 | ) |  | 6,333 |
Loss on disposal of businesses | — |  |  | 85,515 |
Stock-based compensation | 11,171 |  |  | 10,447 |
Excess tax benefits realized from stock-based compensation arrangements | (59 | ) |  | (836 | )
Equity in net income of unconsolidated investments (net of tax) | (22,236 | ) |  | (28,200 | )
Dividends received from unconsolidated investments and nonmarketable securities | 57,149 |  |  | 37,854 |
Pension and postretirement (benefit) expense | (232 | ) |  | 21,946 |
Pension and postretirement contributions | (16,673 | ) |  | (10,718 | )
Unrealized gain on investments in marketable securities | (597 | ) |  | (525 | )
Deferred income taxes | (53,593 | ) |  | (24,412 | )
Working capital changes | 14,823 |  |  | 89,020 |
Other, net | (43,805 | ) |  | (9,180 | )
Net cash provided by operating activities | 316,903 |  |  | 430,542 |
Cash flows from investing activities: |  |  |
Acquisition of Rockwood, net of cash acquired | (2,051,645 | ) |  | — |
Other acquisitions, net of cash acquired | (48,845 | ) |  | — |
Capital expenditures | (164,568 | ) |  | (76,682 | )
Decrease in restricted cash | 57,550 |  |  | — |
Cash proceeds from divestitures, net | 6,133 |  |  | 104,718 |
Return of capital | 98,000 |  |  | — |
Sales of marketable securities, net | 1,265 |  |  | 943 |
Repayments from (long-term advances to) joint ventures | 2,156 |  |  | (7,499 | )
Net cash (used in) provided by investing activities | (2,099,954 | ) |  | 21,480 |
Cash flows from financing activities: |  |  |
Repayments of long-term debt | (1,332,293 | ) |  | (3,023 | )
Proceeds from borrowings of long-term debt | 1,000,000 |  |  | — |
Repayments of other borrowings, net | (16,854 | ) |  | (23,554 | )
Dividends paid to shareholders | (86,770 | ) |  | (62,827 | )
Dividends paid to noncontrolling interests | (23,195 | ) |  | (7,612 | )
Repurchases of common stock | — |  |  | (150,000 | )
Proceeds from exercise of stock options | 342 |  |  | 2,713 |
Excess tax benefits realized from stock-based compensation arrangements | 59 |  |  | 836 |
Withholding taxes paid on stock-based compensation award distributions | (1,218 | ) |  | (3,208 | )
Debt financing costs | (4,186 | ) |  | (3,074 | )
Other | (3,882 | ) |  | — |
Net cash used in financing activities | (467,997 | ) |  | (249,749 | )
Net effect of foreign exchange on cash and cash equivalents | (4,230 | ) |  | (26,392 | )
(Decrease) increase in cash and cash equivalents | (2,255,278 | ) |  | 175,881 |
Cash and cash equivalents at end of period | $ | 234,490 |  |  | $ | 653,120 |

See accompanying Notes to the Condensed Consolidated Financial Statements.
7

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
NOTE 1—Basis of Presentation:
In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Albemarle Corporation and our wholly-owned, majority-owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our” or “the Company”) contain all adjustments necessary for a fair statement, in all material respects, of our condensed consolidated balance sheets as of September 30, 2015 and December 31, 2014, our consolidated statements of income and consolidated statements of comprehensive income (loss) for the three-month and nine-month periods ended September 30, 2015 and 2014 and our condensed consolidated statements of cash flows and consolidated statements of changes in equity for the nine-month periods ended September 30, 2015 and 2014. All adjustments are of a normal and recurring nature. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014, which was filed with the Securities and Exchange Commission (“SEC”) on March 2, 2015. The December 31, 2014 condensed consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles (“GAAP”) in the United States (“U.S.”). The results of operations for the three-month and nine-month periods ended September 30, 2015 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made to the accompanying consolidated financial statements and the notes thereto to conform to the current presentation.
As described further in Note 2, “Acquisitions,” we completed our acquisition of Rockwood Holdings, Inc. (“Rockwood”) on January 12, 2015. The unaudited condensed consolidated financial statements contained herein include the results of operations of Rockwood, commencing on January 13, 2015.
NOTE 2—Acquisitions:
On July 15, 2014, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) to acquire all the outstanding shares of Rockwood (the “Merger”). On January 12, 2015 (the “Acquisition Closing Date”), we completed the acquisition of Rockwood for a purchase price of approximately $5.7 billion. As a result, Rockwood became a wholly-owned subsidiary of Albemarle. The cash consideration was funded with proceeds from our 2014 Senior Notes, Term Loan, Cash Bridge Facility and February 2014 Credit Agreement, each of which is more fully described in Item 8 Financial Statements and Supplementary Data—Note 13, “Long-Term Debt,” in our Annual Report on Form 10-K for the year ended December 31, 2014. The fair value of the equity consideration was based on the closing price of Albemarle’s common stock on the Acquisition Closing Date of $59.70 per share, as reported on the New York Stock Exchange.
Pursuant to the Merger Agreement, at the Acquisition Closing Date each issued and outstanding share of Rockwood common stock, par value $0.01 per share, (other than shares owned directly or indirectly by Albemarle, Rockwood or the Merger Sub, as defined in the Merger Agreement, and Appraisal Shares as defined in the Merger Agreement) was canceled and extinguished and converted into the right to receive (i) $50.65 in cash, without interest, and (ii) 0.4803 of a share of Albemarle common stock, par value $0.01 per share, (the “Merger Consideration”). Pursuant to the Merger Agreement, equity awards relating to shares of Rockwood’s common stock were canceled and converted into the right to receive the cash value of the Merger Consideration. On the Acquisition Closing Date, we issued approximately 34.1 million shares of Albemarle common stock.
Subsequent to the acquisition of Rockwood, Albemarle continues to be a leading global developer, manufacturer and marketer of technologically advanced and high value-added specialty chemicals. We are a leading integrated and low cost global producer of lithium and lithium compounds used in lithium ion batteries for electronic devices, alternative transportation vehicles and energy storage technologies, meeting the significant growth in global demand for these products. We are also one of the largest global producers of surface treatments and coatings for metal processing, servicing the automotive, aerospace and general industrial markets.
Included in Net sales and Net income attributable to Albemarle Corporation for the three-month period ended September 30, 2015 is approximately $359.8 million and $18.2 million, respectively, attributable to the businesses acquired from Rockwood. Included in Net sales and Net income attributable to Albemarle Corporation for the nine-month period ended September 30, 2015 is approximately $1.1 billion and $43.9 million, respectively, attributable to the businesses acquired from Rockwood.
Our consolidated statements of income for the three-month and nine-month periods ended September 30, 2015 include $41.8 million and $120.5 million, respectively, of acquisition and integration related costs directly related to the acquisition of Rockwood (mainly consisting of advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and
8

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
$1.0 million and $6.0 million, respectively, of costs in connection with other significant projects. Acquisition and integration related costs directly related to the acquisition of Rockwood were $9.3 million during the three months and nine months ended September 30, 2014. Acquisition and integration related costs in connection with other significant projects were $1.0 million and $5.8 million during the three-month and nine-month periods ended September 30, 2014, respectively.
Preliminary Purchase Price Allocation
The aggregate purchase price noted above was allocated to the major categories of assets and liabilities acquired based upon their estimated fair values at the Acquisition Closing Date, which were based, in part, upon outside preliminary appraisals for certain assets, including specifically-identified intangible assets. The excess of the purchase price over the preliminary estimated fair value of the net assets acquired was approximately $2.7 billion and was recorded as goodwill.
The following table summarizes the consideration paid for Rockwood and the amounts of the assets acquired and liabilities assumed as of the acquisition date, which have been allocated on a preliminary basis (in thousands):

Purchase price: |
Cash paid | $ | 3,606,784 |
Shares issued | 2,036,550 |
Appraisal shares | 74,934 |
Total purchase price | $ | 5,718,268 |
Net assets acquired: |
Cash and cash equivalents | $ | 1,555,139 |
Trade and other accounts receivable | 262,947 |
Inventories | 292,503 |
Other current assets | 86,267 |
Property, plant and equipment | 1,395,684 |
Investments | 529,453 |
Other assets | 28,386 |
Definite-lived intangible assets: |
Patents and technology | 227,840 |
Trade names and trademarks | 258,740 |
Customer lists and relationships | 1,319,060 |
Indefinite-lived intangible assets: |
Trade names and trademarks | 104,380 |
Other | 27,450 |
Current liabilities | (409,799 | )
Long-term debt | (1,319,132 | )
Pension benefits | (316,086 | )
Other noncurrent liabilities | (168,435 | )
Deferred income taxes | (830,572 | )
Noncontrolling interests | (3,022 | )
Total identifiable net assets | 3,040,803 |
Goodwill | 2,677,465 |
Total net assets acquired | $ | 5,718,268 |

The allocation of the purchase price to the assets acquired and liabilities assumed, including the residual amount allocated to goodwill, is based upon preliminary information and is subject to change within the measurement period (up to one year from the acquisition date) as additional information concerning final asset and liability valuations is obtained. Significant changes in our purchase price allocation since our initial preliminary estimates reported in the first quarter of 2015 were primarily related to decreases in the estimated fair values of certain current assets, property, plant and equipment, investments,
9

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
intangible assets, current liabilities and deferred income taxes, which resulted in an increase to recognized goodwill of approximately $52.6 million. The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the fair value of property, plant and equipment, investments, intangible assets, environmental liabilities, appraisal shares, legal reserves, contingent liabilities, deferred income taxes and other assets and liabilities. The fair values of the assets acquired and liabilities assumed are based on management’s preliminary estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. While the Company believes that such preliminary estimates provide a reasonable basis for estimating the fair value of assets acquired and liabilities assumed, it will evaluate any necessary information prior to finalization of the amounts. During the measurement-period, the Company will adjust assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in revised estimated values of those assets or liabilities as of that date. The effect of measurement-period adjustments to the estimated fair values will be reflected as if the adjustments had been completed on the acquisition date. The impact of all changes that do not qualify as measurement-period adjustments will be included in current period earnings. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the consolidated financial statements could be subject to a possible impairment of the intangible assets or goodwill, or require acceleration of the amortization of intangible assets in subsequent periods.
Goodwill arising from the acquisition consists largely of the anticipated synergies and economies of scale from the combined companies and the overall strategic importance of the acquired businesses to Albemarle. The goodwill attributable to the acquisition will not be amortizable or deductible for tax purposes.
The weighted-average amortization periods for the intangible assets acquired are 17 years for patents and technology, 20 years for trade names and trademarks and 24 years for customer lists and relationships. The weighted-average amortization period for all definite-lived intangible assets acquired is 23 years.
Long-term debt assumed primarily includes Rockwood’s 4.625% senior notes with an aggregate principal amount of $1.25 billion and a fair value adjustment of approximately $43.7 million related to the senior notes. The fair value adjustment was based primarily on reported market values using Level 1 inputs.
As discussed further in Note 18, “Recently Issued Accounting Pronouncements,” in the third quarter of 2015 the Company early-adopted new accounting guidance that changes the reporting requirements for measurement-period adjustments that occur in periods after a business combination is consummated. There were no significant measurement-period adjustments recorded in the consolidated statement of income for the three-months ended September 30, 2015 that related to previous reporting periods.
Unaudited Pro Forma Financial Information
The following unaudited pro forma results of operations of the Company for the three-month and nine-month periods ended September 30, 2015 and 2014 assume that the Merger occurred on January 1, 2014. The pro forma amounts include certain adjustments, including interest expense, depreciation, amortization expense and income taxes. Pro forma amounts were adjusted to include these costs. The pro forma amounts for the three-month and nine-month periods ended September 30, 2015 were adjusted to exclude approximately $41.8 million and $120.5 million, respectively, of nonrecurring acquisition and integration related costs, and approximately $16.8 million and $102.3 million, respectively, of charges related to the utilization of the inventory markup as further described in Note 11, “Segment Information.” The pro forma results do not include adjustments related to cost savings or other synergies that are anticipated as a result of the Merger. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred as of January 1, 2014, nor are they indicative of future results of operations.
10

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
| (in thousands, except per share amounts)
Pro forma Net sales | $ | 905,093 |  |  | $ | 998,718 |  |  | $ | 2,754,312 |  |  | $ | 2,920,082 |
Pro forma Net income from continuing operations | $ | 111,211 |  |  | $ | 143,675 |  |  | $ | 335,602 |  |  | $ | 316,238 |
Pro forma Net income from continuing operations per share: |  |  |  |  |  |  |
Basic | $ | 0.99 |  |  | $ | 1.28 |  |  | $ | 3.03 |  |  | $ | 2.79 |
Diluted | $ | 0.99 |  |  | $ | 1.27 |  |  | $ | 3.02 |  |  | $ | 2.76 |

Litigation Related to the Merger
On February 19, 2015, Verition Multi-Strategy Master Fund Ltd. and Verition Partners Master Fund Ltd, who collectively owned approximately 882,000 shares of Rockwood common stock immediately prior to the Merger, commenced an action in the Delaware Chancery Court seeking appraisal of their shares of Rockwood common stock pursuant to Delaware General Corporation Law § 262. These shareholders exercised their right not to receive the Merger Consideration for each share of Rockwood common stock owned by such shareholders. Following the Merger, these shareholders ceased to have any rights with respect to their Rockwood shares, except for their rights to seek an appraisal of the cash value of their Rockwood shares under Delaware law. On March 16, 2015, Albemarle, on behalf of Rockwood, filed an Answer and Verified List in response to the appraisal petition. On November 2, 2015, the court granted the parties’ jointly stipulated amended scheduling order, which set forth dates for fact and expert discovery, as well as trial. Fact discovery has commenced and remains ongoing, and the Court has set a date of June 27, 2016 for trial on the merits. While Albemarle intends to vigorously defend against this action, the outcome of the appraisal process cannot be predicted with any certainty at this time. Included in Accrued expenses in our condensed consolidated balance sheet at September 30, 2015 is an estimated liability of $74.9 million in connection with this portion of the Merger Consideration. The fair value of the liability was considered a Level 2 measurement as the value was based on inputs other than quoted prices that are observable for the liability.
Acquisition of Remaining Interest in Shanghai Chemetall Chemicals Co., Ltd.
On January 29, 2015, we acquired the remaining 40% interest in Shanghai Chemetall Chemicals Co., Ltd., (“Shanghai Chemetall”) for approximately $57.6 million ($45.6 million net of cash acquired), the proceeds of which came from the release of restricted cash acquired from Rockwood at closing. As of the acquisition date, Shanghai Chemetall became a wholly-owned subsidiary of Albemarle and is being consolidated into the Chemetall® Surface Treatment segment. The purchase price and the fair value of our equity interest immediately before the date of acquisition (approximately $60 million), as well as the fair value of the noncontrolling interest in Nanjing Chemetall Surface Technologies Co., Ltd., have been allocated to the net assets acquired at the acquisition date. The purchase price allocation, including the residual amount allocated to goodwill, is preliminary and subject to change based on the finalization of the valuation of assets and liabilities and the fair value of the previously held equity investment.
11

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 3—Goodwill and Other Intangibles:
The following table summarizes the changes in goodwill by reportable segment for the nine months ended September 30, 2015 (in thousands):

Balance at December 31, 2014 | $ | 243,262 |
Acquisition of Rockwood | 2,677,465 |
Other acquisitions(a) | 9,275 |
Foreign currency translation adjustments | (118,916 | )
Balance at September 30, 2015 | $ | 2,811,086 |

(a) | Primarily relates to the acquisition of the remaining interest in Shanghai Chemetall. See Note 2, “Acquisitions.”

The following table summarizes the changes in other intangibles and related accumulated amortization for the nine months ended September 30, 2015 (in thousands):

| Customer Lists and Relationships |  | Trade Names and Trademarks |  | Patents and Technology |  | Other |  | Total
Gross Asset Value |  |  |  |  |  |  |  |  |
Balance at December 31, 2014 | $ | 48,479 |  |  | $ | 17,555 |  |  | $ | 40,398 |  |  | $ | 23,441 |  |  | $ | 129,873 |
Acquisition of Rockwood | 1,319,060 |  |  | 363,120 |  |  | 227,840 |  |  | 27,450 |  |  | 1,937,470 |
Other acquisitions(a) | 76,940 |  |  | — |  |  | 1,433 |  |  | 73 |  |  | 78,446 |
Foreign currency translation adjustments and other | (74,388 | ) |  | (17,722 | ) |  | (10,735 | ) |  | (1,917 | ) |  | (104,762 | )
Balance at September 30, 2015 | $ | 1,370,091 |  |  | $ | 362,953 |  |  | $ | 258,936 |  |  | $ | 49,047 |  |  | $ | 2,041,027 |
Accumulated Amortization |  |  |  |  |  |  |  |  |
Balance at December 31, 2014 | $ | (22,931 | ) |  | $ | (7,912 | ) |  | $ | (32,831 | ) |  | $ | (22,074 | ) |  | $ | (85,748 | )
Amortization | (41,796 | ) |  | (9,216 | ) |  | (10,157 | ) |  | (365 | ) |  | (61,534 | )
Foreign currency translation adjustments and other | 1,482 |  |  | 139 |  |  | 1,102 |  |  | 525 |  |  | 3,248 |
Balance at September 30, 2015 | $ | (63,245 | ) |  | $ | (16,989 | ) |  | $ | (41,886 | ) |  | $ | (21,914 | ) |  | $ | (144,034 | )
Net Book Value at December 31, 2014 | $ | 25,548 |  |  | $ | 9,643 |  |  | $ | 7,567 |  |  | $ | 1,367 |  |  | $ | 44,125 |
Net Book Value at September 30, 2015 | $ | 1,306,846 |  |  | $ | 345,964 |  |  | $ | 217,050 |  |  | $ | 27,133 |  |  | $ | 1,896,993 |

(a) | Primarily relates to the acquisition of the remaining interest in Shanghai Chemetall. See Note 2, “Acquisitions.”

Total estimated amortization expense of other intangibles acquired in the Rockwood acquisition for the next five years is as follows (in thousands):

| Estimated Amortization Expense
Remainder of 2015 | $ | 20,588 |
2016 | $ | 82,350 |
2017 | $ | 82,350 |
2018 | $ | 82,350 |
2019 | $ | 82,350 |

As discussed in Note 2, “Acquisitions,” amounts of goodwill and other intangibles recorded in connection with the Rockwood and Shanghai Chemetall acquisitions are preliminary. Additionally, the preliminary allocation of goodwill and identifiable assets to our reportable segments has not been completed as of the date the financial statements have been issued.
12

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 4—Foreign Exchange:
Foreign exchange transaction (losses) gains were $(1.2) million and $51.8 million for the three-month and nine-month periods ended September 30, 2015, respectively, and $(0.8) million and $(2.1) million for the three-month and nine-month periods ended September 30, 2014, respectively, and are included in Other income (expenses), net, in our consolidated statements of income, with the unrealized portion included in Other, net, in our condensed consolidated statements of cash flows. The gains in the nine month period ended September 30, 2015 are primarily related to cash denominated in U.S. Dollars held by foreign subsidiaries where the European Union Euro serves as the functional currency.
NOTE 5—Income Taxes:
The effective income tax rate for the three-month and nine-month periods ended September 30, 2015 was 20.7% and 23.7%, respectively, compared to 12.9% and 17.8% for the three-month and nine-month periods ended September 30, 2014, respectively. The Company’s effective income tax rate fluctuates based on, among other factors, our level and location of income. The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the 2015 and 2014 periods is mainly due to the impact of earnings from outside the U.S. The increase in the effective tax rates for the three-month and nine-month periods ended September 30, 2015 compared to the same periods in 2014 is primarily driven by the Rockwood acquisition, which caused a reduction in various benefits in our effective tax rate. Our effective income tax rate for the nine-month period ended September 30, 2015 was also affected by discrete net tax expense items of $2.9 million related mainly to prior year uncertain tax position adjustments associated with lapses in statutes of limitations, items associated with U.S. provision to return adjustments, and the OPEB plan termination gain described in Note 12, “Pension Plans and Other Postretirement Benefits.” Our effective income tax rate for the three-month period ended September 30, 2014 was also impacted by discrete net tax benefit items of $3.2 million, related principally to the expiration of the U.S. federal statute of limitations and a pension plan actuarial loss that was recorded in the period. Our effective income tax rate for the nine-month period ended September 30, 2014 was also affected by tax benefits of $14.7 million related to restructuring charges, a pension plan actuarial loss and the release of reserves related principally to the expiration of the U.S. federal statute of limitations that occurred in such period.
Included in Other current assets in our condensed consolidated balance sheets for the periods ended September 30, 2015 and December 31, 2014 are income tax receivables of $93.1 million and $22.8 million, respectively.
Based on management’s continued evaluation of uncertain tax positions acquired in the Rockwood transaction and the progress of various tax audits and other tax matters, the Company believes that it is reasonably possible that a material change in its uncertain tax positions, which is not currently estimable, could occur within twelve months of the reporting date.
13

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 6—Earnings Per Share:
Basic and diluted earnings per share from continuing operations for the three-month and nine-month periods ended September 30, 2015 and 2014 are calculated as follows:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
| (In thousands, except per share amounts)
Basic earnings per share from continuing operations |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income from continuing operations | $ | 70,872 |  |  | $ | 88,019 |  |  | $ | 177,387 |  |  | $ | 243,427 |
Net income from continuing operations attributable to noncontrolling interests | (5,480 | ) |  | (8,546 | ) |  | (16,733 | ) |  | (23,130 | )
Net income from continuing operations attributable to Albemarle Corporation | $ | 65,392 |  |  | $ | 79,473 |  |  | $ | 160,654 |  |  | $ | 220,297 |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares for basic earnings per share(a) | 112,202 |  |  | 78,244 |  |  | 110,840 |  |  | 78,880 |
Basic earnings per share from continuing operations | $ | 0.58 |  |  | $ | 1.02 |  |  | $ | 1.45 |  |  | $ | 2.79 |
Diluted earnings per share from continuing operations |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income from continuing operations | $ | 70,872 |  |  | $ | 88,019 |  |  | $ | 177,387 |  |  | $ | 243,427 |
Net income from continuing operations attributable to noncontrolling interests | (5,480 | ) |  | (8,546 | ) |  | (16,733 | ) |  | (23,130 | )
Net income from continuing operations attributable to Albemarle Corporation | $ | 65,392 |  |  | $ | 79,473 |  |  | $ | 160,654 |  |  | $ | 220,297 |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares for basic earnings per share(a) | 112,202 |  |  | 78,244 |  |  | 110,840 |  |  | 78,880 |
Incremental shares under stock compensation plans | 342 |  |  | 415 |  |  | 365 |  |  | 407 |
Weighted-average common shares for diluted earnings per share(a) | 112,544 |  |  | 78,659 |  |  | 111,205 |  |  | 79,287 |
Diluted earnings per share from continuing operations | $ | 0.58 |  |  | $ | 1.01 |  |  | $ | 1.44 |  |  | $ | 2.78 |

(a) | 2015 includes the impact of 34,113 shares issued in connection with the Rockwood acquisition.

On February 24, 2015, the Company increased the regular quarterly dividend by 5% to $0.29 per share. On July 9, 2015, the Company declared a cash dividend of $0.29 per share, which was paid on October 1, 2015 to shareholders of record at the close of business as of September 16, 2015. On October 5, 2015, the Company declared a cash dividend of $0.29 per share, which is payable on January 4, 2016 to shareholders of record at the close of business as of December 15, 2015.
NOTE 7—Inventories:
The following table provides a breakdown of inventories at September 30, 2015 and December 31, 2014:

| September 30, |  | December 31,
| 2015 |  | 2014
| (In thousands)
Finished goods | $ | 414,607 |  |  | $ | 262,769 |
Raw materials | 113,687 |  |  | 53,152 |
Work in process | 45,140 |  |  | — |
Stores, supplies and other | 55,959 |  |  | 42,440 |
Total inventories | $ | 629,393 |  |  | $ | 358,361 |

14

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 8—Investments:
The Company holds a 49% equity interest in Talison Lithium Pty. Ltd. (“Talison”), which we acquired in the Rockwood acquisition. With regards to the Company’s ownership in Talison, the parties share risks and benefits disproportionate to their voting interests. As a result, the Company considers Talison to be a variable interest entity (“VIE”). However, the Company does not consolidate Talison as it is not the primary beneficiary. The carrying amount of our 49% equity interest in Talison, which is our most significant VIE, was $263.7 million at September 30, 2015. The Company’s aggregate net investment in all other entities which it considers to be VIE’s for which the Company is not the primary beneficiary was $27.0 million and $6.2 million at September 30, 2015 and December 31, 2014, respectively. Our unconsolidated VIE’s are reported in Investments in the condensed consolidated balance sheets. The Company does not guarantee debt for, or have other financial support obligations to, these entities, and its maximum exposure to loss in connection with its continuing involvement with these entities is limited to the carrying value of the investments.
Included in the condensed consolidated statement of cash flows for the nine months ended September 30, 2015, is a return of capital from Talison of $98.0 million.
NOTE 9—Long-Term Debt:
Long-term debt at September 30, 2015 and December 31, 2014 consisted of the following:

| September 30, |  | December 31,
| 2015 |  | 2014
| (In thousands)
1.875% Senior notes, net of unamortized discount of $5,449 at September 30, 2015 and $6,605 at December 31, 2014 | $ | 781,701 |  |  | $ | 844,315 |
3.00% Senior notes, net of unamortized discount of $260 at September 30, 2015 and $306 at December 31, 2014 | 249,740 |  |  | 249,694 |
4.15% Senior notes, net of unamortized discount of $1,330 at September 30, 2015 and $1,439 at December 31, 2014 | 423,670 |  |  | 423,561 |
4.50% Senior notes, net of unamortized discount of $1,636 at September 30, 2015 and $1,871 at December 31, 2014 | 348,364 |  |  | 348,129 |
4.625% Senior notes, including unamortized premium of $38,303 at September 30, 2015 | 1,287,643 |  |  | — |
5.10% Senior notes, net of unamortized discount of $3 at December 31, 2014 | — |  |  | 324,997 |
5.45% Senior notes, net of unamortized discount of $1,003 at September 30, 2015 and $1,029 at December 31, 2014 | 348,997 |  |  | 348,971 |
Commercial paper notes | 272,950 |  |  | 367,178 |
Fixed-rate foreign borrowings | 4,069 |  |  | 1,958 |
Variable-rate foreign bank loans | 86,534 |  |  | 25,139 |
Variable-rate domestic bank loans | 18,210 |  |  | — |
Capital lease obligations | 21,373 |  |  | — |
Miscellaneous | 81 |  |  | 189 |
Total long-term debt | 3,843,332 |  |  | 2,934,131 |
Less amounts due within one year | 284,368 |  |  | 711,096 |
Long-term debt, less current portion | $ | 3,558,964 |  |  | $ | 2,223,035 |

The cash consideration paid in connection with the acquisition of Rockwood was funded with proceeds from senior notes we issued in 2014 (the “2014 Senior Notes”) and borrowings in January 2015 consisting of the following: (a) $1.0 billion under our August 15, 2014 term loan credit agreement (the “August 2014 Term Loan Agreement”); (b) $800.0 million under a senior unsecured cash bridge facility (the “Cash Bridge Facility”); and (c) $250.0 million under our revolving credit agreement (the “February 2014 Credit Agreement”). In the first quarter of 2015, amounts borrowed under the August 2014 Term Loan Agreement, Cash Bridge Facility and February 2014 Credit Agreement in connection with the Rockwood acquisition were repaid in full. Such repayments were made with a combination of existing cash, cash acquired from Rockwood, cash from operations and borrowings under our commercial paper program. For further details about the 2014 Senior Notes, August 2014 Term Loan Agreement, Cash Bridge Facility and the February 2014 Credit Agreement, see Item 8 Financial Statements and Supplementary Data—Note 13, “Long-Term Debt,” in our Annual Report on Form 10-K for the year ended December 31, 2014.
15

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Upon completion of the Rockwood acquisition, we assumed Rockwood’s senior notes with an aggregate principal amount of $1.25 billion. These senior notes bore interest at a rate of 4.625% payable semi-annually on April 15 and October 15 of each year, and had a scheduled maturity of October 15, 2020. At September 30, 2015, the carrying amount of the 4.625% senior notes included an unamortized premium of $38.3 million, which resulted from an adjustment to fair value upon our assumption of the notes from Rockwood. The effective interest rate of the notes was approximately 3.95%.
Under the terms of the indenture governing the 4.625% senior notes, as amended and supplemented, on October 15, 2015, our wholly-owned subsidiary, Rockwood Specialties Group, Inc., redeemed all of the outstanding 4.625% senior notes at a redemption price equal to 103.469% of the principal amount of the notes, representing a premium of $43.3 million, plus accrued and unpaid interest to the redemption date. The guarantees of the 4.625% senior notes and the 2014 Senior Notes, as more fully described in Note 19, “Consolidating Guarantor Financial Information,” were released upon repayment of the 4.625% senior notes. We expect to recognize a loss on early extinguishment of the 4.625% senior notes of approximately $5.4 million in the fourth quarter of 2015.
The 4.625% senior notes were repaid with proceeds from a new term loan agreement the Company entered into with JPMorgan Chase Bank, N.A. (the “Administrative Agent”) and certain other lenders on September 14, 2015 (the “September 2015 Term Loan Agreement”). Initial borrowings under the September 2015 Term Loan Agreement, which occurred on October 15, 2015, consisted of a 364-day term loan facility in an aggregate principal amount of $300 million (the “364-Day Facility”) and a five-year term loan facility in an aggregate principal amount of $950 million (the “Five-Year Facility”). Borrowings under the facilities bear interest equal to, at the option of the Company: (a) the London Inter-Bank Offered Rate (“LIBOR”) plus a margin ranging from 1.000% to 1.875% per annum depending upon the long-term, unsecured, senior, non-credit enhanced debt rating of the Company, or (b) a base rate (defined as the highest of (i) the Federal Funds Rate plus 0.50%; (ii) the rate of interest in effect for such day as publicly announced from time to time by the Administrative Agent as its “prime rate”; or (iii) one-month LIBOR plus 1.00%) plus a margin of 0.000% to 0.875% per annum depending upon the long-term, unsecured, senior, non-credit enhanced debt rating of the Company. As of October 15, 2015, the date of initial funding, the interest rate on both facilities was LIBOR plus 1.375%.
Borrowings under the 364-Day Facility are required to be repaid 364 days after initial funding. Borrowings under the Five-Year Facility are required to be repaid in equal quarterly installments on the last business day of each of March, June, September and December, beginning with September 30, 2016, and ending with the last such day to occur prior to the fifth anniversary after initial funding (each a “Payment Date”), in an aggregate principal amount equal to (a) in the case of each Payment Date occurring on or after the first anniversary and prior to the second anniversary of initial funding, 1.25% of the aggregate principal amount of such loans, and (b) in the case of each Payment Date occurring on or after the second anniversary of initial funding, equal to 2.5% of the aggregate principal amount of such loans. On the fifth anniversary after initial funding, any remaining amounts outstanding under the Five-Year Facility become due and payable. Additionally, the agreement requires that proceeds from the Company’s previously announced intended divestitures of its Minerals, Fine Chemistry Services and Metal Sulfides businesses must be used to repay amounts outstanding under the September 2015 Term Loan Agreement. Borrowings under the September 2015 Term Loan Agreement are subject to customary affirmative and negative covenants, including a maximum leverage ratio requirement that is aligned with the maximum leverage ratio requirement of our February 2014 Credit Agreement.
Our $325.0 million aggregate principal amount of senior notes, which were issued on January 20, 2005 and bore interest at a rate of 5.10%, matured and were repaid on February 1, 2015. These senior notes were classified as Current portion of long-term debt in the condensed consolidated balance sheet at December 31, 2014.
Current portion of long-term debt at September 30, 2015 consists primarily of commercial paper notes with a weighted-average interest rate of approximately 0.84% and a weighted-average maturity of 21 days.
On September 14, 2015, certain amendments were made to the February 2014 Credit Agreement which include the following, among other things: (a) an extension of the maturity date to February 7, 2020 from February 7, 2019; (b) with regard to the borrowing rate, the margin over LIBOR, previously ranging from 0.900% to 1.500%, will now range from 1.000% to 1.700%; and (c) the Company’s credit rating as determined by Fitch Ratings will now be considered in the determination of the applicable margin over LIBOR.
The carrying value of our 1.875% Euro-denominated senior notes has been designated as an effective hedge of our net investment in foreign subsidiaries where the Euro serves as the functional currency, and gains or losses on the revaluation of these senior notes to our reporting currency are recorded in accumulated other comprehensive loss. During the three-month and nine-month periods ended September 30, 2015, (losses) gains of $(3.4) million and $39.7 million (net of income taxes),
16

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
respectively, were recorded in accumulated other comprehensive loss in connection with the revaluation of these senior notes to our reporting currency.
During the nine months ended September 30, 2015, we expensed the remaining $2.3 million of structuring and underwriting fees paid in 2014 for bridge financing arrangements in connection with the Rockwood acquisition. This amount is included in Other income (expenses), net, in our consolidated statement of income for the nine months ended September 30, 2015. Also, during the nine months ended September 30, 2015, we paid approximately $4.2 million of debt financing costs primarily related to the 2014 Senior Notes, the September 2015 Term Loan, and amendments to the February 2014 Credit Agreement.
NOTE 10—Commitments and Contingencies:
In connection with the closing of the Rockwood acquisition on January 12, 2015, we have become liable for both recorded and unrecorded contingencies of Rockwood. We are not aware of any unrecorded contingencies assumed in connection with the Rockwood acquisition whose ultimate outcome will have a material adverse effect on our consolidated results of operations, financial condition or cash flows on an annual basis, although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period. We believe that amounts recorded are adequate for known items which might become due in the current year.
Environmental
We had the following activity in our recorded environmental liabilities for the nine months ended September 30, 2015, as follows (in thousands):

Beginning balance at December 31, 2014 | $ | 9,235 |
Expenditures | (2,526 | )
Acquisition of Rockwood | 35,367 |
Divestitures | (1,826 | )
Accretion of discount | 710 |
Revisions of estimates | 9 |
Foreign currency translation adjustments | (1,628 | )
Ending balance at September 30, 2015 | 39,341 |
Less amounts reported in Accrued expenses | 3,085 |
Amounts reported in Other noncurrent liabilities | $ | 36,256 |

As part of the Rockwood acquisition, we assumed $35.4 million of environmental remediation liabilities globally, the majority of which relate to sites in Germany and the U.S. where the Company is currently operating groundwater monitoring and/or remediation systems. For certain locations where the Company is operating these groundwater monitoring and/or remediation systems, prior owners or insurers have assumed all or most of the responsibility. Environmental remediation liabilities assumed as part of the Rockwood acquisition includes discounted liabilities of $25.7 million, discounted at rates ranging from 2.8% to 4.3%, with the undiscounted amount totaling $43.9 million.
The amounts recorded represent our future remediation and other anticipated environmental liabilities. These liabilities typically arise during the normal course of our operational and environmental management activities or at the time of acquisition of the site, and are based on internal analysis as well as input from outside consultants. As evaluations proceed at each relevant site, changes in risk assessment practices, remediation techniques and regulatory requirements can occur, therefore such liability estimates may be adjusted accordingly. The timing and duration of remediation activities at these sites will be determined when evaluations are completed. Although it is difficult to quantify the potential financial impact of these remediation liabilities, management estimates (based on the latest available information) that there is a reasonable possibility that future environmental remediation costs associated with our past operations, in excess of amounts already recorded, could be up to approximately $22 million before income taxes.
We believe that any sum we may be required to pay in connection with environmental remediation matters in excess of the amounts recorded would likely occur over a period of time and would likely not have a material adverse effect upon our results of operations, financial condition or cash flows on a consolidated annual basis although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period.
17

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Asset Retirement Obligations
The following is a summary of the activity in our asset retirement obligations for the nine months ended September 30, 2015 (in thousands):

Beginning balance at December 31, 2014 | $ | 15,085 |
Acquisition of Rockwood | 17,265 |
Liabilities incurred | 1,025 |
Accretion of discount | 932 |
Foreign currency translation adjustments | (34 | )
Ending balance at September 30, 2015 | $ | 34,273 |

Our asset retirement obligations are recorded in Other noncurrent liabilities in the condensed consolidated balance sheets. Asset retirement obligations assumed through the acquisition of Rockwood primarily relate to post-closure reclamation of sites involved in the surface mining and manufacturing of lithium.
Litigation
We are involved from time to time in legal proceedings of types regarded as common in our business, including administrative or judicial proceedings seeking remediation under environmental laws, such as the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund, products liability, breach of contract liability and premises liability litigation. Where appropriate, we may establish financial reserves for such proceedings. We also maintain insurance to mitigate certain of such risks. Costs for legal services are generally expensed as incurred.
Indemnities
We are indemnified by third parties in connection with certain matters related to acquired and divested businesses. Although we believe that the financial condition of those parties who may have indemnification obligations to the Company is generally sound, in the event the Company seeks indemnity under any of these agreements or through other means, there can be no assurance that any party who may have obligations to indemnify us will adhere to their obligations and we may have to resort to legal action to enforce our rights under the indemnities.
The Company may be subject to indemnity claims relating to properties or businesses it divested, including properties or businesses that Rockwood divested prior to the Acquisition Closing Date. In the opinion of management, and based upon information currently available, the ultimate resolution of any indemnification obligations owed to the Company or by the Company is not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.
Other
We have contracts with certain of our customers, which serve as guarantees on product delivery and performance according to customer specifications that can cover both shipments on an individual basis as well as blanket coverage of multiple shipments under certain customer supply contracts. The financial coverage provided by these guarantees is typically based on a percentage of net sales value.
Also, see Note 2, “Acquisitions” for a discussion about litigation in connection with the acquisition of Rockwood.
NOTE 11—Segment Information:
As a result of the Rockwood acquisition, we have realigned our organizational structure under three reportable segments. Our new reportable business segments consist of the following: Performance Chemicals, Refining Solutions and Chemetall Surface Treatment. The Performance Chemicals segment includes the Lithium, Performance Catalyst Solutions (“PCS”) and Bromine product categories. The Refining Solutions segment consists of the Company’s Heavy Oil Upgrading and Clean Fuels Technologies (“CFT”) product categories. The Chemetall Surface Treatment segment consists of the Surface Treatment product category.
Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. The new business structure aligns with the markets and customers we serve through each of the segments. The new structure also facilitates the continued standardization of business processes across the organization, and is
18

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions.
Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2014 have been recast to reflect the change in segments noted above and a change in our measure of segment profit or loss to adjusted EBITDA as discussed below. Segment results for all periods presented exclude discontinued operations as further described in Note 17, “Discontinued Operations”.
During the first quarter we announced our intention to pursue strategic alternatives for three operating segments - Minerals, Fine Chemistry Services and Metal Sulfides, which together comprise the “All Other” category. All three operating segments have been and are expected to continue to be profitable, but do not fit into any of our core businesses subsequent to the acquisition of Rockwood. We expect to use the cash generated from the sale of these businesses to reduce borrowings outstanding under the September 2015 Term Loan Agreement. We have considered the accounting guidance in Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, and determined that the relevant asset groups did not meet the criteria to be accounted for as assets held for sale as of the balance sheet date.
The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.
Beginning in 2015, the Company uses earnings before interest, taxes, depreciation and amortization, as adjusted for certain non-recurring or unusual items such as restructuring charges, facility divestiture charges and other significant non-recurring items (“adjusted EBITDA”), on a segment basis to assess the ongoing performance of the Company’s business segments. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, GAAP. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
| (In thousands)
Net sales: |  |  |  |  |  |  |
Performance Chemicals | $ | 399,536 |  |  | $ | 299,947 |  |  | $ | 1,224,864 |  |  | $ | 856,221 |
Refining Solutions | 185,102 |  |  | 218,950 |  |  | 528,841 |  |  | 618,635 |
Chemetall Surface Treatment | 211,877 |  |  | — |  |  | 617,163 |  |  | — |
All Other | 102,224 |  |  | 123,521 |  |  | 337,997 |  |  | 372,126 |
Corporate | 6,354 |  |  | — |  |  | 12,117 |  |  | — |
Total net sales | $ | 905,093 |  |  | $ | 642,418 |  |  | $ | 2,720,982 |  |  | $ | 1,846,982 |
Adjusted EBITDA: |  |  |  |  |  |  |
Performance Chemicals | $ | 136,209 |  |  | $ | 82,329 |  |  | $ | 415,419 |  |  | $ | 232,668 |
Refining Solutions | 54,517 |  |  | 61,674 |  |  | 144,910 |  |  | 189,259 |
Chemetall Surface Treatment | 53,898 |  |  | — |  |  | 148,344 |  |  | — |
All Other | 6,262 |  |  | 20,971 |  |  | 29,540 |  |  | 63,482 |
Corporate | (15,890 | ) |  | (20,370 | ) |  | (7,508 | ) |  | (60,087 | )
Total adjusted EBITDA | $ | 234,996 |  |  | $ | 144,604 |  |  | $ | 730,705 |  |  | $ | 425,322 |

See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP, (in thousands):
19

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)

| Performance Chemicals |  | Refining Solutions |  | Chemetall Surface Treatment |  | Reportable Segments Total |  | All Other |  | Corporate |  | Consolidated Total
Three months ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 136,209 |  |  | $ | 54,517 |  |  | $ | 53,898 |  |  | $ | 244,624 |  |  | $ | 6,262 |  |  | $ | (15,890 | ) |  | $ | 234,996 |
Depreciation and amortization | (31,482 | ) |  | (8,804 | ) |  | (20,260 | ) |  | (60,546 | ) |  | (5,645 | ) |  | (2,712 | ) |  | (68,903 | )
Utilization of inventory markup(a) | (16,834 | ) |  | — |  |  | — |  |  | (16,834 | ) |  | — |  |  | — |  |  | (16,834 | )
Restructuring and other, net(c) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,804 |  |  | 6,804 |
Acquisition and integration related costs(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (42,798 | ) |  | (42,798 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (32,058 | ) |  | (32,058 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (16,892 | ) |  | (16,892 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,077 |  |  | 1,077 |
Net income (loss) attributable to Albemarle Corporation | $ | 87,893 |  |  | $ | 45,713 |  |  | $ | 33,638 |  |  | $ | 167,244 |  |  | $ | 617 |  |  | $ | (102,469 | ) |  | $ | 65,392 |
Three months ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 82,329 |  |  | $ | 61,674 |  |  | $ | — |  |  | $ | 144,003 |  |  | $ | 20,971 |  |  | $ | (20,370 | ) |  | $ | 144,604 |
Depreciation and amortization | (12,593 | ) |  | (8,823 | ) |  | — |  |  | (21,416 | ) |  | (3,492 | ) |  | (722 | ) |  | (25,630 | )
Restructuring and other, net(c) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (293 | ) |  | (293 | )
Acquisition and integration related costs(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10,261 | ) |  | (10,261 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (8,749 | ) |  | (8,749 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11,737 | ) |  | (11,737 | )
Loss from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6,679 | ) |  | (6,679 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,440 | ) |  | (1,440 | )
Other(d) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7,021 | ) |  | (7,021 | )
Net income (loss) attributable to Albemarle Corporation | $ | 69,736 |  |  | $ | 52,851 |  |  | $ | — |  |  | $ | 122,587 |  |  | $ | 17,479 |  |  | $ | (67,272 | ) |  | $ | 72,794 |
Nine months ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 415,419 |  |  | $ | 144,910 |  |  | $ | 148,344 |  |  | $ | 708,673 |  |  | $ | 29,540 |  |  | $ | (7,508 | ) |  | $ | 730,705 |
Depreciation and amortization | (93,608 | ) |  | (25,397 | ) |  | (57,567 | ) |  | (176,572 | ) |  | (16,867 | ) |  | (6,933 | ) |  | (200,372 | )
Utilization of inventory markup(a) | (79,239 | ) |  | — |  |  | (20,030 | ) |  | (99,269 | ) |  | (3,029 | ) |  | — |  |  | (102,298 | )
Restructuring and other, net(c) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,804 |  |  | 6,804 |
Acquisition and integration related costs(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (126,487 | ) |  | (126,487 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (100,986 | ) |  | (100,986 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (48,171 | ) |  | (48,171 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5,900 |  |  | 5,900 |
Other(d) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,441 | ) |  | (4,441 | )
Net income (loss) attributable to Albemarle Corporation | $ | 242,572 |  |  | $ | 119,513 |  |  | $ | 70,747 |  |  | $ | 432,832 |  |  | $ | 9,644 |  |  | $ | (281,822 | ) |  | $ | 160,654 |
Nine months ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 232,668 |  |  | $ | 189,259 |  |  | $ | — |  |  | $ | 421,927 |  |  | $ | 63,482 |  |  | $ | (60,087 | ) |  | $ | 425,322 |
Depreciation and amortization(e) | (37,742 | ) |  | (25,351 | ) |  | — |  |  | (63,093 | ) |  | (10,279 | ) |  | (1,807 | ) |  | (75,179 | )
Restructuring and other, net(c) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (20,625 | ) |  | (20,625 | )
Acquisition and integration related costs(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (15,104 | ) |  | (15,104 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (26,255 | ) |  | (26,255 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (46,700 | ) |  | (46,700 | )
Loss from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (68,473 | ) |  | (68,473 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14,141 | ) |  | (14,141 | )
Other(d) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7,021 | ) |  | (7,021 | )
Net income (loss) attributable to Albemarle Corporation | $ | 194,926 |  |  | $ | 163,908 |  |  | $ | — |  |  | $ | 358,834 |  |  | $ | 53,203 |  |  | $ | (260,213 | ) |  | $ | 151,824 |

(a) | In connection with the acquisition of Rockwood, the Company valued Rockwood’s existing inventory at fair value as of the Acquisition Closing Date, which resulted in a markup of the underlying net book value of the inventory totaling approximately $103 million. The inventory markup is being expensed over the estimated remaining selling period. For the three-month and nine-month periods ended

20

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
September 30, 2015, $7.7 million and $75.4 million, respectively, was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $9.1 million and $26.9 million, respectively, related to the utilization of the inventory markup.

(b) | See Note 2, “Acquisitions.”

(c) | See Note 15, “Restructuring and Other.”

(d) | Financing-related fees expensed in connection with the acquisition of Rockwood.

(e) | Excludes discontinued operations.

On October 26, 2015 we announced that effective January 1, 2016, Performance Chemicals will be split into two separate global business units: (1) Bromine Specialties, and (2) Lithium and Advanced Materials, which will include Performance Catalyst Solutions and Curatives.
NOTE 12—Pension Plans and Other Postretirement Benefits:
In connection with the acquisition of Rockwood, in the first quarter of 2015 we assumed the obligations of various defined benefit pension plans that were maintained by Rockwood which cover certain employees, primarily in the U.S., the United Kingdom and Germany. The majority of the plans’ assets are invested in diversified equity mutual funds, government and corporate bonds and other fixed income funds.
The following table sets forth the benefit obligations, plan assets, funded status and weighted-average assumption percentages for the defined benefit pension plans acquired in the Rockwood acquisition, as of the Acquisition Closing Date (in thousands):

| U.S. |  | Foreign
Benefit obligation | $ | 39,125 |  |  | $ | 416,150 |
Fair value of plan assets | 29,314 |  |  | 109,875 |
Funded status | $ | (9,811 | ) |  | $ | (306,275 | )
Weighted-average assumption percentages: |  |  |
Discount rate | 4.09 | % |  | 2.35 | %
Expected return on plan assets | 6.03 | % |  | 5.78 | %
Rate of compensation increase | — | % |  | 3.15 | %

The current forecast of benefit payments related to the defined benefit pension plans acquired in the Rockwood acquisition, which reflect expected future service, amounts to (in millions):

| U.S. |  | Foreign
Remainder of 2015 | $ | 0.6 |  |  | $ | 3.9 |
2016 | $ | 1.6 |  |  | $ | 16.4 |
2017 | $ | 1.7 |  |  | $ | 16.0 |
2018 | $ | 1.9 |  |  | $ | 16.8 |
2019 | $ | 2.0 |  |  | $ | 16.9 |
2020-2024 | $ | 11.1 |  |  | $ | 89.8 |

For the remainder of 2015, contributions related to the defined benefit pension plans acquired in the Rockwood acquisition are expected to be approximately $1.5 million.
21

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
The components of pension and postretirement benefits cost (credit) for the three-month and nine-month periods ended September 30, 2015 and 2014 are shown in the table below. The 2015 period includes results of the plans we acquired in the Rockwood acquisition.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
| (In thousands)
Pension Benefits Cost (Credit): |  |  |  |  |  |  |
Service cost | $ | 1,874 |  |  | $ | 2,678 |  |  | $ | 5,544 |  |  | $ | 8,245 |
Interest cost | 10,180 |  |  | 8,006 |  |  | 30,360 |  |  | 24,303 |
Expected return on assets | (11,834 | ) |  | (10,027 | ) |  | (35,367 | ) |  | (30,404 | )
Actuarial loss (gain)(a) | — |  |  | 2,786 |  |  | (51 | ) |  | 18,218 |
Amortization of prior service benefit | 30 |  |  | (119 | ) |  | 89 |  |  | (530 | )
Total net pension benefits cost | $ | 250 |  |  | $ | 3,324 |  |  | $ | 575 |  |  | $ | 19,832 |
Postretirement Benefits Cost (Credit): |  |  |  |  |  |  |
Service cost | $ | 36 |  |  | $ | 54 |  |  | $ | 107 |  |  | $ | 162 |
Interest cost | 643 |  |  | 760 |  |  | 1,930 |  |  | 2,280 |
Expected return on assets | (66 | ) |  | (85 | ) |  | (178 | ) |  | (256 | )
Amortization of prior service benefit | (24 | ) |  | (24 | ) |  | (72 | ) |  | (72 | )
Settlements/curtailments(b) | — |  |  | — |  |  | (2,594 | ) |  | — |
Total net postretirement benefits cost (credit) | $ | 589 |  |  | $ | 705 |  |  | $ | (807 | ) |  | $ | 2,114 |
Total net pension and postretirement benefits cost (credit) | $ | 839 |  |  | $ | 4,029 |  |  | $ | (232 | ) |  | $ | 21,946 |

(a) | In connection with a realignment of our operating segments effective January 1, 2014, in the fourth quarter of 2013 we initiated a workforce reduction plan which resulted in a reduction of approximately 230 employees worldwide. This workforce reduction triggered a net curtailment gain of approximately $0.8 million in the first quarter of 2014 for our U.S. defined benefit plan which covers non-represented employees and our supplemental executive retirement plan (“SERP”). In connection with the curtailment, we were required to remeasure the related assets and obligations for these two plans. As of the January 31, 2014 remeasurement date, the weighted-average discount rate for all of our domestic pension plans was 4.97% compared to 5.14% at December 31, 2013. Taking into account the discount rate reduction and actual return on plan assets through January 31, 2014, we recorded a mark-to-market actuarial loss (net of the curtailment gain) of $15.4 million in the first quarter of 2014 related to these two plans.

In connection with the sale of our antioxidant, ibuprofen and propofol businesses and assets to SI Group, Inc. which closed on September 1, 2014, in the third quarter of 2014 we were required to remeasure the assets and obligations of one of our U.S. defined benefit plans for represented employees, which was part of the disposed group. As of the September 1, 2014 remeasurement date, the weighted-average discount rate for all of our domestic pension plans was 4.94% compared to 5.14% at December 31, 2013. Taking into account the discount rate reduction and actual return on plan assets through September 1, 2014, as well as changes to mortality assumptions, we recorded a mark-to-market actuarial loss of $2.8 million in the third quarter of 2014 related to this plan.

(b) | We assumed responsibility for one domestic OPEB plan in connection with the acquisition of Rockwood which covered a small number of active employees and retirees. This plan was terminated in the first quarter of 2015 and provisions were made for the affected employees and retirees to receive benefits under an existing plan. A gain of $2.6 million was recognized in the first quarter of 2015 related to the termination of this plan.

During the three-month and nine-month periods ended September 30, 2015, we made contributions of $4.8 million and $13.8 million, respectively, to our qualified and nonqualified pension plans. During the three-month and nine-month periods ended September 30, 2014, we made contributions of $5.2 million and $7.5 million, respectively, to our qualified and nonqualified pension plans. The 2014 amounts include a contribution of $4.3 million to one of our U.S. defined benefit plans for represented employees which was included in the sale of certain businesses and assets to SI Group, Inc. which closed on September 1, 2014.
We paid $0.9 million and $2.9 million in premiums to the U.S. postretirement benefit plan during the three-month and nine-month periods ended September 30, 2015, respectively. During the three-month and nine-month periods ended September 30, 2014, we paid $0.8 million and $3.2 million, respectively, in premiums to the U.S. postretirement benefit plan.
22

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Multiemployer Plan
Certain current and former employees of Rockwood participate in a multiemployer plan in Germany, the Pensionskasse Dynamit Nobel Versicherungsverein auf Gegenseitigkeit, Troisdorf (“DN Pensionskasse”), that provides monthly payments in the case of disability, death or retirement. The risks of participating in a multiemployer plan are different from single-employer plans in the following ways: (a) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, and (b) if a participating employer stops contributing to the plan, the unfunded obligation of the plan may be borne by remaining participating employers.
Some participants in the plan are subject to collective bargaining arrangements, which have no fixed expiration date. The contribution and benefit levels are not negotiated or significantly influenced by these collective bargaining arrangements. Also, the benefit levels generally are not subject to reduction. Under German insurance law, the DN Pensionskasse must be fully funded at all times. The DN Pensionskasse was fully funded as of December 31, 2014, the most recent year-end date of the plan. This funding level would correspond to the highest funding zone status (at least 80% funded) under U.S. pension regulation. Since the plan liabilities need to be fully funded at all times according to local funding requirements, it is unlikely that the DN Pensionskasse plan will fail to fulfill its obligations, however, in such an event, the Company is liable for the benefits of its employees who participate in the plan. Additional information of the DN Pensionskasse is available in the public domain.
The majority of the Company’s contributions are tied to employees’ contributions, which are generally calculated as a percentage of base compensation, up to a certain statutory ceiling. Our contributions to this plan were €0.5 million (approximately $0.6 million) during the three months ended September 30, 2015, and €1.2 million (approximately $1.4 million) during the nine months ended September 30, 2015. As of the most recent year-end date of the plan, Rockwood’s contributions in 2014 represented more than 5% of total contributions to the DN Pensionskasse in 2014.
The DN Pensionskasse was subject to a financial improvement plan (“FIP”) which expired at the end of 2014. The solvency requirements of the FIP have been met as of December 31, 2014.
NOTE 13—Fair Value of Financial Instruments:
In assessing the fair value of financial instruments, we use methods and assumptions that are based on market conditions and other risk factors existing at the time of assessment. Fair value information for our financial instruments is as follows:
Long-Term Debt—the fair values of our senior notes and other fixed rate foreign borrowings are estimated using Level 1 inputs and account for the majority of the difference between the recorded amount and fair value of our long-term debt. The carrying value of our remaining long-term debt reported in the accompanying condensed consolidated balance sheets approximates fair value as substantially all of such debt bears interest based on prevailing variable market rates currently available in the countries in which we have borrowings.

| September 30, 2015 |  | December 31, 2014
| Recorded Amount |  | Fair Value |  | Recorded Amount |  | Fair Value
| (In thousands)
Long-term debt | $ | 3,843,332 |  |  | $ | 3,882,165 |  |  | $ | 2,934,131 |  |  | $ | 2,994,935 |

Foreign Currency Forward Contracts—we enter into foreign currency forward contracts in connection with our risk management strategies in an attempt to minimize the financial impact of changes in foreign currency exchange rates. These derivative financial instruments are used to manage risk and are not used for trading or other speculative purposes. The fair values of our foreign currency forward contracts are estimated based on current settlement values. At September 30, 2015 and December 31, 2014, we had outstanding foreign currency forward contracts with notional values totaling $423.9 million and $479.9 million, respectively. Our foreign currency forward contracts outstanding at September 30, 2015 and December 31, 2014 have not been designated as hedging instruments under ASC 815, Derivatives and Hedging. At September 30, 2015, $0.5 million was included in Accrued expenses associated with the fair value of our foreign currency forward contracts, and at December 31, 2014, $0.6 million was included in Other accounts receivable associated with the fair value of our foreign currency forward contracts.
Gains and losses on foreign currency forward contracts are recognized currently in Other income (expenses), net; further, fluctuations in the value of these contracts are generally expected to be offset by changes in the value of the underlying exposures being hedged. For the three-month and nine-month periods ended September 30, 2015, we recognized gains (losses)
23

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
of $2.5 million and $(14.1) million, respectively, in Other income (expenses), net, in our consolidated statements of income related to the change in the fair value of our foreign currency forward contracts. For the three-month and nine-month periods ended September 30, 2014, we recognized (losses) of $(5.6) million and $(8.0) million, respectively, in Other income (expenses), net, in our consolidated statements of income related to the change in the fair value of our foreign currency forward contracts. These amounts are generally expected to be offset by changes in the value of the underlying exposures being hedged which are also reported in Other income (expenses), net. Also, for the nine-month periods ended September 30, 2015 and 2014, we recorded $14.1 million and $8.0 million, respectively, related to the change in the fair value of our foreign currency forward contracts, and net cash settlements of $(13.0) million and $(8.3) million, respectively, in Other, net, in our condensed consolidated statements of cash flows.
The counterparties to our foreign currency forward contracts are major financial institutions with which we generally have other financial relationships. We are exposed to credit loss in the event of nonperformance by these counterparties. However, we do not anticipate nonperformance by the counterparties.
NOTE 14—Fair Value Measurement:
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The inputs used to measure fair value are classified into the following hierarchy:

Level 1 | Unadjusted quoted prices in active markets for identical assets or liabilities
Level 2 | Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability
Level 3 | Unobservable inputs for the asset or liability

We endeavor to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Transfers between levels of the fair value hierarchy are deemed to have occurred on the date of the event or change in circumstance that caused the transfer. There were no transfers between Levels 1 and 2 during the nine-month period ended September 30, 2015. The following tables set forth our financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2015 and December 31, 2014 (in thousands):

| September 30, 2015 |  | Quoted Prices in Active Markets for Identical Items (Level 1) |  | Quoted Prices in Active Markets for Similar Items (Level 2) |  | Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Investments under executive deferred compensation plan(a) | $ | 20,722 |  |  | $ | 20,722 |  |  | $ | — |  |  | $ | — |
Private equity securities(b) | $ | 2,626 |  |  | $ | 18 |  |  | $ | — |  |  | $ | 2,608 |
Liabilities: |  |  |  |  |  |  |
Obligations under executive deferred compensation plan(a) | $ | 20,722 |  |  | $ | 20,722 |  |  | $ | — |  |  | $ | — |
Liability for appraisal shares(d) | $ | 74,934 |  |  | $ | — |  |  | $ | 74,934 |  |  | $ | — |
Foreign currency forward contracts(c) | $ | 498 |  |  | $ | — |  |  | $ | 498 |  |  | $ | — |

24

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)

| December 31, 2014 |  | Quoted Prices in Active Markets for Identical Items (Level 1) |  | Quoted Prices in Active Markets for Similar Items (Level 2) |  | Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Investments under executive deferred compensation plan(a) | $ | 22,168 |  |  | $ | 22,168 |  |  | $ | — |  |  | $ | — |
Private equity securities(b) | $ | 1,806 |  |  | $ | 21 |  |  | $ | — |  |  | $ | 1,785 |
Foreign currency forward contracts(c) | $ | 631 |  |  | $ | — |  |  | $ | 631 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Obligations under executive deferred compensation plan(a) | $ | 22,168 |  |  | $ | 22,168 |  |  | $ | — |  |  | $ | — |

(a) | We maintain an Executive Deferred Compensation Plan (“EDCP”) that was adopted in 2001 and subsequently amended. The purpose of the EDCP is to provide current tax planning opportunities as well as supplemental funds upon the retirement or death of certain of our employees. The EDCP is intended to aid in attracting and retaining employees of exceptional ability by providing them with these benefits. We also maintain a Benefit Protection Trust (the “Trust”) that was created to provide a source of funds to assist in meeting the obligations of the EDCP, subject to the claims of our creditors in the event of our insolvency. Assets of the Trust are consolidated in accordance with authoritative guidance. The assets of the Trust consist primarily of mutual fund investments (which are accounted for as trading securities and are marked-to-market on a monthly basis through the consolidated statements of income) and cash and cash equivalents. As such, these assets and obligations are classified within Level 1.

(b) | Primarily consists of private equity securities classified as available-for-sale and are reported in Investments in the condensed consolidated balance sheets. The changes in fair value are reported in Other income (expenses), net, in our consolidated statements of income. Holdings in private equity securities are typically valued using the net asset valuations provided by the underlying private investment companies and as such are classified within Level 3.

(c) | As a result of our global operating and financing activities, we are exposed to market risks from changes in foreign currency exchange rates, which may adversely affect our operating results and financial position. When deemed appropriate, we minimize our risks from foreign currency exchange rate fluctuations through the use of foreign currency forward contracts. Unless otherwise noted, these derivative financial instruments are not designated as hedging instruments under ASC 815, Derivatives and Hedging. The foreign currency forward contracts are valued using broker quotations or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within Level 2.

(d) | See Note 2, “Acquisitions.”

The following table presents the fair value reconciliation of Level 3 assets measured at fair value on a recurring basis for the periods indicated:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
| (In thousands)
Beginning balance | $ | 1,772 |  |  | $ | 1,822 |  |  | $ | 1,785 |  |  | $ | 750 |
Total unrealized gains (losses) included in earnings relating to assets still held at the reporting date | 836 |  |  | (24 | ) |  | 823 |  |  | 48 |
Purchases | — |  |  | — |  |  | — |  |  | 1,000 |
Ending balance | $ | 2,608 |  |  | $ | 1,798 |  |  | $ | 2,608 |  |  | $ | 1,798 |

25

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 15—Restructuring and Other:
Included in Restructuring and other, net, for the three-month and nine-month periods ended September 30, 2015, is a gain of $6.8 million ($4.7 million after income taxes) recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012.
During the first quarter of 2014, we initiated action to reduce high cost supply capacity of certain aluminum alkyl products, primarily through the termination of a third party manufacturing contract. Based on the contract termination, we estimated costs of approximately $14.0 million for contract termination and volume commitments. Additionally, in the first quarter of 2014 we recorded an impairment charge of $3.0 million for certain capital project costs also related to aluminum alkyls capacity which we do not expect to recover. After income taxes, these charges were approximately $11.1 million. In the fourth quarter of 2014 we concluded the contract termination agreement which resulted in an additional charge of $6.5 million ($4.3 million after income taxes). At September 30, 2015, a remaining amount of $9.9 million related to this agreement is included in Accrued expenses in the condensed consolidated balance sheet. In the second quarter of 2014, we recorded $3.3 million ($2.1 million after income taxes) in Restructuring and other, net, for certain multi-product facility project costs that we do not expect to recover in future periods.
26

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 16—Accumulated Other Comprehensive (Loss) Income:
The components and activity in Accumulated other comprehensive (loss) income (net of deferred income taxes) consisted of the following during the periods indicated below (in thousands):

| Foreign Currency Translation(a) |  | Pension and Postretirement Benefits(b) |  | Net Investment Hedge |  | Interest Rate Swap(c) |  | Other |  | Total
Three months ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2015 | $ | (350,460 | ) |  | $ | 4 |  |  | $ | 54,500 |  |  | $ | (19,909 | ) |  | $ | (541 | ) |  | $ | (316,406 | )
Other comprehensive (loss) before reclassifications | (67,520 | ) |  | — |  |  | (3,407 | ) |  | — |  |  | (6 | ) |  | (70,933 | )
Amounts reclassified from accumulated other comprehensive (loss) income | — |  |  | 2 |  |  | — |  |  | 527 |  |  | — |  |  | 529 |
Other comprehensive (loss) income, net of tax | (67,520 | ) |  | 2 |  |  | (3,407 | ) |  | 527 |  |  | (6 | ) |  | (70,404 | )
Other comprehensive loss attributable to noncontrolling interests | 397 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 397 |
Balance at September 30, 2015 | $ | (417,583 | ) |  | $ | 6 |  |  | $ | 51,093 |  |  | $ | (19,382 | ) |  | $ | (547 | ) |  | $ | (386,413 | )
Three months ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2014 | $ | 110,681 |  |  | $ | 19 |  |  | $ | — |  |  | $ | (10,421 | ) |  | $ | (635 | ) |  | $ | 99,644 |
Other comprehensive (loss) before reclassifications | (82,568 | ) |  | — |  |  | — |  |  | (988 | ) |  | (1 | ) |  | (83,557 | )
Amounts reclassified from accumulated other comprehensive (loss) income | (17,750 | ) |  | (147 | ) |  | — |  |  | — |  |  | 34 |  |  | (17,863 | )
Other comprehensive (loss) income, net of tax | (100,318 | ) |  | (147 | ) |  | — |  |  | (988 | ) |  | 33 |  |  | (101,420 | )
Other comprehensive loss attributable to noncontrolling interests | 125 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 125 |
Balance at September 30, 2014 | $ | 10,488 |  |  | $ | (128 | ) |  | $ | — |  |  | $ | (11,409 | ) |  | $ | (602 | ) |  | $ | (1,651 | )
Nine months ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2014 | $ | (52,264 | ) |  | $ | — |  |  | $ | 11,384 |  |  | $ | (20,962 | ) |  | $ | (571 | ) |  | $ | (62,413 | )
Other comprehensive (loss) income before reclassifications | (365,867 | ) |  | — |  |  | 39,709 |  |  | — |  |  | (3 | ) |  | (326,161 | )
Amounts reclassified from accumulated other comprehensive (loss) income | — |  |  | 6 |  |  | — |  |  | 1,580 |  |  | 27 |  |  | 1,613 |
Other comprehensive (loss) income, net of tax | (365,867 | ) |  | 6 |  |  | 39,709 |  |  | 1,580 |  |  | 24 |  |  | (324,548 | )
Other comprehensive loss attributable to noncontrolling interests | 548 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 548 |
Balance at September 30, 2015 | $ | (417,583 | ) |  | $ | 6 |  |  | $ | 51,093 |  |  | $ | (19,382 | ) |  | $ | (547 | ) |  | $ | (386,413 | )
Nine months ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2013 | $ | 116,465 |  |  | $ | 487 |  |  | $ | — |  |  | $ | — |  |  | $ | (707 | ) |  | $ | 116,245 |
Other comprehensive (loss) income before reclassifications | (88,630 | ) |  | — |  |  | — |  |  | (11,409 | ) |  | 2 |  |  | (100,037 | )
Amounts reclassified from accumulated other comprehensive (loss) income | (17,750 | ) |  | (615 | ) |  | — |  |  | — |  |  | 103 |  |  | (18,262 | )
Other comprehensive (loss) income, net of tax | (106,380 | ) |  | (615 | ) |  | — |  |  | (11,409 | ) |  | 105 |  |  | (118,299 | )
Other comprehensive loss attributable to noncontrolling interests | 403 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 403 |
Balance at September 30, 2014 | $ | 10,488 |  |  | $ | (128 | ) |  | $ | — |  |  | $ | (11,409 | ) |  | $ | (602 | ) |  | $ | (1,651 | )

27

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)

(a) | Amounts reclassified from accumulated other comprehensive (loss) income for the three-month and nine-month periods ended September 30, 2014 are included in Loss from discontinued operations (net of tax) and resulted from the release of cumulative foreign currency translation adjustments into earnings upon the sale of our antioxidant, ibuprofen and propofol businesses and assets which closed on September 1, 2014.

(b) | The pre-tax portion of amounts reclassified from accumulated other comprehensive (loss) income consists of amortization of prior service benefit, which is a component of pension and postretirement benefits cost (credit). See Note 12, “Pension Plans and Other Postretirement Benefits.”

(c) | The pre-tax portion of amounts reclassified from accumulated other comprehensive (loss) income is included in interest expense.

The amount of income tax (expense) benefit allocated to each component of Other comprehensive (loss) income for the three-month and nine-month periods ended September 30, 2015 and 2014 is provided in the following tables (in thousands):

| Three Months Ended September 30,
| 2015 |  | 2014
| Foreign Currency Translation |  | Pension and Postretirement Benefits |  | Net Investment Hedge |  | Interest Rate Swap |  | Other |  | Foreign Currency Translation |  | Pension and Postretirement Benefits |  | Interest Rate Swap |  | Other
Other comprehensive (loss) income, before tax | $ | (66,576 | ) |  | $ | 6 |  |  | $ | (5,394 | ) |  | $ | 834 |  |  | $ | (6 | ) |  | $ | (101,675 | ) |  | $ | (143 | ) |  | $ | (1,556 | ) |  | $ | 35 |
Income tax (expense) benefit | (944 | ) |  | (4 | ) |  | 1,987 |  |  | (307 | ) |  | — |  |  | 1,357 |  |  | (4 | ) |  | 568 |  |  | (2 | )
Other comprehensive (loss) income, net of tax | $ | (67,520 | ) |  | $ | 2 |  |  | $ | (3,407 | ) |  | $ | 527 |  |  | $ | (6 | ) |  | $ | (100,318 | ) |  | $ | (147 | ) |  | $ | (988 | ) |  | $ | 33 |
| Nine Months Ended September 30,
| 2015 |  | 2014
| Foreign Currency Translation |  | Pension and Postretirement Benefits |  | Net Investment Hedge |  | Interest Rate Swap |  | Other |  | Foreign Currency Translation |  | Pension and Postretirement Benefits |  | Interest Rate Swap |  | Other
Other comprehensive (loss) income, before tax | $ | (394,926 | ) |  | $ | 17 |  |  | $ | 62,876 |  |  | $ | 2,502 |  |  | $ | 15 |  |  | $ | (107,011 | ) |  | $ | (602 | ) |  | $ | (17,976 | ) |  | $ | 146 |
Income tax benefit (expense) | 29,059 |  |  | (11 | ) |  | (23,167 | ) |  | (922 | ) |  | 9 |  |  | 631 |  |  | (13 | ) |  | 6,567 |  |  | (41 | )
Other comprehensive (loss) income, net of tax | $ | (365,867 | ) |  | $ | 6 |  |  | $ | 39,709 |  |  | $ | 1,580 |  |  | $ | 24 |  |  | $ | (106,380 | ) |  | $ | (615 | ) |  | $ | (11,409 | ) |  | $ | 105 |

NOTE 17—Discontinued Operations:
On April 15, 2014, the Company signed a definitive agreement to sell its antioxidant, ibuprofen and propofol businesses and assets to SI Group, Inc. Included in the transaction were Albemarle’s manufacturing sites in Orangeburg, South Carolina and Jinshan, China, along with Albemarle’s antioxidant product lines manufactured in Ningbo, China. On September 1, 2014, the Company closed the sale of these businesses and assets and received net proceeds of $104.7 million. A working capital settlement of $7.6 million (recorded in Other accounts receivable at December 31, 2014) was received in the first quarter of 2015. Financial results of the disposed group have been presented as discontinued operations in the consolidated statements of income for the 2014 periods. A summary of results of discontinued operations is as follows (in thousands):

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2015 |  | 2014 |  | 2015 |  | 2014
Net sales | $ | — |  |  | $ | 38,025 |  |  | $ | — |  |  | $ | 154,273 |
Loss from discontinued operations | $ | — |  |  | $ | (7,752 | ) |  | $ | — |  |  | $ | (90,439 | )
Income tax benefit | — |  |  | (1,073 | ) |  | — |  |  | (21,966 | )
Loss from discontinued operations (net of tax) | $ | — |  |  | $ | (6,679 | ) |  | $ | — |  |  | $ | (68,473 | )

Included in Loss from discontinued operations are pre-tax charges of $80.7 million ($61.0 million after income taxes) recorded in the second quarter of 2014 and $4.8 million ($3.6 million after income taxes) recorded in the third quarter of 2014 related to the loss on the sale of the disposed group, representing the difference between the carrying value of the related assets
28

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
and their fair value as determined by the sales price less estimated costs to sell. The loss is primarily attributable to the write-off of goodwill, intangibles and long-lived assets, net of cumulative foreign currency translation gains of $17.8 million.
NOTE 18—Recently Issued Accounting Pronouncements:
In April 2014, the Financial Accounting Standards Board (“FASB”) issued accounting guidance that changed the criteria for reporting discontinued operations and modified related disclosure requirements to provide users of financial statements with more information about the assets, liabilities, revenues and expenses of discontinued operations. The guidance modified the definition of discontinued operations by limiting its scope to disposals of components of an entity that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results. Additionally, these new requirements require entities to disclose the pretax profit or loss related to disposals of significant components that do not qualify as discontinued operations. These new requirements became effective on January 1, 2015. The impact of these new requirements is dependent on the nature of dispositions, if any, after adoption.
In May 2014, the FASB issued accounting guidance designed to enhance comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets. The core principle of the guidance is that revenue recognized from a transaction or event that arises from a contract with a customer should reflect the consideration to which an entity expects to be entitled in exchange for goods or services provided. To achieve that core principle the new guidance sets forth a five-step revenue recognition model that will need to be applied consistently to all contracts with customers, except those that are within the scope of other topics in the ASC. Also required are new disclosures to help users of financial statements better understand the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. The new disclosures include qualitative and quantitative information about contracts with customers, significant judgments made in applying the revenue guidance, and assets recognized related to the costs to obtain or fulfill a contract. These new requirements become effective for annual and interim reporting periods beginning after December 15, 2017. Early adoption is permitted for annual and interim reporting periods beginning after December 15, 2016. We are assessing the impact of these new requirements on our financial statements.
In June 2014, the FASB issued accounting guidance which clarifies the proper method of accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. The accounting guidance requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. These new requirements become effective for annual and interim reporting periods beginning after December 15, 2015, and early adoption is permitted. We do not expect this guidance to have a significant impact on our financial statements.
In February 2015, the FASB issued accounting guidance that changes the analysis that reporting entities must perform to determine whether certain types of legal entities should be consolidated. Specifically, the amendments affect (a) limited partnerships and similar legal entities; (b) the consolidation analysis of reporting entities that are involved with variable interest entities, particularly those that have fee arrangements and related party relationships; and (c) certain investment funds. These amendments are effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are assessing the impact of these amendments on our financial statements.
In April and August 2015, the FASB issued accounting guidance that changes the balance sheet presentation of debt issuance costs (except for debt issuance costs related to line-of-credit arrangements). The guidance requires debt issuance costs relating to a recognized debt liability to be presented as a direct deduction from the carrying amount of the associated debt liability in the balance sheet. This new requirement will be effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, and is to be applied on a retrospective basis. Early adoption is permitted. We do not expect this guidance to have a significant impact on our financial statements.
In April 2015, the FASB issued accounting guidance that, among other things, provides for a practical expedient related to interim period remeasurements of defined benefit plan assets and obligations. The practical expedient permits entities to remeasure plan assets and obligations using the month-end that is closest to the date of the actual event. Disclosure of such election and related month-end remeasurement date is required. This guidance will be effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, and is to be applied prospectively. Early application is permitted. We do not expect this guidance to have a significant impact on our financial statements.
29

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
In April 2015, the FASB issued accounting guidance which clarifies the proper method of accounting for fees paid in a cloud computing arrangement. The guidance requires software licenses included in a cloud computing arrangement to be accounted for consistently with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. This new requirement will be effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted. We are assessing the impact of this new requirement on our financial statements.
In May 2015, the FASB issued accounting guidance for which investments measured at net asset value per share (or its equivalent) using the practical expedient should no longer be categorized within the fair value hierarchy. Although removed from the fair value hierarchy, disclosure of the nature, risks and amount of investments for which fair value is measured using the practical expedient is still required. This guidance will be effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, and is to be applied on a retrospective basis. Early adoption is permitted. We do not expect this guidance to have a significant impact on our financial statements.
In July 2015, the FASB issued accounting guidance that requires inventory to be measured at the lower of cost and net realizable value. The scope of this guidance excludes inventory measured using the last-in first-out method or the retail inventory method. This new requirement will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, and is to be applied prospectively. Early application is permitted. We are assessing the impact of this new requirement on our financial statements.
In September 2015, the FASB issued accounting guidance that eliminates the requirement to retrospectively adjust prior period financial statements for measurement-period adjustments that occur in periods after a business combination is consummated. Measurement-period adjustments should continue to be calculated as if they were known at the acquisition date, but will now be recognized in the reporting period in which they are determined. The new guidance also requires that the acquirer present separately on the face of the income statement or disclose in the notes the amount recorded in current-period earnings, by line item, that would have been recorded in previous reporting periods if the adjustment to provisional amounts had been recognized as of the acquisition date. As allowed by the provisions of this new guidance, we early-adopted this new guidance in the third quarter of 2015. The adoption of this new guidance did not have a material impact on our consolidated financial statements.
NOTE 19—Subsequent Events:
On November 5, 2015, we entered into a definitive agreement to sell our Tribotecc Metal Sulfides business to Treibacher Industrie AG for an undisclosed amount of cash. Included in the transaction are sites in Vienna and Arnoldstein, Austria, and Tribotecc’s proprietary sulfide synthesis process. The sale is subject to customary closing conditions and is expected to close by the end of 2015. Additionally, subsequent to September 30, 2015, we considered the accounting guidance in ASC 360, Property, Plant and Equipment, and determined that the assets held for sale criteria were met for our Minerals operating segment. As such, we expect to account for the assets of both businesses as held for sale beginning in the fourth quarter of 2015. As of September 30, 2015, the combined net assets of these businesses totaled approximately $225.0 million. We have also determined that as of September 30, 2015, expected cash flows of both businesses were sufficient to establish recoverability of the asset carrying values, and therefore no impairment charge has been recorded in the accompanying financial statements.
30

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
NOTE 20—Consolidating Guarantor Financial Information:
The 2014 Senior Notes issued by Albemarle Corporation (the “Issuer”) were fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Rockwood Holdings, Inc. (“RHI”) and Rockwood Specialties Group, Inc. (“RSGI”) (the “Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned subsidiaries of the Issuer. The guarantees were general senior unsecured obligations of the Guarantor Subsidiaries and ranked equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantor Subsidiaries that are not, by their terms, otherwise expressly subordinated. The note guarantees were released when the 4.625% senior notes were repaid on October 15, 2015.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among the Issuer, Guarantor Subsidiaries and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantor Subsidiaries to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Issuer, Guarantor Subsidiaries, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.
31

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 357,269 |  |  | $ | — |  |  | $ | 734,109 |  |  | $ | (186,285 | ) |  | $ | 905,093 |
Cost of goods sold | 252,634 |  |  | — |  |  | 526,534 |  |  | (186,285 | ) |  | 592,883 |
Gross profit | 104,635 |  |  | — |  |  | 207,575 |  |  | — |  |  | 312,210 |
Selling, general and administrative expenses | 40,721 |  |  | — |  |  | 96,894 |  |  | — |  |  | 137,615 |
Research and development expenses | 12,874 |  |  | — |  |  | 12,421 |  |  | — |  |  | 25,295 |
Restructuring and other, net | (61 | ) |  | — |  |  | (6,743 | ) |  | — |  |  | (6,804 | )
Acquisition and integration related costs | 28,479 |  |  | — |  |  | 14,319 |  |  | — |  |  | 42,798 |
Intercompany service fee | 5,914 |  |  | — |  |  | (5,914 | ) |  | — |  |  | — |
Operating profit | 16,708 |  |  | — |  |  | 96,598 |  |  | — |  |  | 113,306 |
Interest and financing expenses | (21,758 | ) |  | (12,546 | ) |  | 2,246 |  |  | — |  |  | (32,058 | )
Intergroup interest and financing expenses | (8,697 | ) |  | 15,147 |  |  | (6,450 | ) |  | — |  |  | — |
Other income (expenses), net | (2,320 | ) |  | 4,376 |  |  | (1,590 | ) |  | — |  |  | 466 |
Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments | (16,067 | ) |  | 6,977 |  |  | 90,804 |  |  | — |  |  | 81,714 |
Income tax expense (benefit) | (9,491 | ) |  | 4,020 |  |  | 22,363 |  |  | — |  |  | 16,892 |
Income (loss) from continuing operations before equity in net income of unconsolidated investments | (6,576 | ) |  | 2,957 |  |  | 68,441 |  |  | — |  |  | 64,822 |
Equity in net income of unconsolidated investments (net of tax) | 1,315 |  |  | — |  |  | 4,735 |  |  | — |  |  | 6,050 |
Net income (loss) from continuing operations | (5,261 | ) |  | 2,957 |  |  | 73,176 |  |  | — |  |  | 70,872 |
Income (loss) from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |
Equity in undistributed earnings of subsidiaries | 70,653 |  |  | 33,465 |  |  | 18,211 |  |  | (122,329 | ) |  | — |
Net income | 65,392 |  |  | 36,422 |  |  | 91,387 |  |  | (122,329 | ) |  | 70,872 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | (5,480 | ) |  | — |  |  | (5,480 | )
Net income attributable to Albemarle Corporation | $ | 65,392 |  |  | $ | 36,422 |  |  | $ | 85,907 |  |  | $ | (122,329 | ) |  | $ | 65,392 |

Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 65,392 |  |  | $ | 36,422 |  |  | $ | 91,387 |  |  | $ | (122,329 | ) |  | $ | 70,872 |
Total other comprehensive loss, net of tax | (70,007 | ) |  | (103,764 | ) |  | (118,228 | ) |  | 221,595 |  |  | (70,404 | )
Comprehensive income (loss) | (4,615 | ) |  | (67,342 | ) |  | (26,841 | ) |  | 99,266 |  |  | 468 |
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (5,083 | ) |  | — |  |  | (5,083 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (4,615 | ) |  | $ | (67,342 | ) |  | $ | (31,924 | ) |  | $ | 99,266 |  |  | $ | (4,615 | )

32

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 1,109,661 |  |  | $ | — |  |  | $ | 2,153,749 |  |  | $ | (542,428 | ) |  | $ | 2,720,982 |
Cost of goods sold | 767,626 |  |  | — |  |  | 1,622,121 |  |  | (540,007 | ) |  | 1,849,740 |
Gross profit | 342,035 |  |  | — |  |  | 531,628 |  |  | (2,421 | ) |  | 871,242 |
Selling, general and administrative expenses | 127,591 |  |  | 46 |  |  | 293,455 |  |  | — |  |  | 421,092 |
Research and development expenses | 39,143 |  |  | — |  |  | 37,980 |  |  | — |  |  | 77,123 |
Restructuring and other, net | (61 | ) |  | — |  |  | (6,743 | ) |  | — |  |  | (6,804 | )
Acquisition and integration related costs | 86,648 |  |  | — |  |  | 39,839 |  |  | — |  |  | 126,487 |
Intercompany service fee | 17,557 |  |  | — |  |  | (17,557 | ) |  | — |  |  | — |
Operating profit (loss) | 71,157 |  |  | (46 | ) |  | 184,654 |  |  | (2,421 | ) |  | 253,344 |
Interest and financing expenses | (70,279 | ) |  | (36,257 | ) |  | 5,550 |  |  | — |  |  | (100,986 | )
Intergroup interest and financing expenses | (23,143 | ) |  | 40,862 |  |  | (17,719 | ) |  | — |  |  | — |
Other income (expenses), net | 6,624 |  |  | (26,844 | ) |  | 71,184 |  |  | — |  |  | 50,964 |
Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments | (15,641 | ) |  | (22,285 | ) |  | 243,669 |  |  | (2,421 | ) |  | 203,322 |
Income tax expense (benefit) | (1,148 | ) |  | 6,992 |  |  | 43,219 |  |  | (892 | ) |  | 48,171 |
Income (loss) from continuing operations before equity in net income of unconsolidated investments | (14,493 | ) |  | (29,277 | ) |  | 200,450 |  |  | (1,529 | ) |  | 155,151 |
Equity in net income of unconsolidated investments (net of tax) | 5,072 |  |  | — |  |  | 17,164 |  |  | — |  |  | 22,236 |
Net income (loss) from continuing operations | (9,421 | ) |  | (29,277 | ) |  | 217,614 |  |  | (1,529 | ) |  | 177,387 |
Income (loss) from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |
Equity in undistributed earnings of subsidiaries | 170,075 |  |  | 117,147 |  |  | 43,935 |  |  | (331,157 | ) |  | — |
Net income | 160,654 |  |  | 87,870 |  |  | 261,549 |  |  | (332,686 | ) |  | 177,387 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | (16,733 | ) |  | — |  |  | (16,733 | )
Net income attributable to Albemarle Corporation | $ | 160,654 |  |  | $ | 87,870 |  |  | $ | 244,816 |  |  | $ | (332,686 | ) |  | $ | 160,654 |

Condensed Consolidating Statement of Comprehensive Loss
Nine Months Ended September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 160,654 |  |  | $ | 87,870 |  |  | $ | 261,549 |  |  | $ | (332,686 | ) |  | $ | 177,387 |
Total other comprehensive loss, net of tax | (324,000 | ) |  | (538,439 | ) |  | (662,793 | ) |  | 1,200,684 |  |  | (324,548 | )
Comprehensive loss | (163,346 | ) |  | (450,569 | ) |  | (401,244 | ) |  | 867,998 |  |  | (147,161 | )
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (16,185 | ) |  | — |  |  | (16,185 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (163,346 | ) |  | $ | (450,569 | ) |  | $ | (417,429 | ) |  | $ | 867,998 |  |  | $ | (163,346 | )

33

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 403,072 |  |  | $ | — |  |  | $ | 424,423 |  |  | $ | (185,077 | ) |  | $ | 642,418 |
Cost of goods sold | 275,187 |  |  | — |  |  | 342,149 |  |  | (180,364 | ) |  | 436,972 |
Gross profit | 127,885 |  |  | — |  |  | 82,274 |  |  | (4,713 | ) |  | 205,446 |
Selling, general and administrative expenses | 42,836 |  |  | — |  |  | 23,176 |  |  | — |  |  | 66,012 |
Research and development expenses | 13,959 |  |  | — |  |  | 8,448 |  |  | — |  |  | 22,407 |
Restructuring and other, net | (2,197 | ) |  | — |  |  | 2,490 |  |  | — |  |  | 293 |
Acquisition and integration related costs | 10,261 |  |  | — |  |  | — |  |  | — |  |  | 10,261 |
Intercompany service fee | 11,664 |  |  | — |  |  | (11,664 | ) |  | — |  |  | — |
Operating profit | 51,362 |  |  | — |  |  | 59,824 |  |  | (4,713 | ) |  | 106,473 |
Interest and financing expenses | (8,791 | ) |  | — |  |  | 42 |  |  | — |  |  | (8,749 | )
Other income (expenses), net | (3,151 | ) |  | — |  |  | (3,467 | ) |  | — |  |  | (6,618 | )
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 39,420 |  |  | — |  |  | 56,399 |  |  | (4,713 | ) |  | 91,106 |
Income tax expense | 7,636 |  |  | — |  |  | 5,823 |  |  | (1,722 | ) |  | 11,737 |
Income from continuing operations before equity in net income of unconsolidated investments | 31,784 |  |  | — |  |  | 50,576 |  |  | (2,991 | ) |  | 79,369 |
Equity in net income of unconsolidated investments (net of tax) | 997 |  |  | — |  |  | 7,653 |  |  | — |  |  | 8,650 |
Net income from continuing operations | 32,781 |  |  | — |  |  | 58,229 |  |  | (2,991 | ) |  | 88,019 |
Loss from discontinued operations (net of tax) | 608 |  |  | — |  |  | (7,287 | ) |  | — |  |  | (6,679 | )
Equity in undistributed earnings of subsidiaries | 39,405 |  |  | — |  |  | — |  |  | (39,405 | ) |  | — |
Net income | 72,794 |  |  | — |  |  | 50,942 |  |  | (42,396 | ) |  | 81,340 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | (8,546 | ) |  | — |  |  | (8,546 | )
Net income attributable to Albemarle Corporation | $ | 72,794 |  |  | $ | — |  |  | $ | 42,396 |  |  | $ | (42,396 | ) |  | $ | 72,794 |

Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended September 30, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 72,794 |  |  | $ | — |  |  | $ | 50,942 |  |  | $ | (42,396 | ) |  | $ | 81,340 |
Total other comprehensive loss, net of tax | (101,295 | ) |  | — |  |  | (100,260 | ) |  | 100,135 |  |  | (101,420 | )
Comprehensive loss | (28,501 | ) |  | — |  |  | (49,318 | ) |  | 57,739 |  |  | (20,080 | )
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (8,421 | ) |  | — |  |  | (8,421 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (28,501 | ) |  | $ | — |  |  | $ | (57,739 | ) |  | $ | 57,739 |  |  | $ | (28,501 | )

34

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 1,198,531 |  |  | $ | — |  |  | $ | 1,169,507 |  |  | $ | (521,056 | ) |  | $ | 1,846,982 |
Cost of goods sold | 804,764 |  |  | — |  |  | 953,726 |  |  | (519,916 | ) |  | 1,238,574 |
Gross profit | 393,767 |  |  | — |  |  | 215,781 |  |  | (1,140 | ) |  | 608,408 |
Selling, general and administrative expenses | 141,411 |  |  | — |  |  | 69,716 |  |  | — |  |  | 211,127 |
Research and development expenses | 41,772 |  |  | — |  |  | 25,144 |  |  | — |  |  | 66,916 |
Restructuring and other, net | 8,049 |  |  | — |  |  | 12,576 |  |  | — |  |  | 20,625 |
Acquisition and integration related costs | 15,104 |  |  | — |  |  | — |  |  | — |  |  | 15,104 |
Intercompany service fee | 23,672 |  |  | — |  |  | (23,672 | ) |  | — |  |  | — |
Operating profit | 163,759 |  |  | — |  |  | 132,017 |  |  | (1,140 | ) |  | 294,636 |
Interest and financing expenses | (26,320 | ) |  | — |  |  | 65 |  |  | — |  |  | (26,255 | )
Intergroup interest and financing expenses | 6,010 |  |  | — |  |  | (6,010 | ) |  | — |  |  | — |
Other income (expenses), net | (2,161 | ) |  | — |  |  | (4,293 | ) |  | — |  |  | (6,454 | )
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 141,288 |  |  | — |  |  | 121,779 |  |  | (1,140 | ) |  | 261,927 |
Income tax expense | 40,156 |  |  | — |  |  | 6,960 |  |  | (416 | ) |  | 46,700 |
Income from continuing operations before equity in net income of unconsolidated investments | 101,132 |  |  | — |  |  | 114,819 |  |  | (724 | ) |  | 215,227 |
Equity in net income of unconsolidated investments (net of tax) | 4,926 |  |  | — |  |  | 23,274 |  |  | — |  |  | 28,200 |
Net income from continuing operations | 106,058 |  |  | — |  |  | 138,093 |  |  | (724 | ) |  | 243,427 |
Loss from discontinued operations (net of tax) | (20,549 | ) |  | — |  |  | (47,924 | ) |  | — |  |  | (68,473 | )
Equity in undistributed earnings of subsidiaries | 66,315 |  |  | — |  |  | — |  |  | (66,315 | ) |  | — |
Net income | 151,824 |  |  | — |  |  | 90,169 |  |  | (67,039 | ) |  | 174,954 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | (23,130 | ) |  | — |  |  | (23,130 | )
Net income attributable to Albemarle Corporation | $ | 151,824 |  |  | $ | — |  |  | $ | 67,039 |  |  | $ | (67,039 | ) |  | $ | 151,824 |

Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 151,824 |  |  | $ | — |  |  | $ | 90,169 |  |  | $ | (67,039 | ) |  | $ | 174,954 |
Total other comprehensive loss, net of tax | (117,896 | ) |  | — |  |  | (106,319 | ) |  | 105,916 |  |  | (118,299 | )
Comprehensive income (loss) | 33,928 |  |  | — |  |  | (16,150 | ) |  | 38,877 |  |  | 56,655 |
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (22,727 | ) |  | — |  |  | (22,727 | )
Comprehensive income (loss) attributable to Albemarle Corporation | $ | 33,928 |  |  | $ | — |  |  | $ | (38,877 | ) |  | $ | 38,877 |  |  | $ | 33,928 |

35

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Balance Sheet
September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 4,416 |  |  | $ | 1,103 |  |  | $ | 228,971 |  |  | $ | — |  |  | $ | 234,490 |
Trade accounts receivable, less allowance for doubtful accounts | 92,694 |  |  | — |  |  | 525,607 |  |  | — |  |  | 618,301 |
Other accounts receivable | 15,031 |  |  | 23,915 |  |  | 37,325 |  |  | — |  |  | 76,271 |
Intergroup receivable | 191,295 |  |  | 12,455 |  |  | 352,388 |  |  | (556,138 | ) |  | — |
Inventories | 207,445 |  |  | — |  |  | 435,211 |  |  | (13,263 | ) |  | 629,393 |
Other current assets | 51,717 |  |  | — |  |  | 121,821 |  |  | (11,078 | ) |  | 162,460 |
Total current assets | 562,598 |  |  | 37,473 |  |  | 1,701,323 |  |  | (580,479 | ) |  | 1,720,915 |
Property, plant and equipment, at cost | 1,765,817 |  |  | — |  |  | 2,331,104 |  |  | — |  |  | 4,096,921 |
Less accumulated depreciation and amortization | 1,087,130 |  |  | — |  |  | 408,939 |  |  | — |  |  | 1,496,069 |
Net property, plant and equipment | 678,687 |  |  | — |  |  | 1,922,165 |  |  | — |  |  | 2,600,852 |
Investments | 74,429 |  |  | 4,891 |  |  | 374,549 |  |  | — |  |  | 453,869 |
Investment in subsidiaries | 7,073,096 |  |  | 11,164,495 |  |  | 6,380,635 |  |  | (24,618,226 | ) |  | — |
Other assets | 30,572 |  |  | 3,250 |  |  | 157,527 |  |  | — |  |  | 191,349 |
Goodwill | 49,212 |  |  | — |  |  | 2,761,874 |  |  | — |  |  | 2,811,086 |
Other intangibles, net of amortization | 19,265 |  |  | — |  |  | 1,877,728 |  |  | — |  |  | 1,896,993 |
Intergroup receivable | — |  |  | 3,307,998 |  |  | 1,847,122 |  |  | (5,155,120 | ) |  | — |
Total assets | $ | 8,487,859 |  |  | $ | 14,518,107 |  |  | $ | 17,022,923 |  |  | $ | (30,353,825 | ) |  | $ | 9,675,064 |
Liabilities and Equity |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |
Accounts payable | $ | 121,835 |  |  | $ | — |  |  | $ | 249,814 |  |  | $ | — |  |  | $ | 371,649 |
Intergroup payable | 365,452 |  |  | 102,086 |  |  | 88,600 |  |  | (556,138 | ) |  | — |
Accrued expenses | 189,637 |  |  | 137,161 |  |  | 240,134 |  |  | — |  |  | 566,932 |
Current portion of long-term debt | 272,994 |  |  | — |  |  | 11,374 |  |  | — |  |  | 284,368 |
Dividends payable | 32,295 |  |  | — |  |  | — |  |  | — |  |  | 32,295 |
Income taxes payable | — |  |  | 11,076 |  |  | 68,196 |  |  | (11,968 | ) |  | 67,304 |
Total current liabilities | 982,213 |  |  | 250,323 |  |  | 658,118 |  |  | (568,106 | ) |  | 1,322,548 |
Long-term debt | 2,230,720 |  |  | 1,287,643 |  |  | 40,601 |  |  | — |  |  | 3,558,964 |
Postretirement benefits | 55,401 |  |  | — |  |  | — |  |  | — |  |  | 55,401 |
Pension benefits | 120,593 |  |  | — |  |  | 330,463 |  |  | — |  |  | 451,056 |
Intergroup payable | 1,810,546 |  |  | 1,019,458 |  |  | 2,325,116 |  |  | (5,155,120 | ) |  | — |
Other noncurrent liabilities | 53,933 |  |  | 57,995 |  |  | 138,809 |  |  | — |  |  | 250,737 |
Deferred income taxes | 89,964 |  |  | 3,031 |  |  | 668,849 |  |  | — |  |  | 761,844 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity: |  |  |  |  |  |  |  |  |
Albemarle Corporation shareholders’ equity: |  |  |  |  |  |  |  |  |
Common stock | 1,122 |  |  | — |  |  | 6,808 |  |  | (6,808 | ) |  | 1,122 |
Additional paid-in capital | 2,056,082 |  |  | 12,350,226 |  |  | 12,159,684 |  |  | (24,509,910 | ) |  | 2,056,082 |
Accumulated other comprehensive loss | (386,413 | ) |  | (538,439 | ) |  | (713,001 | ) |  | 1,251,440 |  |  | (386,413 | )
Retained earnings | 1,473,698 |  |  | 87,870 |  |  | 1,277,451 |  |  | (1,365,321 | ) |  | 1,473,698 |
Total Albemarle Corporation shareholders’ equity | 3,144,489 |  |  | 11,899,657 |  |  | 12,730,942 |  |  | (24,630,599 | ) |  | 3,144,489 |
Noncontrolling interests | — |  |  | — |  |  | 130,025 |  |  | — |  |  | 130,025 |
Total equity | 3,144,489 |  |  | 11,899,657 |  |  | 12,860,967 |  |  | (24,630,599 | ) |  | 3,274,514 |
Total liabilities and equity | $ | 8,487,859 |  |  | $ | 14,518,107 |  |  | $ | 17,022,923 |  |  | $ | (30,353,825 | ) |  | $ | 9,675,064 |

36

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Balance Sheet
December 31, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 1,930,802 |  |  | $ | — |  |  | $ | 558,966 |  |  | $ | — |  |  | $ | 2,489,768 |
Trade accounts receivable, less allowance for doubtful accounts | 91,849 |  |  | — |  |  | 293,363 |  |  | — |  |  | 385,212 |
Other accounts receivable | 19,033 |  |  | — |  |  | 30,390 |  |  | — |  |  | 49,423 |
Intergroup receivable | 74,102 |  |  | — |  |  | 18,097 |  |  | (92,199 | ) |  | — |
Inventories | 201,006 |  |  | — |  |  | 171,543 |  |  | (14,188 | ) |  | 358,361 |
Other current assets | 45,901 |  |  | — |  |  | 25,111 |  |  | (4,926 | ) |  | 66,086 |
Total current assets | 2,362,693 |  |  | — |  |  | 1,097,470 |  |  | (111,313 | ) |  | 3,348,850 |
Property, plant and equipment, at cost | 1,726,690 |  |  | — |  |  | 893,980 |  |  | — |  |  | 2,620,670 |
Less accumulated depreciation and amortization | 1,047,372 |  |  | — |  |  | 341,430 |  |  | — |  |  | 1,388,802 |
Net property, plant and equipment | 679,318 |  |  | — |  |  | 552,550 |  |  | — |  |  | 1,231,868 |
Investments | 73,500 |  |  | — |  |  | 120,542 |  |  | — |  |  | 194,042 |
Investment in subsidiaries | 1,551,071 |  |  | — |  |  | — |  |  | (1,551,071 | ) |  | — |
Other assets | 35,837 |  |  | — |  |  | 125,119 |  |  | — |  |  | 160,956 |
Goodwill | 49,212 |  |  | — |  |  | 194,050 |  |  | — |  |  | 243,262 |
Other intangibles, net of amortization | 20,834 |  |  | — |  |  | 23,291 |  |  | — |  |  | 44,125 |
Total assets | $ | 4,772,465 |  |  | $ | — |  |  | $ | 2,113,022 |  |  | $ | (1,662,384 | ) |  | $ | 5,223,103 |
Liabilities and Equity |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |
Accounts payable | $ | 122,479 |  |  | $ | — |  |  | $ | 109,226 |  |  | $ | — |  |  | $ | 231,705 |
Intergroup payable | 18,097 |  |  | — |  |  | 74,102 |  |  | (92,199 | ) |  | — |
Accrued expenses | 84,619 |  |  | — |  |  | 81,555 |  |  | — |  |  | 166,174 |
Current portion of long-term debt | 692,280 |  |  | — |  |  | 18,816 |  |  | — |  |  | 711,096 |
Dividends payable | 21,458 |  |  | — |  |  | — |  |  | — |  |  | 21,458 |
Income taxes payable | 1,396 |  |  | — |  |  | 7,944 |  |  | 113 |  |  | 9,453 |
Total current liabilities | 940,329 |  |  | — |  |  | 291,643 |  |  | (92,086 | ) |  | 1,139,886 |
Long-term debt | 2,214,755 |  |  | — |  |  | 8,280 |  |  | — |  |  | 2,223,035 |
Postretirement benefits | 56,424 |  |  | — |  |  | — |  |  | — |  |  | 56,424 |
Pension benefits | 128,238 |  |  | — |  |  | 42,296 |  |  | — |  |  | 170,534 |
Other noncurrent liabilities | 51,936 |  |  | — |  |  | 35,769 |  |  | — |  |  | 87,705 |
Deferred income taxes | 21,318 |  |  | — |  |  | 35,566 |  |  | — |  |  | 56,884 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity: |  |  |  |  |  |  |  |  |
Albemarle Corporation shareholders’ equity: |  |  |  |  |  |  |  |  |
Common stock | 780 |  |  | — |  |  | 6,808 |  |  | (6,808 | ) |  | 780 |
Additional paid-in capital | 10,447 |  |  | — |  |  | 553,172 |  |  | (553,172 | ) |  | 10,447 |
Accumulated other comprehensive loss | (62,413 | ) |  | — |  |  | (51,073 | ) |  | 51,073 |  |  | (62,413 | )
Retained earnings | 1,410,651 |  |  | — |  |  | 1,061,391 |  |  | (1,061,391 | ) |  | 1,410,651 |
Total Albemarle Corporation shareholders’ equity | 1,359,465 |  |  | — |  |  | 1,570,298 |  |  | (1,570,298 | ) |  | 1,359,465 |
Noncontrolling interests | — |  |  | — |  |  | 129,170 |  |  | — |  |  | 129,170 |
Total equity | 1,359,465 |  |  | — |  |  | 1,699,468 |  |  | (1,570,298 | ) |  | 1,488,635 |
Total liabilities and equity | $ | 4,772,465 |  |  | $ | — |  |  | $ | 2,113,022 |  |  | $ | (1,662,384 | ) |  | $ | 5,223,103 |

37

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2015

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Cash and cash equivalents at beginning of year | $ | 1,930,802 |  |  | $ | — |  |  | $ | 558,966 |  |  | $ | — |  |  | $ | 2,489,768 |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities | 369,333 |  |  | (48,867 | ) |  | 19,839 |  |  | (23,402 | ) |  | 316,903 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |
Acquisition of Rockwood, net of cash acquired | (3,597,083 | ) |  | 159,409 |  |  | 1,386,029 |  |  | — |  |  | (2,051,645 | )
Other acquisitions, net of cash acquired | — |  |  | — |  |  | (48,845 | ) |  | — |  |  | (48,845 | )
Capital expenditures | (51,900 | ) |  | — |  |  | (112,668 | ) |  | — |  |  | (164,568 | )
Decrease in restricted cash | — |  |  | — |  |  | 57,550 |  |  | — |  |  | 57,550 |
Cash proceeds from divestitures, net | — |  |  | — |  |  | 6,133 |  |  | — |  |  | 6,133 |
Return of capital | — |  |  | — |  |  | 98,000 |  |  | — |  |  | 98,000 |
Sales of (investments in) marketable securities, net | 1,271 |  |  | — |  |  | (6 | ) |  | — |  |  | 1,265 |
Repayments from (long-term advances to) joint ventures | 2,156 |  |  | — |  |  | — |  |  | — |  |  | 2,156 |
Proceeds from intercompany investing related activity | — |  |  | 1,213,717 |  |  | 82 |  |  | (1,213,799 | ) |  | — |
Intercompany investing related payments | — |  |  | (1,324,960 | ) |  | (1,341,728 | ) |  | 2,666,688 |  |  | — |
Net cash (used in) provided by investing activities | (3,645,556 | ) |  | 48,166 |  |  | 44,547 |  |  | 1,452,889 |  |  | (2,099,954 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |
Repayments of long-term debt | (1,325,104 | ) |  | — |  |  | (7,189 | ) |  | — |  |  | (1,332,293 | )
Proceeds from borrowings of long-term debt | 1,000,000 |  |  | — |  |  | — |  |  | — |  |  | 1,000,000 |
Repayments of other borrowings, net | (16,018 | ) |  | — |  |  | (836 | ) |  | — |  |  | (16,854 | )
Dividends paid to shareholders | (86,770 | ) |  | — |  |  | — |  |  | — |  |  | (86,770 | )
Dividends paid to noncontrolling interests | — |  |  | — |  |  | (23,195 | ) |  | — |  |  | (23,195 | )
Intercompany dividends paid | — |  |  | — |  |  | (23,402 | ) |  | 23,402 |  |  | — |
Proceeds from exercise of stock options | 342 |  |  | — |  |  | — |  |  | — |  |  | 342 |
Excess tax benefits realized from stock-based compensation arrangements | 59 |  |  | — |  |  | — |  |  | — |  |  | 59 |
Withholding taxes paid on stock-based compensation award distributions | (1,218 | ) |  | — |  |  | — |  |  | — |  |  | (1,218 | )
Debt financing costs | (4,186 | ) |  | — |  |  | — |  |  | — |  |  | (4,186 | )
Other | — |  |  | — |  |  | (3,882 | ) |  | — |  |  | (3,882 | )
Proceeds from intercompany financing related activity | 1,845,770 |  |  | — |  |  | 820,918 |  |  | (2,666,688 | ) |  | — |
Intercompany financing related payments | (62,039 | ) |  | (82 | ) |  | (1,151,678 | ) |  | 1,213,799 |  |  | — |
Net cash provided by (used in) financing activities | 1,350,836 |  |  | (82 | ) |  | (389,264 | ) |  | (1,429,487 | ) |  | (467,997 | )
Net effect of foreign exchange on cash and cash equivalents | (999 | ) |  | 1,886 |  |  | (5,117 | ) |  | — |  |  | (4,230 | )
(Decrease) increase in cash and cash equivalents | (1,926,386 | ) |  | 1,103 |  |  | (329,995 | ) |  | — |  |  | (2,255,278 | )
Cash and cash equivalents at end of period | $ | 4,416 |  |  | $ | 1,103 |  |  | $ | 228,971 |  |  | $ | — |  |  | $ | 234,490 |

38

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2014

(In Thousands) | Issuer |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Cash and cash equivalents at beginning of year | $ | 88,476 |  |  | $ | — |  |  | $ | 388,763 |  |  | $ | — |  |  | $ | 477,239 |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by operating activities | 203,834 |  |  | — |  |  | 232,718 |  |  | (6,010 | ) |  | 430,542 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |
Capital expenditures | (57,124 | ) |  | — |  |  | (19,558 | ) |  | — |  |  | (76,682 | )
Cash proceeds from divestitures, net | 97,523 |  |  | — |  |  | 7,195 |  |  | — |  |  | 104,718 |
Sales of (investments in) marketable securities, net | 962 |  |  | — |  |  | (19 | ) |  | — |  |  | 943 |
Repayments from (long-term advances to) joint ventures | — |  |  | — |  |  | (7,499 | ) |  | — |  |  | (7,499 | )
Net cash provided by (used in) investing activities | 41,361 |  |  | — |  |  | (19,881 | ) |  | — |  |  | 21,480 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |
Repayments of long-term debt | (108 | ) |  | — |  |  | (2,915 | ) |  | — |  |  | (3,023 | )
Repayments of other borrowings, net | (7,124 | ) |  | — |  |  | (16,430 | ) |  | — |  |  | (23,554 | )
Dividends paid to shareholders | (62,827 | ) |  | — |  |  | — |  |  | — |  |  | (62,827 | )
Dividends paid to noncontrolling interests | — |  |  | — |  |  | (7,612 | ) |  | — |  |  | (7,612 | )
Intercompany dividends paid | — |  |  | — |  |  | (6,010 | ) |  | 6,010 |  |  | — |
Repurchases of common stock | (150,000 | ) |  | — |  |  | — |  |  | — |  |  | (150,000 | )
Proceeds from exercise of stock options | 2,713 |  |  | — |  |  | — |  |  | — |  |  | 2,713 |
Excess tax benefits realized from stock-based compensation arrangements | 836 |  |  | — |  |  | — |  |  | — |  |  | 836 |
Withholding taxes paid on stock-based compensation award distributions | (3,208 | ) |  | — |  |  | — |  |  | — |  |  | (3,208 | )
Debt financing costs | (3,074 | ) |  | — |  |  | — |  |  | — |  |  | (3,074 | )
Net cash used in financing activities | (222,792 | ) |  | — |  |  | (32,967 | ) |  | 6,010 |  |  | (249,749 | )
Net effect of foreign exchange on cash and cash equivalents | — |  |  | — |  |  | (26,392 | ) |  | — |  |  | (26,392 | )
Increase in cash and cash equivalents | 22,403 |  |  | — |  |  | 153,478 |  |  | — |  |  | 175,881 |
Cash and cash equivalents at end of period | $ | 110,879 |  |  | $ | — |  |  | $ | 542,241 |  |  | $ | — |  |  | $ | 653,120 |

39

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
The 4.625% senior notes issued in September 2012 by RSGI (the “Issuer”) were fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Albemarle Corporation (the “Parent Company Guarantor”) and RHI (the “Guarantor Subsidiary,” and together with the Parent Company Guarantor, the “Guarantors”). The guarantees are general senior unsecured obligations of the Guarantors and ranked equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantors that were not, by their terms, otherwise expressly subordinated. The note guarantees were released when the 4.625% senior notes were repaid on October 15, 2015.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among Parent Company Guarantor, Issuer, Guarantor Subsidiary and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantors to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Parent Company Guarantor, Issuer, Guarantor Subsidiary, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.
40

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 357,269 |  |  | $ | — |  |  | $ | — |  |  | $ | 734,109 |  |  | $ | (186,285 | ) |  | $ | 905,093 |
Cost of goods sold | 252,634 |  |  | — |  |  | — |  |  | 526,534 |  |  | (186,285 | ) |  | 592,883 |
Gross profit | 104,635 |  |  | — |  |  | — |  |  | 207,575 |  |  | — |  |  | 312,210 |
Selling, general and administrative expenses | 40,721 |  |  | — |  |  | — |  |  | 96,894 |  |  | — |  |  | 137,615 |
Research and development expenses | 12,874 |  |  | — |  |  | — |  |  | 12,421 |  |  | — |  |  | 25,295 |
Restructuring and other, net | (61 | ) |  | — |  |  | — |  |  | (6,743 | ) |  | — |  |  | (6,804 | )
Acquisition and integration related costs | 28,479 |  |  | — |  |  | — |  |  | 14,319 |  |  | — |  |  | 42,798 |
Intercompany service fee | 5,914 |  |  | — |  |  | — |  |  | (5,914 | ) |  | — |  |  | — |
Operating profit | 16,708 |  |  | — |  |  | — |  |  | 96,598 |  |  | — |  |  | 113,306 |
Interest and financing expenses | (21,758 | ) |  | (12,546 | ) |  | — |  |  | 2,246 |  |  | — |  |  | (32,058 | )
Intergroup interest and financing expenses | (8,697 | ) |  | 15,147 |  |  | — |  |  | (6,450 | ) |  | — |  |  | — |
Other income (expenses), net | (2,320 | ) |  | 4,376 |  |  | — |  |  | (1,590 | ) |  | — |  |  | 466 |
Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments | (16,067 | ) |  | 6,977 |  |  | — |  |  | 90,804 |  |  | — |  |  | 81,714 |
Income tax expense (benefit) | (9,491 | ) |  | 4,020 |  |  | — |  |  | 22,363 |  |  | — |  |  | 16,892 |
Income (loss) from continuing operations before equity in net income of unconsolidated investments | (6,576 | ) |  | 2,957 |  |  | — |  |  | 68,441 |  |  | — |  |  | 64,822 |
Equity in net income of unconsolidated investments (net of tax) | 1,315 |  |  | — |  |  | — |  |  | 4,735 |  |  | — |  |  | 6,050 |
Net income (loss) from continuing operations | (5,261 | ) |  | 2,957 |  |  | — |  |  | 73,176 |  |  | — |  |  | 70,872 |
Income (loss) from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Equity in undistributed earnings of subsidiaries | 70,653 |  |  | 15,254 |  |  | 18,211 |  |  | 18,211 |  |  | (122,329 | ) |  | — |
Net income | 65,392 |  |  | 18,211 |  |  | 18,211 |  |  | 91,387 |  |  | (122,329 | ) |  | 70,872 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (5,480 | ) |  | — |  |  | (5,480 | )
Net income attributable to Albemarle Corporation | $ | 65,392 |  |  | $ | 18,211 |  |  | $ | 18,211 |  |  | $ | 85,907 |  |  | $ | (122,329 | ) |  | $ | 65,392 |

Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 65,392 |  |  | $ | 18,211 |  |  | $ | 18,211 |  |  | $ | 91,387 |  |  | $ | (122,329 | ) |  | $ | 70,872 |
Total other comprehensive loss, net of tax | (70,007 | ) |  | (51,882 | ) |  | (51,882 | ) |  | (118,228 | ) |  | 221,595 |  |  | (70,404 | )
Comprehensive income (loss) | (4,615 | ) |  | (33,671 | ) |  | (33,671 | ) |  | (26,841 | ) |  | 99,266 |  |  | 468 |
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (5,083 | ) |  | — |  |  | (5,083 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (4,615 | ) |  | $ | (33,671 | ) |  | $ | (33,671 | ) |  | $ | (31,924 | ) |  | $ | 99,266 |  |  | $ | (4,615 | )

41

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 1,109,661 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,153,749 |  |  | $ | (542,428 | ) |  | $ | 2,720,982 |
Cost of goods sold | 767,626 |  |  | — |  |  | — |  |  | 1,622,121 |  |  | (540,007 | ) |  | 1,849,740 |
Gross profit | 342,035 |  |  | — |  |  | — |  |  | 531,628 |  |  | (2,421 | ) |  | 871,242 |
Selling, general and administrative expenses | 127,591 |  |  | 46 |  |  | — |  |  | 293,455 |  |  | — |  |  | 421,092 |
Research and development expenses | 39,143 |  |  | — |  |  | — |  |  | 37,980 |  |  | — |  |  | 77,123 |
Restructuring and other, net | (61 | ) |  | — |  |  | — |  |  | (6,743 | ) |  | — |  |  | (6,804 | )
Acquisition and integration related costs | 86,648 |  |  | — |  |  | — |  |  | 39,839 |  |  | — |  |  | 126,487 |
Intercompany service fee | 17,557 |  |  | — |  |  | — |  |  | (17,557 | ) |  | — |  |  | — |
Operating profit (loss) | 71,157 |  |  | (46 | ) |  | — |  |  | 184,654 |  |  | (2,421 | ) |  | 253,344 |
Interest and financing expenses | (70,279 | ) |  | (36,257 | ) |  | — |  |  | 5,550 |  |  | — |  |  | (100,986 | )
Intergroup interest and financing expenses | (23,143 | ) |  | 40,862 |  |  | — |  |  | (17,719 | ) |  | — |  |  | — |
Other income (expenses), net | 6,624 |  |  | (26,844 | ) |  | — |  |  | 71,184 |  |  | — |  |  | 50,964 |
Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments | (15,641 | ) |  | (22,285 | ) |  | — |  |  | 243,669 |  |  | (2,421 | ) |  | 203,322 |
Income tax expense (benefit) | (1,148 | ) |  | 6,992 |  |  | — |  |  | 43,219 |  |  | (892 | ) |  | 48,171 |
Income (loss) from continuing operations before equity in net income of unconsolidated investments | (14,493 | ) |  | (29,277 | ) |  | — |  |  | 200,450 |  |  | (1,529 | ) |  | 155,151 |
Equity in net income of unconsolidated investments (net of tax) | 5,072 |  |  | — |  |  | — |  |  | 17,164 |  |  | — |  |  | 22,236 |
Net income (loss) from continuing operations | (9,421 | ) |  | (29,277 | ) |  | — |  |  | 217,614 |  |  | (1,529 | ) |  | 177,387 |
Income (loss) from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Equity in undistributed earnings of subsidiaries | 170,075 |  |  | 73,212 |  |  | 43,935 |  |  | 43,935 |  |  | (331,157 | ) |  | — |
Net income | 160,654 |  |  | 43,935 |  |  | 43,935 |  |  | 261,549 |  |  | (332,686 | ) |  | 177,387 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (16,733 | ) |  | — |  |  | (16,733 | )
Net income attributable to Albemarle Corporation | $ | 160,654 |  |  | $ | 43,935 |  |  | $ | 43,935 |  |  | $ | 244,816 |  |  | $ | (332,686 | ) |  | $ | 160,654 |

Condensed Consolidating Statement of Comprehensive Loss
Nine Months Ended September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 160,654 |  |  | $ | 43,935 |  |  | $ | 43,935 |  |  | $ | 261,549 |  |  | $ | (332,686 | ) |  | $ | 177,387 |
Total other comprehensive loss, net of tax | (324,000 | ) |  | (269,219 | ) |  | (269,220 | ) |  | (662,793 | ) |  | 1,200,684 |  |  | (324,548 | )
Comprehensive loss | (163,346 | ) |  | (225,284 | ) |  | (225,285 | ) |  | (401,244 | ) |  | 867,998 |  |  | (147,161 | )
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (16,185 | ) |  | — |  |  | (16,185 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (163,346 | ) |  | $ | (225,284 | ) |  | $ | (225,285 | ) |  | $ | (417,429 | ) |  | $ | 867,998 |  |  | $ | (163,346 | )

42

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 403,072 |  |  | $ | — |  |  | $ | — |  |  | $ | 424,423 |  |  | $ | (185,077 | ) |  | $ | 642,418 |
Cost of goods sold | 275,187 |  |  | — |  |  | — |  |  | 342,149 |  |  | (180,364 | ) |  | 436,972 |
Gross profit | 127,885 |  |  | — |  |  | — |  |  | 82,274 |  |  | (4,713 | ) |  | 205,446 |
Selling, general and administrative expenses | 42,836 |  |  | — |  |  | — |  |  | 23,176 |  |  | — |  |  | 66,012 |
Research and development expenses | 13,959 |  |  | — |  |  | — |  |  | 8,448 |  |  | — |  |  | 22,407 |
Restructuring and other, net | (2,197 | ) |  | — |  |  | — |  |  | 2,490 |  |  | — |  |  | 293 |
Acquisition and integration related costs | 10,261 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10,261 |
Intercompany service fee | 11,664 |  |  | — |  |  | — |  |  | (11,664 | ) |  | — |  |  | — |
Operating profit | 51,362 |  |  | — |  |  | — |  |  | 59,824 |  |  | (4,713 | ) |  | 106,473 |
Interest and financing expenses | (8,791 | ) |  | — |  |  | — |  |  | 42 |  |  | — |  |  | (8,749 | )
Other income (expenses), net | (3,151 | ) |  | — |  |  | — |  |  | (3,467 | ) |  | — |  |  | (6,618 | )
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 39,420 |  |  | — |  |  | — |  |  | 56,399 |  |  | (4,713 | ) |  | 91,106 |
Income tax expense | 7,636 |  |  | — |  |  | — |  |  | 5,823 |  |  | (1,722 | ) |  | 11,737 |
Income from continuing operations before equity in net income of unconsolidated investments | 31,784 |  |  | — |  |  | — |  |  | 50,576 |  |  | (2,991 | ) |  | 79,369 |
Equity in net income of unconsolidated investments (net of tax) | 997 |  |  | — |  |  | — |  |  | 7,653 |  |  | — |  |  | 8,650 |
Net income from continuing operations | 32,781 |  |  | — |  |  | — |  |  | 58,229 |  |  | (2,991 | ) |  | 88,019 |
Loss from discontinued operations (net of tax) | 608 |  |  | — |  |  | — |  |  | (7,287 | ) |  | — |  |  | (6,679 | )
Equity in undistributed earnings of subsidiaries | 39,405 |  |  | — |  |  | — |  |  | — |  |  | (39,405 | ) |  | — |
Net income | 72,794 |  |  | — |  |  | — |  |  | 50,942 |  |  | (42,396 | ) |  | 81,340 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (8,546 | ) |  | — |  |  | (8,546 | )
Net income attributable to Albemarle Corporation | $ | 72,794 |  |  | $ | — |  |  | $ | — |  |  | $ | 42,396 |  |  | $ | (42,396 | ) |  | $ | 72,794 |

Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended September 30, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 72,794 |  |  | $ | — |  |  | $ | — |  |  | $ | 50,942 |  |  | $ | (42,396 | ) |  | $ | 81,340 |
Total other comprehensive loss, net of tax | (101,295 | ) |  | — |  |  | — |  |  | (100,260 | ) |  | 100,135 |  |  | (101,420 | )
Comprehensive loss | (28,501 | ) |  | — |  |  | — |  |  | (49,318 | ) |  | 57,739 |  |  | (20,080 | )
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (8,421 | ) |  | — |  |  | (8,421 | )
Comprehensive loss attributable to Albemarle Corporation | $ | (28,501 | ) |  | $ | — |  |  | $ | — |  |  | $ | (57,739 | ) |  | $ | 57,739 |  |  | $ | (28,501 | )

43

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net sales | $ | 1,198,531 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,169,507 |  |  | $ | (521,056 | ) |  | $ | 1,846,982 |
Cost of goods sold | 804,764 |  |  | — |  |  | — |  |  | 953,726 |  |  | (519,916 | ) |  | 1,238,574 |
Gross profit | 393,767 |  |  | — |  |  | — |  |  | 215,781 |  |  | (1,140 | ) |  | 608,408 |
Selling, general and administrative expenses | 141,411 |  |  | — |  |  | — |  |  | 69,716 |  |  | — |  |  | 211,127 |
Research and development expenses | 41,772 |  |  | — |  |  | — |  |  | 25,144 |  |  | — |  |  | 66,916 |
Restructuring and other, net | 8,049 |  |  | — |  |  | — |  |  | 12,576 |  |  | — |  |  | 20,625 |
Acquisition and integration related costs | 15,104 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15,104 |
Intercompany service fee | 23,672 |  |  | — |  |  | — |  |  | (23,672 | ) |  | — |  |  | — |
Operating profit | 163,759 |  |  | — |  |  | — |  |  | 132,017 |  |  | (1,140 | ) |  | 294,636 |
Interest and financing expenses | (26,320 | ) |  | — |  |  | — |  |  | 65 |  |  | — |  |  | (26,255 | )
Intergroup interest and financing expenses | 6,010 |  |  | — |  |  | — |  |  | (6,010 | ) |  | — |  |  | — |
Other income (expenses), net | (2,161 | ) |  | — |  |  | — |  |  | (4,293 | ) |  | — |  |  | (6,454 | )
Income from continuing operations before income taxes and equity in net income of unconsolidated investments | 141,288 |  |  | — |  |  | — |  |  | 121,779 |  |  | (1,140 | ) |  | 261,927 |
Income tax expense | 40,156 |  |  | — |  |  | — |  |  | 6,960 |  |  | (416 | ) |  | 46,700 |
Income from continuing operations before equity in net income of unconsolidated investments | 101,132 |  |  | — |  |  | — |  |  | 114,819 |  |  | (724 | ) |  | 215,227 |
Equity in net income of unconsolidated investments (net of tax) | 4,926 |  |  | — |  |  | — |  |  | 23,274 |  |  | — |  |  | 28,200 |
Net income from continuing operations | 106,058 |  |  | — |  |  | — |  |  | 138,093 |  |  | (724 | ) |  | 243,427 |
Loss from discontinued operations (net of tax) | (20,549 | ) |  | — |  |  | — |  |  | (47,924 | ) |  | — |  |  | (68,473 | )
Equity in undistributed earnings of subsidiaries | 66,315 |  |  | — |  |  | — |  |  | — |  |  | (66,315 | ) |  | — |
Net income | 151,824 |  |  | — |  |  | — |  |  | 90,169 |  |  | (67,039 | ) |  | 174,954 |
Net income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (23,130 | ) |  | — |  |  | (23,130 | )
Net income attributable to Albemarle Corporation | $ | 151,824 |  |  | $ | — |  |  | $ | — |  |  | $ | 67,039 |  |  | $ | (67,039 | ) |  | $ | 151,824 |

Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Net income | $ | 151,824 |  |  | $ | — |  |  | $ | — |  |  | $ | 90,169 |  |  | $ | (67,039 | ) |  | $ | 174,954 |
Total other comprehensive loss, net of tax | (117,896 | ) |  | — |  |  | — |  |  | (106,319 | ) |  | 105,916 |  |  | (118,299 | )
Comprehensive income (loss) | 33,928 |  |  | — |  |  | — |  |  | (16,150 | ) |  | 38,877 |  |  | 56,655 |
Comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | — |  |  | (22,727 | ) |  | — |  |  | (22,727 | )
Comprehensive income (loss) attributable to Albemarle Corporation | $ | 33,928 |  |  | $ | — |  |  | $ | — |  |  | $ | (38,877 | ) |  | $ | 38,877 |  |  | $ | 33,928 |

44

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Balance Sheet
September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 4,416 |  |  | $ | 1,103 |  |  | $ | — |  |  | $ | 228,971 |  |  | $ | — |  |  | $ | 234,490 |
Trade accounts receivable, less allowance for doubtful accounts | 92,694 |  |  | — |  |  | — |  |  | 525,607 |  |  | — |  |  | 618,301 |
Other accounts receivable | 15,031 |  |  | 23,915 |  |  | — |  |  | 37,325 |  |  | — |  |  | 76,271 |
Intergroup receivable | 191,295 |  |  | 12,455 |  |  | — |  |  | 352,388 |  |  | (556,138 | ) |  | — |
Inventories | 207,445 |  |  | — |  |  | — |  |  | 435,211 |  |  | (13,263 | ) |  | 629,393 |
Other current assets | 51,717 |  |  | — |  |  | — |  |  | 121,821 |  |  | (11,078 | ) |  | 162,460 |
Total current assets | 562,598 |  |  | 37,473 |  |  | — |  |  | 1,701,323 |  |  | (580,479 | ) |  | 1,720,915 |
Property, plant and equipment, at cost | 1,765,817 |  |  | — |  |  | — |  |  | 2,331,104 |  |  | — |  |  | 4,096,921 |
Less accumulated depreciation and amortization | 1,087,130 |  |  | — |  |  | — |  |  | 408,939 |  |  | — |  |  | 1,496,069 |
Net property, plant and equipment | 678,687 |  |  | — |  |  | — |  |  | 1,922,165 |  |  | — |  |  | 2,600,852 |
Investments | 74,429 |  |  | 4,891 |  |  | — |  |  | 374,549 |  |  | — |  |  | 453,869 |
Investment in subsidiaries | 7,073,096 |  |  | 4,783,860 |  |  | 6,380,635 |  |  | 6,380,635 |  |  | (24,618,226 | ) |  | — |
Other assets | 30,572 |  |  | 3,250 |  |  | — |  |  | 157,527 |  |  | — |  |  | 191,349 |
Goodwill | 49,212 |  |  | — |  |  | — |  |  | 2,761,874 |  |  | — |  |  | 2,811,086 |
Other intangibles, net of amortization | 19,265 |  |  | — |  |  | — |  |  | 1,877,728 |  |  | — |  |  | 1,896,993 |
Intergroup receivable | — |  |  | 3,305,771 |  |  | 2,227 |  |  | 1,847,122 |  |  | (5,155,120 | ) |  | — |
Total assets | $ | 8,487,859 |  |  | $ | 8,135,245 |  |  | $ | 6,382,862 |  |  | $ | 17,022,923 |  |  | $ | (30,353,825 | ) |  | $ | 9,675,064 |
Liabilities and Equity |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |
Accounts payable | $ | 121,835 |  |  | $ | — |  |  | $ | — |  |  | $ | 249,814 |  |  | $ | — |  |  | $ | 371,649 |
Intergroup payable | 365,452 |  |  | 102,004 |  |  | 82 |  |  | 88,600 |  |  | (556,138 | ) |  | — |
Accrued expenses | 189,637 |  |  | 137,161 |  |  | — |  |  | 240,134 |  |  | — |  |  | 566,932 |
Current portion of long-term debt | 272,994 |  |  | — |  |  | — |  |  | 11,374 |  |  | — |  |  | 284,368 |
Dividends payable | 32,295 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 32,295 |
Income taxes payable | — |  |  | 11,076 |  |  | — |  |  | 68,196 |  |  | (11,968 | ) |  | 67,304 |
Total current liabilities | 982,213 |  |  | 250,241 |  |  | 82 |  |  | 658,118 |  |  | (568,106 | ) |  | 1,322,548 |
Long-term debt | 2,230,720 |  |  | 1,287,643 |  |  | — |  |  | 40,601 |  |  | — |  |  | 3,558,964 |
Postretirement benefits | 55,401 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 55,401 |
Pension benefits | 120,593 |  |  | — |  |  | — |  |  | 330,463 |  |  | — |  |  | 451,056 |
Intergroup payable | 1,810,546 |  |  | 155,701 |  |  | 863,757 |  |  | 2,325,116 |  |  | (5,155,120 | ) |  | — |
Other noncurrent liabilities | 53,933 |  |  | 57,995 |  |  | — |  |  | 138,809 |  |  | — |  |  | 250,737 |
Deferred income taxes | 89,964 |  |  | 3,031 |  |  | — |  |  | 668,849 |  |  | — |  |  | 761,844 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity: |  |  |  |  |  |  |  |  |  |  |
Albemarle Corporation shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |
Common stock | 1,122 |  |  | — |  |  | — |  |  | 6,808 |  |  | (6,808 | ) |  | 1,122 |
Additional paid-in capital | 2,056,082 |  |  | 6,605,919 |  |  | 5,744,307 |  |  | 12,159,684 |  |  | (24,509,910 | ) |  | 2,056,082 |
Accumulated other comprehensive loss | (386,413 | ) |  | (269,220 | ) |  | (269,219 | ) |  | (713,001 | ) |  | 1,251,440 |  |  | (386,413 | )
Retained earnings | 1,473,698 |  |  | 43,935 |  |  | 43,935 |  |  | 1,277,451 |  |  | (1,365,321 | ) |  | 1,473,698 |
Total Albemarle Corporation shareholders’ equity | 3,144,489 |  |  | 6,380,634 |  |  | 5,519,023 |  |  | 12,730,942 |  |  | (24,630,599 | ) |  | 3,144,489 |
Noncontrolling interests | — |  |  | — |  |  | — |  |  | 130,025 |  |  | — |  |  | 130,025 |
Total equity | 3,144,489 |  |  | 6,380,634 |  |  | 5,519,023 |  |  | 12,860,967 |  |  | (24,630,599 | ) |  | 3,274,514 |
Total liabilities and equity | $ | 8,487,859 |  |  | $ | 8,135,245 |  |  | $ | 6,382,862 |  |  | $ | 17,022,923 |  |  | $ | (30,353,825 | ) |  | $ | 9,675,064 |

45

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Balance Sheet
December 31, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 1,930,802 |  |  | $ | — |  |  | $ | — |  |  | $ | 558,966 |  |  | $ | — |  |  | $ | 2,489,768 |
Trade accounts receivable, less allowance for doubtful accounts | 91,849 |  |  | — |  |  | — |  |  | 293,363 |  |  | — |  |  | 385,212 |
Other accounts receivable | 19,033 |  |  | — |  |  | — |  |  | 30,390 |  |  | — |  |  | 49,423 |
Intergroup receivable | 74,102 |  |  | — |  |  | — |  |  | 18,097 |  |  | (92,199 | ) |  | — |
Inventories | 201,006 |  |  | — |  |  | — |  |  | 171,543 |  |  | (14,188 | ) |  | 358,361 |
Other current assets | 45,901 |  |  | — |  |  | — |  |  | 25,111 |  |  | (4,926 | ) |  | 66,086 |
Total current assets | 2,362,693 |  |  | — |  |  | — |  |  | 1,097,470 |  |  | (111,313 | ) |  | 3,348,850 |
Property, plant and equipment, at cost | 1,726,690 |  |  | — |  |  | — |  |  | 893,980 |  |  | — |  |  | 2,620,670 |
Less accumulated depreciation and amortization | 1,047,372 |  |  | — |  |  | — |  |  | 341,430 |  |  | — |  |  | 1,388,802 |
Net property, plant and equipment | 679,318 |  |  | — |  |  | — |  |  | 552,550 |  |  | — |  |  | 1,231,868 |
Investments | 73,500 |  |  | — |  |  | — |  |  | 120,542 |  |  | — |  |  | 194,042 |
Investment in subsidiaries | 1,551,071 |  |  | — |  |  | — |  |  | — |  |  | (1,551,071 | ) |  | — |
Other assets | 35,837 |  |  | — |  |  | — |  |  | 125,119 |  |  | — |  |  | 160,956 |
Goodwill | 49,212 |  |  | — |  |  | — |  |  | 194,050 |  |  | — |  |  | 243,262 |
Other intangibles, net of amortization | 20,834 |  |  | — |  |  | — |  |  | 23,291 |  |  | — |  |  | 44,125 |
Total assets | $ | 4,772,465 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,113,022 |  |  | $ | (1,662,384 | ) |  | $ | 5,223,103 |
Liabilities and Equity |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |
Accounts payable | $ | 122,479 |  |  | $ | — |  |  | $ | — |  |  | $ | 109,226 |  |  | $ | — |  |  | $ | 231,705 |
Intergroup payable | 18,097 |  |  | — |  |  | — |  |  | 74,102 |  |  | (92,199 | ) |  | — |
Accrued expenses | 84,619 |  |  | — |  |  | — |  |  | 81,555 |  |  | — |  |  | 166,174 |
Current portion of long-term debt | 692,280 |  |  | — |  |  | — |  |  | 18,816 |  |  | — |  |  | 711,096 |
Dividends payable | 21,458 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 21,458 |
Income taxes payable | 1,396 |  |  | — |  |  | — |  |  | 7,944 |  |  | 113 |  |  | 9,453 |
Total current liabilities | 940,329 |  |  | — |  |  | — |  |  | 291,643 |  |  | (92,086 | ) |  | 1,139,886 |
Long-term debt | 2,214,755 |  |  | — |  |  | — |  |  | 8,280 |  |  | — |  |  | 2,223,035 |
Postretirement benefits | 56,424 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 56,424 |
Pension benefits | 128,238 |  |  | — |  |  | — |  |  | 42,296 |  |  | — |  |  | 170,534 |
Other noncurrent liabilities | 51,936 |  |  | — |  |  | — |  |  | 35,769 |  |  | — |  |  | 87,705 |
Deferred income taxes | 21,318 |  |  | — |  |  | — |  |  | 35,566 |  |  | — |  |  | 56,884 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity: |  |  |  |  |  |  |  |  |  |  |
Albemarle Corporation shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |
Common stock | 780 |  |  | — |  |  | — |  |  | 6,808 |  |  | (6,808 | ) |  | 780 |
Additional paid-in capital | 10,447 |  |  | — |  |  | — |  |  | 553,172 |  |  | (553,172 | ) |  | 10,447 |
Accumulated other comprehensive loss | (62,413 | ) |  | — |  |  | — |  |  | (51,073 | ) |  | 51,073 |  |  | (62,413 | )
Retained earnings | 1,410,651 |  |  | — |  |  | — |  |  | 1,061,391 |  |  | (1,061,391 | ) |  | 1,410,651 |
Total Albemarle Corporation shareholders’ equity | 1,359,465 |  |  | — |  |  | — |  |  | 1,570,298 |  |  | (1,570,298 | ) |  | 1,359,465 |
Noncontrolling interests | — |  |  | — |  |  | — |  |  | 129,170 |  |  | — |  |  | 129,170 |
Total equity | 1,359,465 |  |  | — |  |  | — |  |  | 1,699,468 |  |  | (1,570,298 | ) |  | 1,488,635 |
Total liabilities and equity | $ | 4,772,465 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,113,022 |  |  | $ | (1,662,384 | ) |  | $ | 5,223,103 |

46

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2015

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Cash and cash equivalents at beginning of year | $ | 1,930,802 |  |  | $ | — |  |  | $ | — |  |  | $ | 558,966 |  |  | $ | — |  |  | $ | 2,489,768 |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities | 369,333 |  |  | (48,949 | ) |  | 82 |  |  | 19,839 |  |  | (23,402 | ) |  | 316,903 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |
Acquisition of Rockwood, net of cash acquired | (3,597,083 | ) |  | 159,409 |  |  | — |  |  | 1,386,029 |  |  | — |  |  | (2,051,645 | )
Other acquisitions, net of cash acquired | — |  |  | — |  |  | — |  |  | (48,845 | ) |  | — |  |  | (48,845 | )
Capital expenditures | (51,900 | ) |  | — |  |  | — |  |  | (112,668 | ) |  | — |  |  | (164,568 | )
Decrease in restricted cash | — |  |  | — |  |  | — |  |  | 57,550 |  |  | — |  |  | 57,550 |
Cash proceeds from divestitures, net | — |  |  | — |  |  | — |  |  | 6,133 |  |  | — |  |  | 6,133 |
Return of capital | — |  |  | — |  |  | — |  |  | 98,000 |  |  | — |  |  | 98,000 |
Sales of (investments in) marketable securities, net | 1,271 |  |  | — |  |  | — |  |  | (6 | ) |  | — |  |  | 1,265 |
Repayments from (long-term advances to) joint ventures | 2,156 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,156 |
Proceeds from intercompany investing related activity | — |  |  | 1,213,717 |  |  | — |  |  | 82 |  |  | (1,213,799 | ) |  | — |
Intercompany investing related payments | — |  |  | (1,324,960 | ) |  | — |  |  | (1,341,728 | ) |  | 2,666,688 |  |  | — |
Net cash (used in) provided by investing activities | (3,645,556 | ) |  | 48,166 |  |  | — |  |  | 44,547 |  |  | 1,452,889 |  |  | (2,099,954 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Repayments of long-term debt | (1,325,104 | ) |  | — |  |  | — |  |  | (7,189 | ) |  | — |  |  | (1,332,293 | )
Proceeds from borrowings of long-term debt | 1,000,000 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,000,000 |
Repayments of other borrowings, net | (16,018 | ) |  | — |  |  | — |  |  | (836 | ) |  | — |  |  | (16,854 | )
Dividends paid to shareholders | (86,770 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (86,770 | )
Dividends paid to noncontrolling interests | — |  |  | — |  |  | — |  |  | (23,195 | ) |  | — |  |  | (23,195 | )
Intercompany dividends paid | — |  |  | — |  |  | — |  |  | (23,402 | ) |  | 23,402 |  |  | — |
Proceeds from exercise of stock options | 342 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 342 |
Excess tax benefits realized from stock-based compensation arrangements | 59 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 59 |
Withholding taxes paid on stock-based compensation award distributions | (1,218 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,218 | )
Debt financing costs | (4,186 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,186 | )
Other | — |  |  | — |  |  | — |  |  | (3,882 | ) |  | — |  |  | (3,882 | )
Proceeds from intercompany financing related activity | 1,845,770 |  |  | — |  |  | — |  |  | 820,918 |  |  | (2,666,688 | ) |  | — |
Intercompany financing related payments | (62,039 | ) |  | — |  |  | (82 | ) |  | (1,151,678 | ) |  | 1,213,799 |  |  | — |
Net cash provided by (used in) financing activities | 1,350,836 |  |  | — |  |  | (82 | ) |  | (389,264 | ) |  | (1,429,487 | ) |  | (467,997 | )
Net effect of foreign exchange on cash and cash equivalents | (999 | ) |  | 1,886 |  |  | — |  |  | (5,117 | ) |  | — |  |  | (4,230 | )
(Decrease) increase in cash and cash equivalents | (1,926,386 | ) |  | 1,103 |  |  | — |  |  | (329,995 | ) |  | — |  |  | (2,255,278 | )
Cash and cash equivalents at end of period | $ | 4,416 |  |  | $ | 1,103 |  |  | $ | — |  |  | $ | 228,971 |  |  | $ | — |  |  | $ | 234,490 |

47

Table of Contents
ALBEMARLE CORPORATION AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements - (Continued)
(Unaudited)
Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2014

(In Thousands) | Parent Company Guarantor |  | Issuer |  | Guarantor Subsidiary |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated Total
Cash and cash equivalents at beginning of year | $ | 88,476 |  |  | $ | — |  |  | $ | — |  |  | $ | 388,763 |  |  | $ | — |  |  | $ | 477,239 |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |
Net cash provided by operating activities | 203,834 |  |  | — |  |  | — |  |  | 232,718 |  |  | (6,010 | ) |  | 430,542 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (57,124 | ) |  | — |  |  | — |  |  | (19,558 | ) |  | — |  |  | (76,682 | )
Cash proceeds from divestitures, net | 97,523 |  |  | — |  |  | — |  |  | 7,195 |  |  | — |  |  | 104,718 |
Sales of (investments in) marketable securities, net | 962 |  |  | — |  |  | — |  |  | (19 | ) |  | — |  |  | 943 |
Repayments from (long-term advances to) joint ventures | — |  |  | — |  |  | — |  |  | (7,499 | ) |  | — |  |  | (7,499 | )
Net cash provided by (used in) investing activities | 41,361 |  |  | — |  |  | — |  |  | (19,881 | ) |  | — |  |  | 21,480 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Repayments of long-term debt | (108 | ) |  | — |  |  | — |  |  | (2,915 | ) |  | — |  |  | (3,023 | )
Repayments of other borrowings, net | (7,124 | ) |  | — |  |  | — |  |  | (16,430 | ) |  | — |  |  | (23,554 | )
Dividends paid to shareholders | (62,827 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (62,827 | )
Dividends paid to noncontrolling interests | — |  |  | — |  |  | — |  |  | (7,612 | ) |  | — |  |  | (7,612 | )
Intercompany dividends paid | — |  |  | — |  |  | — |  |  | (6,010 | ) |  | 6,010 |  |  | — |
Repurchases of common stock | (150,000 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (150,000 | )
Proceeds from exercise of stock options | 2,713 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,713 |
Excess tax benefits realized from stock-based compensation arrangements | 836 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 836 |
Withholding taxes paid on stock-based compensation award distributions | (3,208 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (3,208 | )
Debt financing costs | (3,074 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (3,074 | )
Net cash used in financing activities | (222,792 | ) |  | — |  |  | — |  |  | (32,967 | ) |  | 6,010 |  |  | (249,749 | )
Net effect of foreign exchange on cash and cash equivalents | — |  |  | — |  |  | — |  |  | (26,392 | ) |  | — |  |  | (26,392 | )
Increase in cash and cash equivalents | 22,403 |  |  | — |  |  | — |  |  | 153,478 |  |  | — |  |  | 175,881 |
Cash and cash equivalents at end of period | $ | 110,879 |  |  | $ | — |  |  | $ | — |  |  | $ | 542,241 |  |  | $ | — |  |  | $ | 653,120 |

48

Table of Contents

Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking Statements
Some of the information presented in this Quarterly Report on Form 10-Q, including the documents incorporated by reference, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations, which are in turn based on assumptions that we believe are reasonable based on our current knowledge of our business and operations. We have used words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and variations of such words and similar expressions to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, there can be no assurance that our actual results will not differ materially from the results and expectations expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, without limitation:

• | changes in economic and business conditions;

• | changes in financial and operating performance of our major customers and industries and markets served by us;

• | the timing of orders received from customers;

• | the gain or loss of significant customers;

• | competition from other manufacturers;

• | changes in the demand for our products or the end-user markets in which our products are sold;

• | limitations or prohibitions on the manufacture and sale of our products;

• | availability of raw materials;

• | changes in the cost of raw materials and energy, and our ability to pass through such increases;

• | changes in our markets in general;

• | fluctuations in foreign currencies;

• | changes in laws and government regulation impacting our operations or our products;

• | the occurrence of claims or litigation;

• | the occurrence of natural disasters;

• | hazards associated with chemicals manufacturing;

• | the inability to maintain current levels of product or premises liability insurance or the denial of such coverage;

• | political unrest affecting the global economy, including adverse effects from terrorism or hostilities;

• | political instability affecting our manufacturing operations or joint ventures;

• | changes in accounting standards;

• | the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs;

• | changes in the jurisdictional mix of our earnings and changes in tax laws and rates;

• | changes in monetary policies, inflation or interest rates that may impact our ability to raise capital or increase our cost of funds, impact the performance of our pension fund investments and increase our pension expense and funding obligations;

• | volatility and uncertainties in the debt and equity markets;

• | technology or intellectual property infringement, including cyber-security breaches, and other innovation risks;

• | decisions we may make in the future;

• | the ability to successfully operate and integrate Rockwood’s operations and realize anticipated synergies and other benefits; and

• | the other factors detailed from time to time in the reports we file with the SEC.

We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. The following discussion should be read together with our consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q.
49

Table of Contents
The following is a discussion and analysis of our financial condition and results of operations since December 31, 2014. A discussion of consolidated financial condition and sources of additional capital is included under a separate heading “Financial Condition and Liquidity” on page 64.
Overview
We are a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals that meets customer needs across an exceptionally diverse range of end markets including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, crop protection, household appliances, heating, ventilation, aluminum finishing, food safety and custom chemistry services markets. We believe that our commercial and geographic diversity, technical expertise, innovative capability, flexible, low-cost global manufacturing base, experienced management team and strategic focus on our core base technologies will enable us to maintain leading market positions in those areas of the specialty chemicals industry in which we operate, serving our customers with first rate service and delivery while maintaining a balanced stewardship of resources within the environment and markets we serve.
Secular trends favorably impacting demand within the end markets that we serve combined with our diverse product portfolio, broad geographic presence and customer-focused solutions will continue to be key drivers to our future earnings growth. We continue to build upon our existing green solutions portfolio and our ongoing mission to provide innovative, yet commercially viable, clean energy products and services to the marketplace. We believe our disciplined cost reduction efforts, ongoing productivity improvements and our recently completed acquisition of Rockwood position us well to take advantage of strengthening economic conditions as they occur while softening the negative impact of the current challenging global economic environment.
Third Quarter 2015
During the third quarter of 2015:

• | We announced the start of commissioning activities associated with our new, state-of-the-art lithium carbonate production plant located at our La Negra site in northern Chile. The 20,000 MT plant will enable the Company to meet the accelerating demand for lithium.

• | We announced our intent to transfer the production of n-Butyllithium from our facility in New Johnsonville, Tennessee, to existing plants in Germany and Taiwan. The transfer process is expected to be completed in the first quarter of 2016. The New Johnsonville facility will continue to manufacture some specialty lithium products and will support blending operations for customers in North America.

• | We announced that we will relocate our corporate headquarters and Performance Chemicals business from Baton Rouge, LA to Charlotte, NC. In addition, we will relocate Baton Rouge employees in our Refining Solutions business to our existing Clear Lake, TX office. Approximately 120 employees will be relocated to Charlotte or Clear Lake, with the majority of the relocations expected to take place in June 2016.

• | We announced our intention to redeem all of the outstanding 4.625% senior notes due 2020 issued by our wholly-owned subsidiary, Rockwood Specialties Group, Inc. The Notes were redeemed on October 15, 2015 at a redemption price of 103.469% of the principal amount of $1.25 billion, plus accrued and unpaid interest to the redemption date. The 4.625% senior notes were repaid with proceeds from a new term loan credit facility, comprised of a 364-day term loan facility in an aggregate principal amount of $300 million and a five-year term loan facility in an aggregate principal amount of $950 million.

• | We announced our intention to add up to 50,000 MT of mineral conversion production capacity to significantly boost battery grade lithium production to meet the growing needs of the energy storage market, in particular for customers in the global transportation industry utilizing lithium ion battery technology. Albemarle has commenced feasibility studies and is evaluating potential sites. The plant is expected to be operational in 2020.

• | Our board of directors declared a quarterly dividend of $0.29 per share on July 9, 2015, which was paid on October 1, 2015 to shareholders of record at the close of business as of September 16, 2015.

• | Our net sales for the quarter were $905.1 million, up 41% from net sales of $642.4 million in the third quarter of 2014.

• | Earnings per share from continuing operations was $0.58 (on a diluted basis), a decrease of 43% from third quarter 2014 results.

• | Cash provided by operating activities was $183.7 million in the third quarter, an increase of 36% from third quarter 2014.

50

Table of Contents
Outlook
The current global business environment presents a diverse set of opportunities and challenges in the markets we serve, from slow and uneven global growth, currency market volatility, significantly lower crude oil prices, a dynamic pricing environment in bromine derivatives and an ever-changing landscape in electronics, to the continuous need for cutting edge catalysts and technology by our refinery customers, diverse energy storage needs including exciting opportunities in electric vehicles, and increasingly stringent environmental standards. Amidst these dynamics, we believe our business fundamentals are sound and that we are strategically well-positioned as we remain focused on increasing sales volumes, significant deleveraging following our acquisition of Rockwood, optimizing and improving the value of our portfolio through pricing and product development, managing costs and delivering value to our customers. We believe that our businesses remain positioned to capitalize on new business opportunities and long-term trends driving growth within our end markets and to respond quickly to improved economic conditions. Additionally, we are well on track to achieve our expectations regarding synergies from the acquisition of the Rockwood businesses earlier in the year.
Performance Chemicals: Net sales for the first nine months of 2015 were up slightly, overall, compared to the prior year, as we effectively managed through an uncertain environment characterized by a much stronger U.S. Dollar, particularly as compared to the European Union Euro and the Japanese Yen, and reduced oil prices. In addition to these headwinds, for the fourth quarter we expect softening demand in certain products and applications amid cautious inventory management by our customers. We believe we can sustain healthy margins, as demonstrated in the first nine months of the year, with continued focus on maximizing the value of our bromine franchise and leveraging the growth opportunities, given our capabilities, in the lithium markets we serve.
We believe that the combination of solid, long-term business fundamentals, with our strong cost position, product innovations and effective management of raw material inventory inflation will enable us to manage our business through end market challenges and to capitalize on opportunities that are expected with favorable market trends in select end markets and with a more evenly sustained economic recovery.
On a long-term basis, we continue to believe that improving global standards of living, widespread digitization, increasing demand for data management capacity and the potential for increasingly stringent fire safety regulations in developing markets are likely to drive continued demand for fire safety products. Demand for drilling completion fluids in 2015 has held up better than expected in the first nine months, but may still be impacted negatively as a result of sustained lower oil prices impacting offshore drilling projects around the world. Longer term, absent an increase in regulatory pressure on offshore drilling, we would expect this business to resume a solid growth trajectory once oil prices recover from recent levels as we expect that deep water drilling will continue to increase around the world. We are focused on profitably growing our globally competitive bromine and derivatives production network to serve all major bromine consuming products and markets. We believe the global supply/demand gap will tighten as demand for existing and possible new uses of bromine expands over time.
Refining Solutions: We expect continued long-term growth in our Refining Solutions business, despite some near-term concerns about how the price of oil will impact the crude slate used by refineries and the resulting demand for catalysts, fewer “first fill” opportunities than the prior year, stronger competition than in years past due to the cost impacts of a stronger U.S. dollar, especially as compared to the European Union Euro, and some expected product mix impacts.
On a longer term basis, we believe increased global demand for transportation fuels and implementation of more stringent fuel quality requirements will drive growth in our Refining Solutions business. Delivering superior end-use performance continues to be the most effective way to create sustainable value in the refinery catalysts industry, and we believe our technologies continue to provide significant performance and financial benefits to refiners challenged to meet tighter regulations around the world, those managing new contaminants present in North America tight oil, and those in the Middle East and Asia seeking to use heavier feedstock while pushing for higher propylene yields. While lower oil prices may impact the overall crude slate for a period of time, longer term, we believe that the global crude supply will get heavier and more sour, trends that bode well for catalysts demand. Given this and based on our technology, current production capacities and expected growth in end market demand, we believe that we remain well-positioned for the future.
Chemetall Surface Treatment: Demand for surface treatment products generally follows the activity levels of metal processing manufacturers, including the automotive, steel and aerospace industries, as well as products sold to general industrial markets, including heavy equipment, household appliances, manufacturing, heating, ventilation and aluminum finishing. We believe that our strong customer relationships and service, coupled with the growth coming from recently completed acquisitions, will lead to continued growth for the remainder of 2015 despite headwinds from the stronger U.S. Dollar.
51

Table of Contents
On a longer term basis, we expect to continue to generate growth from our focus on new product development, improving process technologies, expanding our customer base, and broadening our technology capabilities in existing and new markets through internal research and development and bolt-on acquisitions.
All Other: During the first quarter we announced our intention to pursue strategic alternatives for three operating segments - Minerals, Fine Chemistry Services and Metal Sulfides, which together comprise the “All Other” category. All three operating segments have been and are expected to continue to be profitable, but do not fit into any of our core businesses subsequent to the acquisition of Rockwood. We expect to use the cash generated from the sale of these businesses to reduce borrowings outstanding under the September 2015 Term Loan Agreement.
Corporate: In the first quarter of 2015, we increased our quarterly dividend payout to $0.29 per share. We continue to focus on cash generation, working capital management and process efficiencies. We expect our global effective tax rate for 2015 to be approximately 20.4%; however, our rate will vary based on the locales in which income is actually earned and remains subject to potential volatility from changing legislation in the U.S. and other tax jurisdictions.
In 2014, the Company and ICL announced entering into an agreement to establish a manufacturing joint venture for the production of ICL’s FR-122P polymeric flame retardant and Albemarle’s GreenCrest™ polymeric flame retardant. The parties have recently terminated their agreement due to the likelihood that, for purposes of competition law approvals, the duration of the proposed joint venture would need to be shortened to such an extent that the return on investment would no longer be attractive. In lieu of the joint venture, the parties are discussing a long-term supply arrangement pursuant to which ICL would supply the GreenCrest™ polymeric flame retardant to the Company.
On October 26, 2015, we announced that effective January 1, 2016, Performance Chemicals will be split into two separate global business units: (1) Bromine Specialties, and (2) Lithium and Advanced Materials, which will include Performance Catalyst Solutions and Curatives.
On November 5, 2015, we entered into a definitive agreement to sell our Tribotecc Metal Sulfides business to Treibacher Industrie AG for an undisclosed amount of cash. Included in the transaction are sites in Vienna and Arnoldstein, Austria, and Tribotecc’s proprietary sulfide synthesis process. The sale is subject to customary closing conditions and is expected to close by the end of 2015.
We remain committed to evaluating the merits of any opportunities that may arise for acquisitions or other business development activities that will complement our business footprint. Additional information regarding our products, markets and financial performance is provided at our web site, www.albemarle.com. Our web site is not a part of this document nor is it incorporated herein by reference.
52

Table of Contents
Results of Operations
The following data and discussion provides an analysis of certain significant factors affecting our results of operations during the periods included in the accompanying consolidated statements of income.
Third Quarter 2015 Compared to Third Quarter 2014
Selected Financial Data (Unaudited)

| Three Months Ended September 30, |  | Percentage Change
| 2015 |  | 2014 |  | 2015 vs. 2014
| (In thousands, except percentages and per share amounts)
NET SALES | $ | 905,093 |  |  | $ | 642,418 |  |  | 41 | %
Cost of goods sold | 592,883 |  |  | 436,972 |  |  | 36 | %
GROSS PROFIT | 312,210 |  |  | 205,446 |  |  | 52 | %
GROSS PROFIT MARGIN | 34.5 | % |  | 32.0 | % |  |
Selling, general and administrative expenses | 137,615 |  |  | 66,012 |  |  | 108 | %
Research and development expenses | 25,295 |  |  | 22,407 |  |  | 13 | %
Restructuring and other, net | (6,804 | ) |  | 293 |  |  | * |
Acquisition and integration related costs | 42,798 |  |  | 10,261 |  |  | 317 | %
OPERATING PROFIT | 113,306 |  |  | 106,473 |  |  | 6 | %
OPERATING PROFIT MARGIN | 12.5 | % |  | 16.6 | % |  |
Interest and financing expenses | (32,058 | ) |  | (8,749 | ) |  | 266 | %
Other income (expenses), net | 466 |  |  | (6,618 | ) |  | * |
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS | 81,714 |  |  | 91,106 |  |  | (10 | )%
Income tax expense | 16,892 |  |  | 11,737 |  |  | 44 | %
Effective tax rate | 20.7 | % |  | 12.9 | % |  |
INCOME FROM CONTINUING OPERATIONS BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS | 64,822 |  |  | 79,369 |  |  | (18 | )%
Equity in net income of unconsolidated investments (net of tax) | 6,050 |  |  | 8,650 |  |  | (30 | )%
NET INCOME FROM CONTINUING OPERATIONS | 70,872 |  |  | 88,019 |  |  | (19 | )%
Loss from discontinued operations (net of tax) | — |  |  | (6,679 | ) |  | (100 | )%
NET INCOME | 70,872 |  |  | 81,340 |  |  | (13 | )%
Net income attributable to noncontrolling interests | (5,480 | ) |  | (8,546 | ) |  | (36 | )%
NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION | $ | 65,392 |  |  | $ | 72,794 |  |  | (10 | )%
NET INCOME FROM CONTINUING OPERATIONS AS A PERCENTAGE OF NET SALES | 7.8 | % |  | 13.7 | % |  |
Basic earnings (loss) per share: |  |  |  |  |
Continuing operations | $ | 0.58 |  |  | $ | 1.02 |  |  | (43 | )%
Discontinued operations | — |  |  | (0.09 | ) |  | (100 | )%
| $ | 0.58 |  |  | $ | 0.93 |  |  | (38 | )%
Diluted earnings (loss) per share: |  |  |  |  |
Continuing operations | $ | 0.58 |  |  | $ | 1.01 |  |  | (43 | )%
Discontinued operations | — |  |  | (0.08 | ) |  | (100 | )%
| $ | 0.58 |  |  | $ | 0.93 |  |  | (38 | )%

*Percentage calculation is not meaningful.
53

Table of Contents
Net Sales
For the three-month period ended September 30, 2015, we recorded net sales of $905.1 million, an increase of $262.7 million, or 41%, compared to net sales of $642.4 million for the three-month period ended September 30, 2014. Approximately $359.8 million of the increase was attributable to the impact of the Rockwood acquisition. Excluding the acquisition of Rockwood, net sales decreased by $97.1 million primarily due to $24.5 million of unfavorable impacts from currency translation and $81.2 million of unfavorable volumes partly offset by $8.7 million of favorable price impacts. The decrease in sales volumes was attributable to lower Bromine, Fine Chemistry Services, and CFT partly offset by increased sales volumes of Heavy Oil Upgrading and PCS. The favorable price impact was predominantly driven by Bromine partly offset by unfavorable price impacts in CFT.
Gross Profit
For the three-month period ended September 30, 2015, our gross profit increased $106.8 million, or 52%, from the corresponding 2014 period. Approximately $129.6 million of the increase was attributable to the performance of the acquired Rockwood businesses, net of a $7.7 million charge for the utilization of the inventory markup recorded as part of purchase accounting for the acquisition. Excluding the acquisition of Rockwood, gross profit decreased by $22.8 million due primarily to lower sales volumes offset partly by favorable sales prices and $9.8 million of lower raw material and utility costs. Overall, these factors contributed to a higher gross profit margin for the three-month period ended September 30, 2015 of 34.5%, up from 32.0% in the corresponding period of 2014.
Selling, General and Administrative Expenses
For the three-month period ended September 30, 2015, our selling, general and administrative (“SG&A”) expenses increased $71.6 million, or 108%, from the three-month period ended September 30, 2014. Approximately $74.8 million of the increase was attributable to the impact of the Rockwood acquisition. Excluding the acquisition of Rockwood, SG&A expenses decreased by $3.2 million. As a percentage of net sales, SG&A expenses were 15.2% for the three-month period ended September 30, 2015, compared to 10.3% for the corresponding period in 2014.
Research and Development Expenses
For the three-month period ended September 30, 2015, our research and development (“R&D”) expenses increased $2.9 million, or 13%, from the three-month period ended September 30, 2014. Approximately $6.0 million of the increase was attributable to the impact of the Rockwood acquisition. Excluding the acquisition of Rockwood, R&D expenses decreased by $3.1 million. As a percentage of net sales, R&D expenses were 2.8% and 3.5% for the three-month periods ended September 30, 2015 and 2014, respectively.
Restructuring and Other, Net
Included in restructuring and other, net, for the third quarter of 2015 is a gain of $6.8 million ($4.7 million after income taxes) recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012. Restructuring and other, net, for the third quarter of 2014 includes $0.3 million ($0.2 million after income taxes) of other charges.
Acquisition and Integration Related Costs
The three-month period ended September 30, 2015 includes $41.8 million of acquisition and integration related costs directly related to the acquisition of Rockwood (mainly consisting of advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and $1.0 million of costs in connection with other significant projects. The three-month period ended September 30, 2014 includes $9.3 million of acquisition and integration related costs directly related to the acquisition of Rockwood and $1.0 million of costs in connection with other significant projects.
Interest and Financing Expenses
Interest and financing expenses for the three-month period ended September 30, 2015 increased $23.3 million to $32.1 million from the corresponding 2014 period, due mainly to higher borrowing levels in connection with the acquisition of Rockwood.
Other Income (Expenses), Net
Other income (expenses), net, for the three-month period ended September 30, 2015 was $0.5 million versus $(6.6) million for the corresponding 2014 period. The $7.1 million favorable variance was predominantly due to $7.0 million of amortization for bridge facility fees and other financing fees in the prior year related to the acquisition of Rockwood.
54

Table of Contents
Income Tax Expense
The effective income tax rate for the third quarter of 2015 was 20.7% compared to 12.9% for the third quarter of 2014. Our effective income tax rate differs from the U.S. federal statutory income tax rates in the comparative periods mainly due to the impact of earnings from outside the U.S. The increase in the effective tax rate for the 2015 period as compared to the 2014 period is primarily driven by the Rockwood acquisition, which caused a reduction in various benefits in our effective tax rate. Our effective income tax rate in the 2014 period was also impacted by discrete net tax benefit items of $3.2 million related principally to the expiration of the U.S. federal statute of limitations and a pension plan actuarial loss that was recorded in the period.
Equity in Net Income of Unconsolidated Investments
Equity in net income of unconsolidated investments was $6.1 million for the three-month period ended September 30, 2015 compared to $8.7 million in the same period last year. The current year equity in net income of unconsolidated investments includes a $9.1 million charge for utilization of fair value adjustments to inventories. Excluding this charge, equity in net income of unconsolidated investments increased by $6.5 million primarily due to equity income derived from unconsolidated investments we acquired from Rockwood (Performance Chemicals and Chemetall Surface Treatment segments), partially offset by lower equity income reported by our Refining Solutions segment joint venture Nippon Ketjen Company Limited primarily due to lower sales volumes.
Loss from Discontinued Operations
Loss from discontinued operations, after income taxes, of $6.7 million for the three-month period ended September 30, 2014 includes a pre-tax charge of $4.8 million ($3.6 million after income taxes) related to the loss on the sale of our antioxidant, ibuprofen and propofol businesses and assets to SI Group, Inc., which closed on September 1, 2014.
Net Income Attributable to Noncontrolling Interests
For the three-month period ended September 30, 2015, net income attributable to noncontrolling interests was $5.5 million compared to $8.5 million in the same period last year. This decrease of $3.0 million was due primarily to changes in consolidated income related to our Jordanian joint venture.
Net Income Attributable to Albemarle Corporation
Net income attributable to Albemarle Corporation decreased to $65.4 million in the three-month period ended September 30, 2015, from $72.8 million in the three-month period ended September 30, 2014. The total estimated impact of the Rockwood acquisition is a loss of approximately $15.0 million before income taxes, including earnings of the acquiree (as included in Item 1 Financial Statements - Note 2, “Acquisitions”), acquisition and integration related costs and interest expense associated with additional borrowings. Excluding the acquisition of Rockwood, net income attributable to Albemarle increased by approximately $7.6 million due primarily to the 2015 gain on sale of land in restructuring and other of $6.8 million, and approximately $6.7 million loss on discontinued operations in 2014, partly offset by a $5.1 million increase in income tax expenses.
Other Comprehensive Loss, Net of Tax
Total other comprehensive loss, after income taxes, was $70.4 million for the three-month period ended September 30, 2015 compared to $101.4 million for the corresponding period in 2014. The majority of these amounts are the result of translating our foreign subsidiary financial statements from their local currencies to U.S. Dollars. In the 2015 period, other comprehensive loss from foreign currency translation adjustments was $67.5 million, mainly as a result of unfavorable movements in the British Pound Sterling of approximately $30 million, the Brazilian Real of approximately $18 million, the Chinese Renminbi of approximately $7 million, the Korean Won of approximately $7 million, and a net unfavorable variance in various other currencies totaling approximately $29 million (each approximately $5 million or less), partially offset by a favorable movement in the European Union Euro of approximately $25 million. Also included in total other comprehensive loss for the 2015 period is a loss of $3.4 million in connection with the revaluation of our €700.0 million senior notes which were designated as a hedge of our net investment in foreign operations in the fourth quarter of 2014. In the 2014 period, other comprehensive loss from foreign currency translation adjustments was $100.3 million, mainly as a result of unfavorable movements in the European Union Euro of approximately $68 million, the Chinese Renminbi of approximately $17 million, and the Brazilian Real of approximately $12 million. Also included in total other comprehensive loss for the 2014 period is an unrealized loss of $1.0 million related to our interest rate swap which settled during the fourth quarter of 2014.
Segment Information Overview. We have identified three reportable segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. The Performance Chemicals segment includes the Lithium, PCS and Bromine product categories. The Refining Solutions segment consists of the
55

Table of Contents
Company’s Heavy Oil Upgrading and Clean Fuels Technologies businesses. The Chemetall Surface Treatment segment consists of the Surface Treatment product category.
Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2014 have been recast to reflect the change in segments previously noted and a change in our measure of segment profit or loss to adjusted EBITDA as discussed below. During the first quarter we announced our intention to pursue strategic alternatives for three operating segments - Minerals, Fine Chemistry Services and Metal Sulfides, which together comprise the “All Other” category. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.
Beginning in 2015, the Company uses earnings before interest, taxes, depreciation and amortization, as adjusted for certain non-recurring or unusual items such as restructuring charges, facility divestiture charges and other significant non-recurring items (“adjusted EBITDA”), on a segment basis to assess the ongoing performance of the Company’s business segments. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, GAAP. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.

| Three Months Ended September 30, |  | Percentage Change
| 2015 |  | % |  | 2014 |  | % |  | 2015 vs. 2014
| (In thousands, except percentages)
Net sales: |  |  |  |  |  |  |  |  |
Performance Chemicals | $ | 399,536 |  |  | 44.1 | % |  | $ | 299,947 |  |  | 46.7 | % |  | 33 | %
Refining Solutions | 185,102 |  |  | 20.5 | % |  | 218,950 |  |  | 34.1 | % |  | (15 | )%
Chemetall Surface Treatment | 211,877 |  |  | 23.4 | % |  | — |  |  | — | % |  | * |
All Other | 102,224 |  |  | 11.3 | % |  | 123,521 |  |  | 19.2 | % |  | (17 | )%
Corporate | 6,354 |  |  | 0.7 | % |  | — |  |  | — | % |  | * |
Total net sales | $ | 905,093 |  |  | 100.0 | % |  | $ | 642,418 |  |  | 100.0 | % |  | 41 | %
Adjusted EBITDA: |  |  |  |  |  |  |  |  |
Performance Chemicals | $ | 136,209 |  |  | 58.0 | % |  | $ | 82,329 |  |  | 56.9 | % |  | 65 | %
Refining Solutions | 54,517 |  |  | 23.2 | % |  | 61,674 |  |  | 42.7 | % |  | (12 | )%
Chemetall Surface Treatment | 53,898 |  |  | 22.9 | % |  | — |  |  | — | % |  | * |
All Other | 6,262 |  |  | 2.7 | % |  | 20,971 |  |  | 14.5 | % |  | (70 | )%
Corporate | (15,890 | ) |  | (6.8 | )% |  | (20,370 | ) |  | (14.1 | )% |  | (22 | )%
Total adjusted EBITDA | $ | 234,996 |  |  | 100.0 | % |  | $ | 144,604 |  |  | 100.0 | % |  | 63 | %

*Percentage calculation is not meaningful.
56

Table of Contents
See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP, (in thousands):

| Performance Chemicals |  | Refining Solutions |  | Chemetall Surface Treatment |  | Reportable Segments Total |  | All Other |  | Corporate |  | Consolidated Total
Three months ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 136,209 |  |  | $ | 54,517 |  |  | $ | 53,898 |  |  | $ | 244,624 |  |  | $ | 6,262 |  |  | $ | (15,890 | ) |  | $ | 234,996 |
Depreciation and amortization | (31,482 | ) |  | (8,804 | ) |  | (20,260 | ) |  | (60,546 | ) |  | (5,645 | ) |  | (2,712 | ) |  | (68,903 | )
Utilization of inventory markup(a) | (16,834 | ) |  | — |  |  | — |  |  | (16,834 | ) |  | — |  |  | — |  |  | (16,834 | )
Restructuring and other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,804 |  |  | 6,804 |
Acquisition and integration related costs | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (42,798 | ) |  | (42,798 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (32,058 | ) |  | (32,058 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (16,892 | ) |  | (16,892 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,077 |  |  | 1,077 |
Net income (loss) attributable to Albemarle Corporation | $ | 87,893 |  |  | $ | 45,713 |  |  | $ | 33,638 |  |  | $ | 167,244 |  |  | $ | 617 |  |  | $ | (102,469 | ) |  | $ | 65,392 |
Three months ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 82,329 |  |  | $ | 61,674 |  |  | $ | — |  |  | $ | 144,003 |  |  | $ | 20,971 |  |  | $ | (20,370 | ) |  | $ | 144,604 |
Depreciation and amortization | (12,593 | ) |  | (8,823 | ) |  | — |  |  | (21,416 | ) |  | (3,492 | ) |  | (722 | ) |  | (25,630 | )
Restructuring and other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (293 | ) |  | (293 | )
Acquisition and integration related costs | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10,261 | ) |  | (10,261 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (8,749 | ) |  | (8,749 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11,737 | ) |  | (11,737 | )
Loss from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6,679 | ) |  | (6,679 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,440 | ) |  | (1,440 | )
Other(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7,021 | ) |  | (7,021 | )
Net income (loss) attributable to Albemarle Corporation | $ | 69,736 |  |  | $ | 52,851 |  |  | $ | — |  |  | $ | 122,587 |  |  | $ | 17,479 |  |  | $ | (67,272 | ) |  | $ | 72,794 |

(a) | In connection with the acquisition of Rockwood, the Company valued Rockwood’s existing inventory at fair value as of the Acquisition Closing Date, which resulted in a markup of the underlying net book value of the inventory totaling approximately $103 million. The inventory markup is being expensed over the estimated remaining selling period. For the three-month period ended September 30, 2015, $7.7 million was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $9.1 million, related to the utilization of the inventory markup.

(b) | Financing-related fees expensed in connection with the acquisition of Rockwood.

Performance Chemicals
Performance Chemicals segment net sales for the three-month period ended September 30, 2015 were $399.5 million, up $99.6 million, or 33%, in comparison to the same period in 2014. The increase was driven mainly by $128.4 million of additional Lithium sales from the acquisition of Rockwood, $12.3 million of favorable Bromine price impacts due to announced price increases, and $3.9 million of favorable PCS sales volumes offset partly by $38.4 million of unfavorable Bromine volumes partly related to price increases and $7.5 million of unfavorable impacts from currency translation. Adjusted EBITDA for Performance Chemicals was up 65%, or $53.9 million, to $136.2 million for the three-month period ended September 30, 2015, compared to the same period in 2014, primarily due to the acquisition of Rockwood, favorable PCS sales volumes and favorable Bromine price impacts on announced price increases, offset by unfavorable Bromine sales volumes and $4.0 million of unfavorable impacts from currency translation.
Refining Solutions
Refining Solutions segment net sales for the three-month period ended September 30, 2015 were $185.1 million, a decrease of $33.8 million, or 15%, compared to the three-month period ended September 30, 2014. This decrease was due to $31.1 million of lower Clean Fuels Technology volumes due to market conditions, $4.2 million of unfavorable Clean Fuels Technology price due to mix and $9.1 million of unfavorable currency exchange impacts partially offset by $14.0 million of higher Heavy Oil Upgrading volumes due to continued strong demand. Refining Solutions adjusted EBITDA decreased 12%, or $7.2 million, to $54.5 million for the three-month period ended September 30, 2015 in comparison to the corresponding
57

Table of Contents
period of 2014. This decrease was due primarily to lower overall sales volumes, unfavorable price and $3.3 million of unfavorable impacts from currency translation.
Chemetall Surface Treatment
Arising from the acquisition of Rockwood, Chemetall Surface Treatment segment net sales and adjusted EBITDA for the three-month period ended September 30, 2015 were $211.9 million, and $53.9 million, respectively.
All Other
All Other net sales for the three-month period ended September 30, 2015 were $102.2 million, a decrease of $21.3 million, or 17%, compared to the three-month period ended September 30, 2014. The decrease was driven mainly by $32.8 million of unfavorable Fine Chemistry Services volumes due to timing of projects, and $7.9 million of unfavorable impacts from currency translation impacts, partially offset by the acquisition of Rockwood. All Other adjusted EBITDA was down 70%, or $14.7 million, for the three-month period ended September 30, 2015 in comparison to the corresponding period of 2014. This decrease was due primarily to lower overall sales and unfavorable impacts from currency translation, partially offset by the acquisition of Rockwood.
Corporate
Corporate adjusted EBITDA was a loss of $15.9 million for the three-month period ended September 30, 2015, compared to a loss of $20.4 million for the corresponding period of 2014. The change was due mainly to the acquisition of Rockwood which was more than offset by achieved synergies.
58

Table of Contents
Nine Months 2015 Compared to Nine Months 2014
Selected Financial Data (Unaudited)

| Nine Months Ended September 30, |  | Percentage Change
| 2015 |  | 2014 |  | 2015 vs. 2014
| (In thousands, except percentages and per share amounts)
NET SALES | $ | 2,720,982 |  |  | $ | 1,846,982 |  |  | 47 | %
Cost of goods sold | 1,849,740 |  |  | 1,238,574 |  |  | 49 | %
GROSS PROFIT | 871,242 |  |  | 608,408 |  |  | 43 | %
GROSS PROFIT MARGIN | 32.0 | % |  | 32.9 | % |  |
Selling, general and administrative expenses | 421,092 |  |  | 211,127 |  |  | 99 | %
Research and development expenses | 77,123 |  |  | 66,916 |  |  | 15 | %
Restructuring and other, net | (6,804 | ) |  | 20,625 |  |  | (133 | )%
Acquisition and integration related costs | 126,487 |  |  | 15,104 |  |  | * |
OPERATING PROFIT | 253,344 |  |  | 294,636 |  |  | (14 | )%
OPERATING PROFIT MARGIN | 9.3 | % |  | 16.0 | % |  |
Interest and financing expenses | (100,986 | ) |  | (26,255 | ) |  | 285 | %
Other income (expenses), net | 50,964 |  |  | (6,454 | ) |  | * |
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS | 203,322 |  |  | 261,927 |  |  | (22 | )%
Income tax expense | 48,171 |  |  | 46,700 |  |  | 3 | %
Effective tax rate | 23.7 | % |  | 17.8 | % |  |
INCOME FROM CONTINUING OPERATIONS BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS | 155,151 |  |  | 215,227 |  |  | (28 | )%
Equity in net income of unconsolidated investments (net of tax) | 22,236 |  |  | 28,200 |  |  | (21 | )%
NET INCOME FROM CONTINUING OPERATIONS | 177,387 |  |  | 243,427 |  |  | (27 | )%
Loss from discontinued operations (net of tax) | — |  |  | (68,473 | ) |  | (100 | )%
NET INCOME | 177,387 |  |  | 174,954 |  |  | 1 | %
Net income attributable to noncontrolling interests | (16,733 | ) |  | (23,130 | ) |  | (28 | )%
NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION | $ | 160,654 |  |  | $ | 151,824 |  |  | 6 | %
NET INCOME FROM CONTINUING OPERATIONS AS A PERCENTAGE OF NET SALES | 6.5 | % |  | 13.2 | % |  |
Basic earnings (loss) per share: |  |  |  |  |
Continuing operations | $ | 1.45 |  |  | $ | 2.79 |  |  | (48 | )%
Discontinued operations | — |  |  | (0.87 | ) |  | (100 | )%
| $ | 1.45 |  |  | $ | 1.92 |  |  | (24 | )%
Diluted earnings (loss) per share: |  |  |  |  |
Continuing operations | $ | 1.44 |  |  | $ | 2.78 |  |  | (48 | )%
Discontinued operations | — |  |  | (0.87 | ) |  | (100 | )%
| $ | 1.44 |  |  | $ | 1.91 |  |  | (25 | )%

*Percentage calculation is not meaningful.
59

Table of Contents
Net Sales
For the nine-month period ended September 30, 2015, we recorded net sales of $2.7 billion, an increase of $874.0 million, or 47%, compared to net sales of $1.8 billion for the nine-month period ended September 30, 2014. Approximately $1.1 billion of the increase was attributable to the impact of the Rockwood acquisition. Excluding the acquisition of Rockwood, net sales decreased by $178.2 million primarily due to $88.7 million of unfavorable sales volumes, $74.9 million of unfavorable impacts from currency translation and $14.6 million of unfavorable price impacts due to market conditions and portfolio mix. The unfavorable sales volumes were due to lower Clean Fuels Technologies, Fine Chemistry Services, and Bromine volumes partially offset by increased Heavy Oil Upgrading and PCS sales volumes. The unfavorable price impacts were primarily due to lower Refining Solutions, Fine Chemistry Services, and PCS prices partly offset by favorable price impacts for Bromine.
Gross Profit
For the nine-month period ended September 30, 2015, our gross profit increased $262.8 million, or 43%, from the corresponding 2014 period. Approximately $325.6 million of the increase was attributable to the performance of the acquired Rockwood businesses, net of a $75.4 million charge for the utilization of the inventory markup recorded as part of purchase accounting for the acquisition. Excluding the acquisition of Rockwood, gross profit decreased by $62.6 million due primarily to unfavorable impacts from currency translation, unfavorable price impacts due to market conditions and portfolio mix and lower overall sales volumes. Overall, these factors contributed to a lower gross profit margin for the nine-month period ended September 30, 2015 of 32.0%, down from 32.9% in the corresponding period of 2014.
Selling, General and Administrative Expenses
For the nine-month period ended September 30, 2015, our SG&A expenses increased $210.0 million, or 99%, from the nine-month period ended September 30, 2014. Approximately $229.1 million of the increase was attributable to the impact of the Rockwood acquisition. Excluding the acquisition of Rockwood, SG&A expenses decreased by $19.1 million due primarily to $12.5 million of mark-to-market actuarial losses allocated to SG&A in the 2014 period as well as achieved synergies in connection with the acquisition of Rockwood. As a percentage of net sales, SG&A expenses were 15.5% for the nine-month period ended September 30, 2015, compared to 11.4% for the corresponding period in 2014.
The mark-to-market actuarial loss included in SG&A for 2014 resulted from the following:

(a) | A curtailment in the first quarter of 2014 related to our U.S. defined benefit plan which covers non-represented employees and our SERP, which triggered a remeasurement of the related assets and obligations. The curtailment was in connection with our workforce reduction plan initiated in the fourth quarter of 2013. The mark-to-market actuarial loss was primarily attributable to: (a) a decrease in the weighted-average discount rate for all of our domestic pension plans to 4.97% as of the remeasurement date, from 5.14% at December 31, 2013; and (b) the annualized actual return on the assets of the plan subject to remeasurement being approximately (5.00%), significantly lower than the expected return of 7.00%, as a result of overall market and investment portfolio performance.

(b) | A remeasurement in the third quarter of 2014 of the assets and obligations of one of our U.S. defined benefit plans for represented employees, which was included in the sale of our antioxidant, ibuprofen and propofol businesses and assets that closed on September 1, 2014. The mark-to-market actuarial loss was primarily attributable to: (a) a decrease in the weighted-average discount rate for all of our domestic pension plans to 4.94% as of the remeasurement date from 5.14% at December 31, 2013; (b) changes in mortality assumptions related to the plan; partially offset by (c) the annualized actual return on the assets of the plan subject to remeasurement being approximately 11.2%, higher than the expected return of 7.00% as a result of overall market and investment portfolio performance.

Research and Development Expenses
For the nine-month period ended September 30, 2015, our R&D expenses increased $10.2 million, or 15%, from the nine-month period ended September 30, 2014, primarily due to the acquisition of Rockwood. As a percentage of net sales, R&D expenses were 2.8% and 3.6% for the nine-month periods ended September 30, 2015 and 2014, respectively.
Restructuring and Other, Net
Included in restructuring and other, net, for the nine-month period ended September 30, 2015 is a gain of $6.8 million ($4.7 million after income taxes) recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012. Restructuring and other, net, of $20.6 million for the nine-month period ended September 30, 2014 includes the following items:
60

Table of Contents

(a) | Estimated costs of $14.0 million ($9.2 million after income taxes) in connection with action we initiated in the first quarter to reduce the high cost supply capacity of certain aluminum alkyl products, primarily through the termination of a third party manufacturing contract.

(b) | An impairment charge of $3.0 million ($1.9 million after income taxes) for certain capital project costs also related to aluminum alkyls capacity which we do not expect to recover.

(c) | A write-off of $3.3 million ($2.1 million after income taxes) for certain multi-product facility project costs that we do not expect to recover in future periods.

(d) | $0.3 million ($0.2 million after income taxes) of other charges.

Acquisition and Integration Related Costs
The nine-month period ended September 30, 2015 includes $120.5 million of acquisition and integration related costs directly related to the acquisition of Rockwood (mainly consisting of advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and $6.0 million of costs in connection with other significant projects. The nine-month period ended September 30, 2014 includes $9.3 million of acquisition and integration related costs directly related to the acquisition of Rockwood and $5.8 million of costs in connection with other significant projects.
Interest and Financing Expenses
Interest and financing expenses for the nine-month period ended September 30, 2015 increased $74.7 million to $101.0 million from the corresponding 2014 period, due mainly to higher borrowing levels in connection with the acquisition of Rockwood.
Other Income (Expenses), Net
Other income (expenses), net, for the nine-month period ended September 30, 2015 was $51.0 million versus $(6.5) million for the corresponding 2014 period. The change was due mainly to $54.1 million of favorable foreign currency translation gains and a $2.6 million reduction in amortization of bridge facility fees and other financing fees related to the acquisition of Rockwood. The foreign currency gains are primarily related to cash denominated in U.S. Dollars held by foreign subsidiaries where the European Union Euro serves as the functional currency.
Income Tax Expense
The effective income tax rate for the first nine months of 2015 was 23.7% compared to 17.8% for the first nine months of 2014. Our effective income tax rate differs from the U.S. federal statutory income tax rates in the comparative periods mainly due to the impact of earnings from outside the U.S. The increase in the effective tax rate for the 2015 period as compared to the 2014 period is primarily driven by the Rockwood acquisition, which caused a reduction in various benefits in our effective tax rate. Additionally, our effective tax rate in the 2015 period was also affected by discrete net tax expense items of $2.9 million related mainly to prior year uncertain tax position adjustments associated with lapses in statutes of limitations, items associated with U.S. provision to return adjustments, and an OPEB plan termination gain recorded in the period. Our effective income tax rate in the 2014 period was affected by tax benefits of $14.7 million related to restructuring charges, a pension plan actuarial loss and the release of reserves related principally to the expiration of the U.S. federal statute of limitations.
Equity in Net Income of Unconsolidated Investments
Equity in net income of unconsolidated investments was $22.2 million for the nine-month period ended September 30, 2015 compared to $28.2 million in the same period last year. The current year equity in net income of unconsolidated investments includes a $26.9 million charge for utilization of fair value adjustments to inventories. Excluding this charge, equity in net income of unconsolidated investments increased by $20.9 million primarily due to equity income derived from unconsolidated investments we acquired from Rockwood (Performance Chemicals and Chemetall Surface Treatment segments), partially offset by lower equity income reported by our Refining Solutions segment joint venture Nippon Ketjen Company Limited primarily due to lower sales volumes.
Loss from Discontinued Operations
Loss from discontinued operations, after income taxes, for the nine-month period ended September 30, 2014 of $68.5 million includes a pre-tax charge of $85.5 million ($64.6 million after income taxes) related to the loss on the sale of our antioxidant, ibuprofen and propofol businesses and assets to SI Group, Inc., which closed on September 1, 2014. The loss represented the difference between the carrying value of the related assets and their fair value as determined by the sales price less estimated costs to sell. The loss was primarily attributable to the write-off of goodwill, intangibles and long-lived assets, net of cumulative foreign currency translation gains of $17.8 million.
61

Table of Contents
Net Income Attributable to Noncontrolling Interests
For the nine-month period ended September 30, 2015, net income attributable to noncontrolling interests was $16.7 million compared to $23.1 million in the same period last year. This decrease of $6.4 million was due primarily to changes in consolidated income related to our Jordanian joint venture.
Net Income Attributable to Albemarle Corporation
Net income attributable to Albemarle Corporation increased to $160.7 million in the nine-month period ended September 30, 2015, from $151.8 million in the nine-month period ended September 30, 2014. The total estimated impact of the Rockwood acquisition is a loss of approximately $68.0 million before income taxes, including earnings of the acquiree (as included in Item 1 Financial Statements - Note 2, “Acquisitions”), acquisition and integration related costs, interest expense associated with additional borrowings, and other currency transaction gains related to the execution of the closing. Excluding the impact of the Rockwood acquisition, net income increased approximately $77.0 million primarily due to the loss from discontinued operations and restructuring and other charges in the prior year of $68.5 million and $20.6 million, respectively, plus the gain on sale of land of $6.8 million in restructuring and other for the 2015 period, partly offset by unfavorable impacts in operating profit of approximately $19.0 million, including the unfavorable impacts of currency translation.
Other Comprehensive Loss, Net of Tax
Total other comprehensive loss, after income taxes, was $324.5 million for the nine-month period ended September 30, 2015 compared to $118.3 million for the corresponding period in 2014. The majority of these amounts are the result of translating our foreign subsidiary financial statements from their local currencies to U.S. Dollars. In the 2015 period, other comprehensive loss from foreign currency translation adjustments was $365.9 million, mainly as a result of unfavorable movements in the European Union Euro of approximately $226 million, the British Pound Sterling of approximately $55 million, the Brazilian Real of approximately $30 million, the Turkish Lira of approximately $12 million, the Korean Won of approximately $10 million, the Chinese Renminbi of approximately $6 million, the South African Rand of approximately $6 million and a net unfavorable variance in various other currencies totaling approximately $20 million (each approximately $5 million or less). Also included in total other comprehensive loss for the 2015 period is income of $39.7 million in connection with the revaluation of our €700.0 million senior notes which were designated as a hedge of our net investment in foreign operations in the fourth quarter of 2014. In the 2014 period, other comprehensive loss from foreign currency translation adjustments was $106.4 million, mainly as a result of unfavorable movements in the European Union Euro of approximately $84 million, the Brazilian Real of approximately $5 million and the Chinese Renminbi of approximately $17 million. Also included in total other comprehensive loss for the 2014 period is an unrealized loss of $11.4 million related to our interest rate swap which settled during the fourth quarter of 2014.
Segment Information Overview. Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2014 have been recast to reflect the change in segments previously noted and a change in our measure of segment profit or loss to adjusted EBITDA as discussed below. During the first quarter we announced our intention to pursue strategic alternatives for three operating segments - Minerals, Fine Chemistry Services and Metal Sulfides, which together comprise the “All Other” category. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.
Beginning in 2015, the Company uses earnings before interest, taxes, depreciation and amortization, as adjusted for certain non-recurring or unusual items such as restructuring charges, facility divestiture charges and other significant non-recurring items (“adjusted EBITDA”), on a segment basis to assess the ongoing performance of the Company’s business segments. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, GAAP. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.
62

Table of Contents

| Nine Months Ended September 30, |  | Percentage Change
| 2015 |  | % |  | 2014 |  | % |  | 2015 vs. 2014
| (In thousands, except percentages)
Net sales: |  |  |  |  |  |  |  |  |
Performance Chemicals | $ | 1,224,864 |  |  | 45.0 | % |  | $ | 856,221 |  |  | 46.4 | % |  | 43 | %
Refining Solutions | 528,841 |  |  | 19.4 | % |  | 618,635 |  |  | 33.5 | % |  | (15 | )%
Chemetall Surface Treatment | 617,163 |  |  | 22.7 | % |  | — |  |  | — | % |  | * |
All Other | 337,997 |  |  | 12.4 | % |  | 372,126 |  |  | 20.1 | % |  | (9 | )%
Corporate | 12,117 |  |  | 0.5 | % |  | — |  |  | — | % |  | * |
Total net sales | $ | 2,720,982 |  |  | 100.0 | % |  | $ | 1,846,982 |  |  | 100.0 | % |  | 47 | %
Adjusted EBITDA: |  |  |  |  |  |  |  |  |
Performance Chemicals | $ | 415,419 |  |  | 56.9 | % |  | $ | 232,668 |  |  | 54.7 | % |  | 79 | %
Refining Solutions | 144,910 |  |  | 19.8 | % |  | 189,259 |  |  | 44.5 | % |  | (23 | )%
Chemetall Surface Treatment | 148,344 |  |  | 20.3 | % |  | — |  |  | — | % |  | * |
All Other | 29,540 |  |  | 4.0 | % |  | 63,482 |  |  | 14.9 | % |  | (53 | )%
Corporate | (7,508 | ) |  | (1.0 | )% |  | (60,087 | ) |  | (14.1 | )% |  | (88 | )%
Total adjusted EBITDA | $ | 730,705 |  |  | 100.0 | % |  | $ | 425,322 |  |  | 100.0 | % |  | 72 | %

*Percentage calculation is not meaningful.
See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP, (in thousands):

| Performance Chemicals |  | Refining Solutions |  | Chemetall Surface Treatment |  | Reportable Segments Total |  | All Other |  | Corporate |  | Consolidated Total
Nine Months Ended September 30, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 415,419 |  |  | $ | 144,910 |  |  | $ | 148,344 |  |  | $ | 708,673 |  |  | $ | 29,540 |  |  | $ | (7,508 | ) |  | $ | 730,705 |
Depreciation and amortization | (93,608 | ) |  | (25,397 | ) |  | (57,567 | ) |  | (176,572 | ) |  | (16,867 | ) |  | (6,933 | ) |  | (200,372 | )
Utilization of inventory markup(a) | (79,239 | ) |  | — |  |  | (20,030 | ) |  | (99,269 | ) |  | (3,029 | ) |  | — |  |  | (102,298 | )
Restructuring and other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,804 |  |  | 6,804 |
Acquisition and integration related costs | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (126,487 | ) |  | (126,487 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (100,986 | ) |  | (100,986 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (48,171 | ) |  | (48,171 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5,900 |  |  | 5,900 |
Other(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,441 | ) |  | (4,441 | )
Net income (loss) attributable to Albemarle Corporation | $ | 242,572 |  |  | $ | 119,513 |  |  | $ | 70,747 |  |  | $ | 432,832 |  |  | $ | 9,644 |  |  | $ | (281,822 | ) |  | $ | 160,654 |
Nine Months Ended September 30, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjusted EBITDA | $ | 232,668 |  |  | $ | 189,259 |  |  | $ | — |  |  | $ | 421,927 |  |  | $ | 63,482 |  |  | $ | (60,087 | ) |  | $ | 425,322 |
Depreciation and amortization(c) | (37,742 | ) |  | (25,351 | ) |  | — |  |  | (63,093 | ) |  | (10,279 | ) |  | (1,807 | ) |  | (75,179 | )
Restructuring and other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (20,625 | ) |  | (20,625 | )
Acquisition and integration related costs | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (15,104 | ) |  | (15,104 | )
Interest and financing expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (26,255 | ) |  | (26,255 | )
Income tax expense | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (46,700 | ) |  | (46,700 | )
Loss from discontinued operations (net of tax) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (68,473 | ) |  | (68,473 | )
Non-operating pension and OPEB items | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14,141 | ) |  | (14,141 | )
Other(b) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7,021 | ) |  | (7,021 | )
Net income (loss) attributable to Albemarle Corporation | $ | 194,926 |  |  | $ | 163,908 |  |  | $ | — |  |  | $ | 358,834 |  |  | $ | 53,203 |  |  | $ | (260,213 | ) |  | $ | 151,824 |

63

Table of Contents

(a) | In connection with the acquisition of Rockwood, the Company valued Rockwood’s existing inventory at fair value as of the Acquisition Closing Date, which resulted in a markup of the underlying net book value of the inventory totaling approximately $103 million. The inventory markup is being expensed over the estimated remaining selling period. For the nine-month period ended September 30, 2015, $75.4 million was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $26.9 million, related to the utilization of the inventory markup.

(b) | Financing-related fees expensed in connection with the acquisition of Rockwood.

(c) | Excludes discontinued operations.

Performance Chemicals
Performance Chemicals segment net sales for the nine-month period ended September 30, 2015 were $1.2 billion, up $368.6 million, or 43%, in comparison to the same period in 2014. The increase was driven mainly by the acquisition of Rockwood, $25.3 million of favorable PCS volumes and $10.5 million of favorable Bromine price impacts, partly offset by $10.3 million of unfavorable Bromine volumes and $22.9 million of unfavorable impacts from currency translation. Adjusted EBITDA for Performance Chemicals was up 79%, or $182.8 million, to $415.4 million for the nine-month period ended September 30, 2015, compared to the same period in 2014, due to the acquisition of Rockwood, higher overall sales volume and favorable pricing impacts offset partly by unfavorable impacts of currency translation.
Refining Solutions
Refining Solutions segment net sales for the nine-month period ended September 30, 2015 were $528.8 million, a decrease of $89.8 million, or 15%, compared to the nine-month period ended September 30, 2014. This decrease was due to $61.4 million of unfavorable Clean Fuels Technologies volumes due to customer demand, $12.8 million unfavorable Clean Fuels Technology and Heavy Oil Upgrading pricing impacts due to product and customer mix, and $26.1 million of unfavorable impacts from currency translation. Refining Solutions adjusted EBITDA decreased 23%, or $44.3 million, to $144.9 million for the nine-month period ended September 30, 2015 in comparison to the corresponding period of 2014. This decrease was due primarily to lower overall sales, unfavorable pricing and mix, and unfavorable impacts of currency translation partially offset by $12.6 million in favorable pricing on raw materials and natural gas.
Chemetall Surface Treatment
Arising from the acquisition of Rockwood, Chemetall Surface Treatment segment net sales and adjusted EBITDA for the nine-month period ended September 30, 2015 were $617.2 million, and $148.3 million, respectively.
All Other
All Other net sales for the nine-month period ended September 30, 2015 were $338.0 million, a decrease of $34.1 million, or 9%, compared to the nine-month period ended September 30, 2014. The decrease was driven mainly by $66.5 million of unfavorable Fine Chemistry Services volumes due to timing of projects, and $25.9 million of unfavorable impacts from currency translation impacts, partially offset by the acquisition of Rockwood. All Other adjusted EBITDA was down 53%, or $33.9 million, for the nine-month period ended September 30, 2015 in comparison to the corresponding period of 2014. This decrease was due primarily to lower overall sales and unfavorable impacts from currency translation, partially offset by the acquisition of Rockwood.
Corporate
Corporate adjusted EBITDA was a loss of $7.5 million for the nine-month period ended September 30, 2015, a decrease of $52.6 million from the corresponding period of 2014. The change was due mainly to $54.1 million of foreign currency translation gains and achieved synergies partially offset by the acquisition of Rockwood. The foreign translation gains are primarily related to cash denominated in U.S. Dollars held by foreign subsidiaries where the European Union Euro serves as the functional currency.
Financial Condition and Liquidity
Overview
The principal uses of cash in our business generally have been capital investments, funding working capital, acquisitions and repayment of debt. We also make contributions to our defined benefit pension plans, pay dividends to our shareholders and repurchase shares of our common stock. Historically, cash to fund the needs of our business has been principally provided by cash from operations, debt financing and equity issuances.
We are continually focused on working capital efficiency particularly in the areas of accounts receivable and inventory. We anticipate that cash on hand, cash provided by operating activities and long-term borrowings will be sufficient to pay our operating expenses, satisfy debt service obligations, fund capital expenditures and other investing activities, fund pension contributions and pay dividends for the foreseeable future.
64

Table of Contents
Cash Flow
During the first nine months of 2015, cash on hand, cash provided by operations, a return of capital from an unconsolidated investment and proceeds from borrowings funded $2.1 billion for acquisitions, $164.6 million of capital expenditures for plant, machinery and equipment, and dividends to shareholders of $86.8 million. Our operations provided $316.9 million of cash flows during the first nine months of 2015, as compared to $430.5 million for the first nine months of 2014. Overall, our cash and cash equivalents decreased by approximately $2.3 billion to $234.5 million at September 30, 2015, down from $2.5 billion at December 31, 2014.
Net current assets were $398.4 million and $2.21 billion at September 30, 2015 and December 31, 2014, respectively, with the decrease being largely due to lower cash and cash equivalents in connection with acquisitions in 2015. Other changes in the components of net current assets are due to the timing of the sale of goods and other normal transactions leading up to the balance sheet dates and are not the result of any policy changes by the Company, nor do they reflect any change in either the quality of our net current assets or our expectation of success in converting net working capital to cash in the normal course of business.
Capital expenditures for the nine-month period ended September 30, 2015 of $164.6 million were associated with property, plant and equipment additions. We expect our capital expenditures to approximate $234 million in 2015 for capacity increases, cost reduction and continuity of operations projects.
On February 24, 2015, we increased our quarterly dividend rate to $0.29 per share, a 5% increase from the quarterly rate of $0.275 per share paid in 2014.
During the first nine months of 2015, we incurred $120.5 million of acquisition and integration related costs directly related to the acquisition of Rockwood (mainly consisting of advisory fees, costs to achieve synergies, relocation costs, and other integration costs) and $6.0 million of costs in connection with other significant projects. We currently estimate incurring additional acquisition and integration related costs of approximately $80 million through 2016 in connection with the acquisition of Rockwood.
On February 19, 2015, Verition Multi-Strategy Master Fund Ltd and Verition Partners Master Fund Ltd, who collectively owned approximately 882,000 shares of Rockwood common stock immediately prior to the Merger, commenced an action in the Delaware Chancery Court seeking appraisal of their shares of Rockwood common stock pursuant to Delaware General Corporation Law § 262. These shareholders exercised their right not to receive the Merger Consideration which was comprised of (i) $50.65 in cash, without interest, and (ii) 0.4803 of a share of Albemarle common stock, for each share of Rockwood common stock owned by such shareholders. Following the Merger, these shareholders ceased to have any rights with respect to their Rockwood shares, except for their rights to seek an appraisal of the cash value of their Rockwood shares under Delaware law. On March 16, 2015, Albemarle, on behalf of Rockwood, filed an Answer and Verified List in response to the appraisal petition. On November 2, 2015, the court granted the parties’ jointly stipulated amended scheduling order, which set forth dates for fact and expert discovery, as well as trial. Fact discovery has commenced and remains ongoing, and the Court has set a date of June 27, 2016 for trial on the merits. While Albemarle intends to vigorously defend against this action, the outcome of the appraisal process cannot be predicted with any certainty at this time. Included in Accrued expenses in our condensed consolidated balance sheet at September 30, 2015 is an estimated liability of $74.9 million in connection with this portion of the Merger Consideration.
At September 30, 2015 and December 31, 2014, our cash and cash equivalents included $222.8 million and $558.7 million, respectively, held by our foreign subsidiaries. The majority of these foreign cash balances are associated with earnings that we have asserted are indefinitely invested and which we plan to use to support our continued growth plans outside the U.S. through funding of capital expenditures, acquisitions, research, operating expenses or other similar cash needs of our foreign operations. From time to time, we repatriate cash from our foreign subsidiaries to the U.S. for normal operating needs through intercompany dividends, but only from subsidiaries whose earnings we have not asserted to be indefinitely invested or whose earnings qualify as “previously taxed income” as defined by the Internal Revenue Code. For the three-month and nine-month periods ended September 30, 2015, we repatriated approximately $3.5 million and $122.4 million of cash, respectively, as part of these foreign cash repatriation activities. For the three-month and nine-month periods ended September 30, 2014, we repatriated approximately $2.0 million and $8.0 million of cash, respectively, as part of these foreign cash repatriation activities. With regard to the access of internal cash from Albemarle, Rockwood and their respective subsidiaries to help fund the Merger, the structure implemented did not impact the indefinite investment assertion of Albemarle as no taxes were triggered in the movements of Albemarle’s cash. With regard to the acquisition of Rockwood, the Company’s initial purchase price accounting included tax liabilities related to the repatriation of cash that occurred in the first quarter of 2015. Included in deferred tax liabilities at September 30, 2015, is $96.8 million related to the expected future repatriation of prior period earnings of Rockwood that we have not asserted to be indefinitely invested and plan to repatriate in 2015. Substantially all future earnings of Rockwood have been elected to be indefinitely invested.
65

Table of Contents
While we continue to closely monitor our cash generation, working capital management and capital spending in light of continuing uncertainties in the global economy, we believe that we will continue to have the financial flexibility and capability to opportunistically fund future growth initiatives. Additionally, we anticipate that future capital spending including business acquisitions, share repurchases and other cash outlays should be financed primarily with cash flow provided by operations and cash on hand, with additional cash needed, if any, provided by borrowings. The amount and timing of any additional borrowings will depend on our specific cash requirements.
Long-Term Debt
The cash consideration paid in connection with the acquisition of Rockwood was funded with proceeds from senior notes we issued in 2014 and borrowings in January 2015 consisting of the following: (a) $1.0 billion under our August 15, 2014 term loan credit agreement (the “August 2014 Term Loan Agreement”); (b) $800.0 million under a senior unsecured cash bridge facility (the “Cash Bridge Facility”); and (c) $250.0 million under our revolving credit agreement (the “February 2014 Credit Agreement”). In the first quarter of 2015, amounts borrowed under the August 2014 Term Loan Agreement, Cash Bridge Facility and February 2014 Credit Agreement in connection with the Rockwood acquisition were repaid in full. Such repayments were made with a combination of existing cash, cash acquired from Rockwood, cash from operations and borrowings under our commercial paper program.
Upon completion of the Rockwood acquisition, we assumed Rockwood’s senior notes with an aggregate principal amount of $1.25 billion. These senior notes bore interest at a rate of 4.625% payable semi-annually on April 15 and October 15 of each year, and had a scheduled maturity of October 15, 2020. Under the terms of the indenture governing the 4.625% senior notes, as amended and supplemented, on October 15, 2015, our wholly-owned subsidiary, Rockwood Specialties Group, Inc., redeemed all of the outstanding 4.625% senior notes at a redemption price equal to 103.469% of the principal amount of the notes, representing a premium of $43.3 million, plus accrued and unpaid interest to the redemption date. The guarantees of the 4.625% senior notes and the 2014 Senior Notes were released upon repayment of the 4.625% senior notes. We expect to recognize a loss on early extinguishment of the 4.625% senior notes of approximately $5.4 million in the fourth quarter of 2015.
The 4.625% senior notes were repaid with proceeds from a new term loan agreement the Company entered into with JPMorgan Chase Bank, N.A. (the “Administrative Agent”) and certain other lenders on September 14, 2015 (the “September 2015 Term Loan Agreement”). Initial borrowings under the September 2015 Term Loan Agreement, which occurred on October 15, 2015, consisted of a 364-day term loan facility in an aggregate principal amount of $300 million (the “364-Day Facility”) and a five-year term loan facility in an aggregate principal amount of $950 million (the “Five-Year Facility”). Borrowings under the facilities bear interest equal to, at the option of the Company: (a) the London Inter-Bank Offered Rate (“LIBOR”) plus a margin ranging from 1.000% to 1.875% per annum depending upon the long-term, unsecured, senior, non-credit enhanced debt rating of the Company, or (b) a base rate (defined as the highest of (i) the Federal Funds Rate plus 0.50%; (ii) the rate of interest in effect for such day as publicly announced from time to time by the Administrative Agent as its “prime rate”; or (iii) one-month LIBOR plus 1.00%) plus a margin of 0.000% to 0.875% per annum depending upon the long-term, unsecured, senior, non-credit enhanced debt rating of the Company. As of October 15, 2015, the date of initial funding, the interest rate on both facilities was LIBOR plus 1.375%.
Borrowings under the 364-Day Facility are required to be repaid 364 days after initial funding. Borrowings under the Five-Year Facility are required to be repaid in equal quarterly installments on the last business day of each of March, June, September and December, beginning with September 30, 2016, and ending with the last such day to occur prior to the fifth anniversary after initial funding (each a “Payment Date”), in an aggregate principal amount equal to (a) in the case of each Payment Date occurring on or after the first anniversary and prior to the second anniversary of initial funding, 1.25% of the aggregate principal amount of such loans, and (b) in the case of each Payment Date occurring on or after the second anniversary of initial funding, equal to 2.5% of the aggregate principal amount of such loans. On the fifth anniversary after initial funding, any remaining amounts outstanding under the Five-Year Facility become due and payable. Additionally, the agreement requires that proceeds from the Company’s previously announced intended divestitures of its Minerals, Fine Chemistry Services and Metal Sulfides businesses must be used to repay amounts outstanding under the September 2015 Term Loan Agreement. Borrowings under the September 2015 Term Loan Agreement are subject to customary affirmative and negative covenants, including a maximum leverage ratio requirement that is aligned with the maximum leverage ratio requirement of our February 2014 Credit Agreement.
Our $325.0 million aggregate principal amount of senior notes, issued on January 20, 2005 and bearing interest at a rate of 5.10%, matured and were repaid on February 1, 2015. We had the following other senior notes outstanding as of September 30, 2015:

• | €700.0 million of 1.875% senior notes, due on December 8, 2021;

• | $250.0 million of 3.00% senior notes, due on December 1, 2019;

66

Table of Contents

• | $350.0 million of 4.50% senior notes, due on December 15, 2020;

• | $425.0 million of 4.15% senior notes, due on December 1, 2024; and

• | $350.0 million of 5.45% senior notes, due on December 1, 2044.

These senior notes are senior unsecured obligations and rank equally with all of our other senior unsecured indebtedness from time to time outstanding, and are effectively subordinated to any of our existing or future secured indebtedness and to the existing and future indebtedness of our subsidiaries. As is customary for such long-term debt instruments, each of these senior notes has terms that allow us to redeem the notes before their maturity, in whole at any time or in part from time to time, at a redemption price equal to the greater of (i) 100% of the principal amount of the senior notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semi-annual basis using the comparable government rate (as defined in the indentures governing the senior notes) plus between 25 and 40 basis points, depending on the note, plus, in each case, accrued interest thereon to the date of redemption. Holders may require us to purchase such notes at 101% upon a change of control triggering event, as defined in the indentures. These senior notes are subject to typical events of default, including bankruptcy and insolvency events, nonpayment and the acceleration of certain subsidiary indebtedness of $40 million or more caused by a nonpayment default.
Our February 2014 Credit Agreement, as amended, provides for borrowings of up to $1.0 billion, and matures on February 7, 2020. Borrowings bear interest at variable rates based on the London Inter-Bank Offered Rate for deposits in the relevant currency plus an applicable margin which ranges from 1.000% to 1.700%, depending on the Company’s credit rating from Standard & Poor’s Ratings Services, Moody’s Investors Services and Fitch Ratings. The applicable margin on the facility was 1.300% as of September 30, 2015. There were no borrowings outstanding under the February 2014 Credit Agreement as of September 30, 2015.
Borrowings under the February 2014 Credit Agreement are conditioned upon compliance with the following covenants: (a) consolidated funded debt, as defined in the agreement, must be less than or equal to 3.50 times consolidated EBITDA, as defined in the agreement, which reflects adjustments for certain non-recurring or unusual items such as restructuring charges, facility divestiture charges and other significant non-recurring items (herein “consolidated adjusted EBITDA” or “adjusted EBITDA”) as of the end of any fiscal quarter; (b) with the exception of certain liens as specified in the agreement, liens may not attach to assets when the aggregate amount of all indebtedness secured by such liens plus unsecured subsidiary indebtedness, other than indebtedness incurred by our subsidiaries under the February 2014 Credit Agreement, would exceed 20% of consolidated net worth, as defined in the agreement; and (c) with the exception of certain indebtedness as specified in the agreement, subsidiary indebtedness may not exceed the difference between 20% of consolidated net worth, as defined in the agreement, and indebtedness secured by liens permitted under the agreement. On August 15, 2014, certain amendments were made to the February 2014 Credit Agreement which includes, among other things, an increase in the maximum leverage ratio (as described above) from 3.50 to 4.50 for the first four quarters following the completion of the acquisition of Rockwood, stepping down by 0.25 on a quarterly basis thereafter until reaching 3.50.
On May 29, 2013, we entered into agreements to initiate a commercial paper program on a private placement basis under which we may issue unsecured commercial paper notes (the “Commercial Paper Notes”) from time-to-time up to a maximum aggregate principal amount outstanding at any time of $750.0 million. The proceeds from the issuance of the Commercial Paper Notes are expected to be used for general corporate purposes, including the repayment of other debt of the Company. Our February 2014 Credit Agreement is available to repay the Commercial Paper Notes, if necessary. Aggregate borrowings outstanding under the February 2014 Credit Agreement and the Commercial Paper Notes will not exceed the $1.0 billion current maximum amount available under the February 2014 Credit Agreement. The Commercial Paper Notes will be sold at a discount from par, or alternatively, will be sold at par and bear interest at rates that will vary based upon market conditions at the time of issuance. The maturities of the Commercial Paper Notes will vary but may not exceed 397 days from the date of issue. The definitive documents relating to the commercial paper program contain customary representations, warranties, default and indemnification provisions. At September 30, 2015, we had $273.0 million of Commercial Paper Notes outstanding bearing a weighted-average interest rate of approximately 0.84% and a weighted-average maturity of 21 days. The commercial paper notes are classified as Current portion of long-term debt in our condensed consolidated balance sheets at September 30, 2015 and December 31, 2014.
The non-current portion of our long-term debt was $3.6 billion at September 30, 2015 and $2.2 billion at December 31, 2014. In addition, at September 30, 2015, we had the ability to borrow $727.0 million under our commercial paper program and the February 2014 Credit Agreement, and $149.2 million under other existing lines of credit, subject to various financial covenants under our February 2014 Credit Agreement. We have the ability and intent to refinance our borrowings under our other existing credit lines with borrowings under the February 2014 Credit Agreement, as applicable. Therefore, the amounts outstanding under those credit lines, if any, are classified as long-term debt. We believe that as of September 30, 2015, we were, and currently are, in compliance with all of our debt covenants.
67

Table of Contents
Off-Balance Sheet Arrangements
In the normal course of business with customers, vendors and others, we have entered into off-balance sheet arrangements, including bank guarantees and letters of credit, which totaled approximately $59.3 million at September 30, 2015. None of these off-balance sheet arrangements has, or is likely to have, a material effect on our current or future financial condition, results of operations, liquidity or capital resources.
Other Obligations
Total expected 2015 contributions to our domestic and foreign qualified and nonqualified pension plans, including our SERP, should approximate $18 million. We may choose to make additional pension contributions in excess of this amount. We have made contributions of $13.8 million to our domestic and foreign pension plans (both qualified and nonqualified) during the nine-month period ended September 30, 2015.
The liability related to uncertain tax positions, including interest and penalties, recorded in Other noncurrent liabilities totaled $104.1 million at September 30, 2015 and $25.3 million at December 31, 2014. Related assets for corresponding offsetting benefits recorded in Other assets totaled $24.0 million at September 30, 2015 and $22.1 million at December 31, 2014. The amount included in Other noncurrent liabilities increased as a result of the inclusion of Rockwood’s uncertain tax positions and from purchase price accounting adjustments to Rockwood’s historic positions. We cannot estimate the amounts of any cash payments associated with these liabilities for the remainder of 2015 or the next twelve months, and we are unable to estimate the timing of any such cash payments in the future at this time. Based on management’s continued evaluation of uncertain tax positions acquired in the Rockwood transaction and the progress of various tax audits and other tax matters, we believe that it is reasonably possible that a material change in our uncertain tax positions, which is not currently estimable, could occur within twelve months of the reporting date.
We are subject to federal, state, local and foreign requirements regulating the handling, manufacture and use of materials (some of which may be classified as hazardous or toxic by one or more regulatory agencies), the discharge of materials into the environment and the protection of the environment. To our knowledge, we are currently complying and expect to continue to comply in all material respects with applicable environmental laws, regulations, statutes and ordinances. Compliance with existing federal, state, local and foreign environmental protection laws is not expected to have a material effect on capital expenditures, earnings or our competitive position, but the costs associated with increased legal or regulatory requirements could have an adverse effect on our results.
Among other environmental requirements, we are subject to the federal Superfund law, and similar state laws, under which we may be designated as a potentially responsible party (“PRP”) and may be liable for a share of the costs associated with cleaning up various hazardous waste sites. Management believes that in cases in which we may have liability as a PRP, our liability for our share of cleanup is de minimis. Further, almost all such sites represent environmental issues that are quite mature and have been investigated, studied and in many cases settled. In de minimis situations, our policy generally is to negotiate a consent decree and to pay any apportioned settlement, enabling us to be effectively relieved of any further liability as a PRP, except for remote contingencies. In other than de minimis PRP matters, our records indicate that unresolved PRP exposures should be immaterial. We accrue and expense our proportionate share of PRP costs. Because management has been actively involved in evaluating environmental matters, we are able to conclude that the outstanding environmental liabilities for unresolved PRP sites should not have a material adverse effect upon our results of operations or financial condition.
Liquidity Outlook
We anticipate that cash on hand and cash provided by operating activities, divestitures and borrowings will be sufficient to pay our operating expenses, satisfy debt service obligations, fund any capital expenditures and share repurchases, make pension contributions and pay dividends for the foreseeable future. With the acquisition of Rockwood now closed, our main focus over the next three years, in terms of uses of cash, will be deleveraging to restore our borrowings to more normal levels and capturing synergies related to the integration of Rockwood. This may include refinancing certain of our existing outstanding debt if market conditions are favorable. Additionally, we will continue to evaluate the merits of any opportunities that may arise for acquisitions of businesses or assets, which may require additional liquidity.
Our cash flows from operations may be negatively affected by adverse consequences to our customers and the markets in which we compete as a result of moderating global economic conditions and reduced capital availability. Additionally, realization and timing of anticipated divestitures could have a significant impact on our cash flows in any given period.
While we maintain business relationships with a diverse group of financial institutions, an adverse change in their credit standing could lead them to not honor their contractual credit commitments, decline funding under existing but uncommitted lines of credit, not renew their extensions of credit or not provide new financing. While the global corporate bond and bank loan markets remain strong, periods of elevated uncertainty related to global economic and/or geopolitical concerns may limit
68

Table of Contents
efficient access to such markets for extended periods of time. If such concerns heighten, we may incur increased borrowing costs and reduced credit capacity as our various credit facilities mature. When the U.S. Federal Reserve or similar national reserve banks in other countries decide to tighten the monetary supply in response, for example, to improving economic conditions, we may incur increased borrowing costs as interest rates increase on our variable rate credit facilities, as our various credit facilities mature or as we refinance any maturing fixed rate debt obligations.
Overall, with generally strong cash-generative businesses and no significant long-term debt maturities before 2019, we believe we have and will maintain a solid liquidity position.
We had cash and cash equivalents totaling $234.5 million as of September 30, 2015, of which $222.8 million is held by our foreign subsidiaries. This cash represents an important source of our liquidity and is invested in short-term investments including time deposits and readily marketable securities with relatively short maturities. Substantially all of this cash is held, and intended for use, outside of the U.S. We anticipate that any needs for liquidity within the U.S. in excess of our cash held in the U.S. can be readily satisfied with borrowings under our existing U.S. credit facilities or our commercial paper program.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements, see Item 1 Financial Statements – Note 18, “Recently Issued Accounting Pronouncements.”

Item 3. | Quantitative and Qualitative Disclosures About Market Risk.

There have been no significant changes in our interest rate risk, foreign currency exchange rate exposure, marketable securities price risk or raw material price risk from the information we provided in our Annual Report on Form 10-K for the year ended December 31, 2014.
We had variable interest rate borrowings of $377.7 million outstanding at September 30, 2015, bearing a weighted average interest rate of 0.90% and representing approximately 10% of our total outstanding debt. A hypothetical 10% change (approximately 9 basis points) in the interest rate applicable to these borrowings would change our annualized interest expense by approximately $0.3 million as of September 30, 2015. We may enter into interest rate swaps, collars or similar instruments with the objective of reducing interest rate volatility relating to our borrowing costs.
Our financial instruments which are subject to foreign currency exchange risk consist of foreign currency forward contracts with an aggregate notional value of $423.9 million and with a fair value representing a net liability position of approximately $0.5 million at September 30, 2015. Fluctuations in the value of these contracts are generally offset by the value of the underlying exposures being hedged. We conducted a sensitivity analysis on the fair value of our foreign currency hedge portfolio assuming an instantaneous 10% change in select foreign currency exchange rates from their levels as of September 30, 2015, with all other variables held constant. A 10% appreciation of the U.S. Dollar against foreign currencies that we hedge would result in a decrease of approximately $26.6 million in the fair value of our foreign currency forward contracts. A 10% depreciation of the U.S. Dollar against these foreign currencies would result in an increase of approximately $24.4 million in the fair value of our foreign currency forward contracts. The sensitivity of the fair value of our foreign currency hedge portfolio represents changes in fair values estimated based on market conditions as of September 30, 2015, without reflecting the effects of underlying anticipated transactions. When those anticipated transactions are realized, actual effects of changing foreign currency exchange rates could have a material impact on our earnings and cash flows in future periods.

Item 4. | Controls and Procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
As previously noted, we completed the acquisition of Rockwood on January 12, 2015. We continue to analyze Rockwood’s systems of disclosure controls and procedures and internal controls over financial reporting and to integrate them within our framework of controls. During the third quarter, we implemented new software for the processing and reporting of payroll and related costs in the United States. The purpose of the change was to increase the overall efficiency of our processes.
69

Table of Contents
The continued integration of Rockwood’s financial systems and organizations, in addition to the implementation of new software for processing and reporting the Company’s payroll and related costs, represent a change in internal controls over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f)) for the third quarter that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
The Company anticipates excluding Rockwood processes from the scope of management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2015, the date of management’s next assessment of the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION

Item 1. | Legal Proceedings.

On July 3, 2006, we received a Notice of Violation (the “2006 NOV”) from the U.S. Environmental Protection Agency Region 4 (“EPA”) regarding the implementation of the Pharmaceutical Maximum Achievable Control Technology (“PharmaMACT”) standards at our former plant in Orangeburg, South Carolina. The alleged violations involved (i) the applicability of the specific regulations to certain intermediates manufactured at the plant, (ii) failure to comply with certain reporting requirements, (iii) improper evaluation and testing to properly implement the regulations and (iv) the sufficiency of the leak detection and repair program at the plant. In the second quarter of 2011, the Company was served with a complaint by the EPA in the U.S. District Court for the District of South Carolina, based on the alleged violations set out in the 2006 NOV seeking civil penalties and injunctive relief. The complaint was subsequently amended to add the State of South Carolina as a plaintiff. On June 11, 2014, we entered into a consent decree with the EPA and the South Carolina Department of Health and Environmental Control (“DHEC”) to settle this matter. Pursuant to the consent decree, in the third quarter of 2014 we paid a civil penalty to the EPA in the amount of approximately $332,000. A civil penalty of approximately $112,000 was waived pursuant to the consent decree and we will not be required to pay this amount to the DHEC.
On February 19, 2015, Verition Multi-Strategy Master Fund Ltd and Verition Partners Master Fund Ltd, who collectively owned approximately 882,000 shares of Rockwood common stock immediately prior to the Merger, commenced an action in the Delaware Chancery Court seeking appraisal of their shares of Rockwood common stock pursuant to Delaware General Corporation Law § 262. These shareholders exercised their right not to receive the Merger Consideration which was comprised of (i) $50.65 in cash, without interest, and (ii) 0.4803 of a share of Albemarle common stock, for each share of Rockwood common stock owned by such shareholders. Following the Merger, these shareholders ceased to have any rights with respect to their Rockwood shares, except for their rights to seek an appraisal of the cash value of their Rockwood shares under Delaware law. On March 16, 2015, Albemarle, on behalf of Rockwood, filed an Answer and Verified List in response to the appraisal petition. On November 2, 2015, the court granted the parties’ jointly stipulated amended scheduling order, which set forth dates for fact and expert discovery, as well as trial. Fact discovery has commenced and remains ongoing, and the Court has set a date of June 27, 2016 for trial on the merits. While Albemarle intends to vigorously defend against this action, the outcome of the appraisal process cannot be predicted with any certainty at this time.
In addition, we are involved from time to time in legal proceedings of types regarded as common in our business, including administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability, breach of contract liability and premises liability litigation. Where appropriate, we may establish financial reserves for such proceedings. We also maintain insurance to mitigate certain of such risks. Additional information with respect to this Item 1 is contained in Note 10 to the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Item 1A. | Risk Factors.

While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. The risk factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2014 describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our results of operations and our financial condition. We do not believe that there have been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds.

NONE
70

Table of Contents

Item 6. | Exhibits.

(a) Exhibits

10.1 |  |  | Third Amendment to Credit Agreement, dated as of September 14, 2015, among Albemarle Corporation and Albemarle Global Finance Company SCA, as borrowers, the several banks and other financial institutions as may from time to time become parties thereto, and Bank of America, N.A., as administrative agent.
10.2 |  |  | Term Loan Agreement, dated as of September 14, 2015, among Albemarle Corporation, as borrower, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent [filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K (No. 1-12658) filed on September 14, 2015, and incorporated herein by reference].
31.1 |  |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a).
31.2 |  |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(a).
32.1 |  |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350.
32.2 |  |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350.
101 |  |  | Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended June 30, 2015, furnished in XBRL (eXtensible Business Reporting Language)).

Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income for the three months and nine months ended September 30, 2015 and 2014, (ii) the Consolidated Statements of Comprehensive Income (Loss) for the three months and nine months ended September 30, 2015 and 2014, (iii) the Condensed Consolidated Balance Sheets at September 30, 2015 and December 31, 2014, (iv) the Consolidated Statements of Changes in Equity for the nine months ended September 30, 2015 and 2014, (v) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014 and (vi) the Notes to the Condensed Consolidated Financial Statements.
71

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  | ALBEMARLE CORPORATION
|  |  | (Registrant)
Date: | November 6, 2015 |  | By: |  | /S/ S COTT A. T OZIER
|  |  |  |  | Scott A. Tozier
|  |  |  |  | Senior Vice President and Chief Financial Officer
|  |  |  |  | (principal financial officer)

72